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Abstract 
The optimisation of problematic reaction steps in the synthesis of a drug compound is crucial 
for pharmaceutical process development. In recent traditions, this has carried out using design of 
experiments (DoE), which shows the key reaction variables and provides optimum reaction 
conditions. The process can require a lot of experiments and be time and resource consuming. The 
speed of optimisation experiments can be increased by using automated platforms complete with 
online analysis, which carry out reactions and acquire analytical samples without any human 
intervention. If these experiments can be carried out in continuous reactors then they will benefit 
from faster kinetics, enhanced heat and mass transfer, improved safety and higher productivity over 
their batch counterparts. 
An automated self-optimising flow reactor combines a continuous reactor with online 
analysis and feedback loop. The feedback loop contains full computerised control and monitoring 
of all equipment as well as a minimising algorithm, which will use the results from the online 
analysis to predict new optimum conditions. The technique has been shown to optimise the 
synthesis of small organic compounds but has, so far, yet to be widely used in pharmaceutical 
process development. 
This thesis has improved self-optimising technologies in order to make it a useful technique 
in pharmaceutical process development. First, the final bond forming step in the synthesis of an 
active pharmaceutical ingredient was optimised for yield. Studies were primarily carried out on a 
model compound in order to establish the correct reactor setup before transferring to the active 
compound, which found an optimum yield of 89%. The work also provided mechanistic evidence 
for generation of impurities. 
Next, response surface models were successfully fitted to the data obtained from a branch 
and fit algorithm optimisation of a Claisen-Schmidt condensation. In depth statistical calculations 
show how DoE models can be generated from self-optimisation data with good fit and 
predictability (R2 > 0.95, Q2 > 0.90), and with the aid of commercial DoE software. 
Further work developed the use of direct mass spectrometry (MS) as the online analytical 
method. The short method times and real-time analysis of MS allowed a steady state detection 
function to be built, followed by a linear calibration model of all the species in the amidation of a 
 7 
methyl ester. The reaction was optimised for yield using branch and fit algorithm, and DoE, with 
excellent agreement between the two techniques in both optimum conditions and responses. 
Finally, changes were made to the optimisation program to reduce the amount of material 
required for automated optimisations. Reaction pulses of sub-reactor volumes were pumped 
through the reactor, dispersed in a continuous phase of miscible solvent. Residence time 
distribution experiments were carried out to characterise the dispersion of the reactor and calculate 
the minimum reactor pulse volume. Optimisations were primarily carried out using pattern search 
algorithm and a multi-objective evolutionary algorithm, the latter of which generated a three target 
function optimum, reducing the amount of waste by 81%. 
Overall this work has shown how self-optimisation can be a valuable tool for pharmaceutical 
process development. The existing technique has been improved by demonstrating its use in the 
synthesis of pharmaceutical compounds, combining it with existing DoE techniques, adding new 
forms of online analysis, and reducing the amount of material required to deliver a multi-target 
optimum. 
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1. Introduction 
The pharmaceutical industry relies on innovative and novel technological advances in the 
chemical sciences to drive forward drug discovery and development. Medicinal chemists discover 
chemical compounds for new medicines and their structure scrutinised until the active 
pharmaceutical ingredient (API) is decided. Next, the company is heavily reliant on the research of 
process development scientists to redesign and improve the synthetic route in order to create a 
robust and efficient manufacturing process.1 One aspect of process development is the optimisation 
of problematic reaction steps, which is typically carried out using design of experiments (DoE).2, 3 
Whilst this approach is highly effective at improving chemical understanding and finding optimal 
conditions, there is always scope to find better techniques. 
In order to facilitate safe and efficient manufacture, continuous flow processing has been 
seen as an attractive technology for API manufacture.4-7 Flow reactors have several unique 
characteristics that allow for more efficient syntheses over batch counterparts. One particular 
aspect is the ease of integration of online analytics and equipment automation. The combination of 
this automated technology with a feedback loop containing an optimising algorithm creates a “self-
optimising” reactor, which can carry out multiple experiments and optimise a reaction without any 
user intervention (Figure 1.1).8-10 The concept was first introduced by Krishdnadasan et al. for the 
highly selective synthesis of CdSe nanoparticles,11 and has since been developed by the groups of 
Jensen12-14 and Poliakoff15-18 for the synthesis of simple organic molecules. In parallel to the work 
in this thesis, the field of self-optimisation has benefitted from further development from Jensen19-21 
and Poliakoff22, 23 with additional contributions from other groups.24-28 
 
Figure 1.1 Schematic of a self-optimising flow reactor 
Pump Reactor Analysis
Feedback 
Loop
ResponseControl
Reagents Products
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This thesis will explore the use of self-optimisation as a technique for improving and 
optimising troublesome steps in pharmaceutical process development. This chapter will introduce 
this subject with a literature review that explores the recent advances in flow chemistry, online 
analysis and automated optimisations. 
1.1 Flow Chemistry 
In batch reactors, reagents are added either instantaneously or with slow controlled addition 
in order to control exotherms. If the reaction needs to be heated, the temperature will change over a 
period of time and it can take minutes to hours to achieve the desired temperature depending on the 
reaction scale and temperature. The maximum temperature that the reaction can be heated to is also 
limited to the boiling point of the solvent.  Similarly, cooling a reaction back to room temperature 
occurs over a period of time and sometimes this is required before a reaction can be quenched. 
Very fast exothermic reactions need to be cooled, sometimes to cryogenic temperatures in order to 
slow down the reaction to controllable rates and prevent runaway reactions. Overall batch reactions 
suffer from a lack of control and non-uniform reaction conditions as well as slow reaction kinetics. 
Flow reactors have smaller dimensions and volumes, resulting in a higher surface area to 
volume ratio, which results in more efficient energy transfer. The smaller volumes also allow for 
the safe operation of elevated pressures whereby it is possible to heat a reaction above the boiling 
point of the solvent and even pump molten reaction mixtures.29-31 Efficient heat transfer enables 
typically cryogenic transformations to be carried out at warmer, and more efficient, temperatures;32-
34 including “flash chemistry” with sub-second reaction times.35, 36 Highly efficient energy transfer 
has also been applied to increased performance with non-thermal energy sources.37 The safety of 
reactions is also increased due to the decrease in exothermic hotspots,38 and lower chemical 
inventory allowing for a lower exposure of highly hazardous reagents.39-44 The surge of academic 
and industrial research into continuous flow chemistry over the past few decades has contributed to 
the advancement of a variety of techniques and technologies that have improved the field 
immensely.45-55 The following sections provide selected examples of these advances. 
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1.1.1 High Energy Transfer 
Chemical reactions in flow can be carried out at more forcing conditions than in batch, 
resulting in improved performance, be that yield, selectivity, rate or productivity. The term was 
derived as “novel process windows” by Hessel et al. in 2009 and has since been used for a variety 
of applications,29-31 most often enhancing performance by carrying out reactions at higher 
temperatures and pressures.50 Elevated pressures are easily achieved by simply forcing the flow 
through an extremely narrow channel in a back pressure regulator. It should be noted that for liquid 
phase reactions, increasing the pressure is unlikely to significantly increase the reaction kinetics but 
simply allows for higher operating temperatures before the reaction boils (Boyle’s Law).  
Borhukova et al. benefitted from novel process windows in the synthesis of rufinamide 
(Scheme 1.1),56 an anticonvulsant used to treat epilepsy in children. The first step used hydrogen 
chloride gas and neat benzyl alcohol 1 to facilitate the efficient synthesis of a benzyl chloride 2 
with water as the only by-product.57 The second step proceeded via a simple substitution between 
the benzyl chloride 1.2 and sodium azide to yield the benzyl azide 1.3. Sodium hydroxide was 
added to prevent formation of the highly toxic and explosive hydrogen azide gas. The last step, a 
Huisgen cycloaddition, typically requires a copper catalyst to control regiochemistry, however with 
process intensification the reaction was carried out catalyst free with excellent yield and 
selectivity.58 A stream of methanol was added to the reaction outlet in order to aid crystallisation, 
which occurred upon standing in the product collection pot. 
 
Scheme 1.1 Synthesis of rufinamide 1.5 under continuous flow conditions, by Borhukova et al. 
The conditions for each step are shown underneath each reaction arrow. Yields were 
improved by using novel process windows.56 
In a similar approach, Snead and Jamison reported the highly atom economic synthesis of 
diphenhydramine hydrochloride 1.8 (Scheme 1.2).59 By introducing the chlorodiphenyl methane 
1.6 and N,N-dimethylethanolamine 1.7 as neat reagents and using high temperatures and pressures, 
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the product 1.8 could be pumped out of the reactor as a molten salt after first reacting with the HCl 
by product in situ. 
 
Scheme 1.2 Continuous flow synthesis of diphenhydramine hydrochloride 1.8. High 
temperatures and pressures enabled the product to be pumped as a molten salt. 
 Improving synthetic methods is not the only benefit of novel process windows; Hone et al. 
showed that through process intensification, multistep kinetic models can be generated by using 
higher forcing conditions rather than longer reaction times. The approach accelerated kinetic model 
development and as such 72 reactions were carried out in 3 hours of total experiment time, which 
were used to fit 8 kinetic parameters.60 
High energy transfer can be used not only for safe operation at high temperatures and 
pressures but also for sudden changes in reactor temperatures, which would not be possible in batch 
due to the lengthy temperature gradients. Gutman et al. carried out the synthesis of sulfoximide 
1.10, an intermediate towards the synthesis of an ATR-kinase inhibitor.61 The combination of azide 
salt and fuming sulfuric acid generated hydrogen azide in situ, which could perform the desired 
functional group transformation with high atom economy. 
 
Scheme 1.3 Formation of sulfoximide 10 under continuous flow conditions. The reaction step 
was carried out at 50 °C followed by an aqueous quench, which needed to be cooled 
rapidly to 0 °C. 
The sulfoximidation reaction was carried out at 50 °C and followed by a quench with ice 
cold water. This required a rapid temperature change to 0 °C, which was easily facilitated using 
two separate continuous reactors and resulted in minimal by product formation. 
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Rapid heat removal has been exploited by the Yoshida group for “flash chemistry” reactions, 
which can be carried out in micro to millisecond time scales.35, 36 For example, with rapid mixing 
and heat removal, it was possible to carry out a desired chemoselective ortho-functionalisation of 
iodophenyl carbamate 1.11 without suffering from a Fries rearrangement (Scheme 1.4).62 In other 
work, it was possible to carry out a Swern oxidation at room temperature with high yields and 
selectivities (Scheme 1.5), a reaction that would ordinarily be performed at -78 °C to control the 
highly exothermic reaction between dimethyl sulfoxide (DMSO) and trifluoroacetic anhydride 
(TFAA).63 These reaction conditions are only possible with the strict control of residence time and 
efficient removal of heat achieved with flow reactors. 
 
Scheme 1.4 Schematic outlining the desired transformation of ortho iodophenyl carbamate 1.11 
with phenyl lithium, then methyl chloroformate to form 1-carbamate-2-ester product 
1.13. In poor mixing reactors, the intermediate 1.12 undergoes Fries’ rearrangement 
to form 1.14 and the undesired 1-carbonate-2-amide product 1.15. The best 
selectivities were achieved at residence times of 330 µs for the first step. 
 
Scheme 1.5 Swern oxidation reaction Scheme . The reaction requires temperatures of -78 °C 
under batch conditions to prevent formation of impurities but was carried out at 
room temperature in flow. 
Energy transfer does not just apply to heat. Photochemical reactions in continuous flow have 
been highly successful because of the short distances photons have to travel to react with the 
reaction media. Arguably the most successful application of continuous photochemistry is 
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converting oxygen to its singlet and triplet states to perform key oxidation steps in the synthesis of 
artemisinin, an effective antimalarial drug.64-67  
 
Scheme 1.6 Reaction Scheme to artemisinin 1.23 from dihydroartemisinic acid 1.20 using a 
combination of oxidation steps using singlet (1.20 to 1.21) and triplet oxygen (1.22 
to 1.23). 
Electrochemical reactions also see an improvement in continuous flow because of the high 
interfacial area between the electrodes and reaction mixture, short distances between electrodes 
allowing for enhanced mass transfer as well as the ability to operate the reactions without 
electrolytes.68, 69 Energy can also be successfully applied to continuous reactors using microwave 
irradiation,70, 71 inductive heating from magnetic fields to heat magnetic particles,72, 73 or sound 
waves to either breakup solid by-products74, 75 or supply energy.76 
1.1.2 Hazardous Chemistries 
The low chemical inventory in continuous flow reactors means that highly hazardous and 
reactive reagents can be safely used at all scales. This is most evident in the use of gases. Increased 
interfacial areas between liquid and gas streams by means of segmented or annular flows means 
that reactions with gases in flow are incredibly efficient with high atom economy and minimal by-
products.41 The disadvantages with gaseous reagents is that its physical state means that it is highly 
reactive and they can be dangerous to use due to specific safety hazards, such as being toxic (F2, 
CO, O3), highly flammable/explosive (O2, H2, CxHy) or simple asphyxiants (N2, CO2). 
Fluorine is a highly reactive element yet is also very important in the synthesis of 
pharmaceuticals and it appears in many APIs or intermediates towards them. Chambers et al. 
developed a stainless steel/nickel falling film reactor for the fluorination of 1,3-dicarbonyl 
substrates and their scale-up.77, 78 A solution of 10% F2 in N2 (v/v) was used because pure F2 gas 
would have uncontrollable reactivity. This type of reactor could then be coupled to an additional 
stream of hydrazine to yield 1,2-pyrazoles.79 
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The synthesis of heterocycles is a potentially dangerous process if the necessary hazards 
have not been addressed. Nitrogen containing heterocycles are popular for commercial explosives 
because they form and then release benign N2 gas upon detonation. Therefore the synthesis of 
nitrogen containing heterocycles is not without its dangers. In the previous section, examples 
showed inorganic azides (M-N3, highly toxic) forming triazole rings by reacting with a terminal 
alkyne.56-58 Disregarding their toxicity, all azides can from the explosive gas hydrogen azide and 
some are explosive in their natural state, either with ignition from sparks or shocks. Deadman et al. 
avoided preparing a stock of tosyl azide 1.25 (explosive, highly toxic) by reacting tosyl chloride 
1.24 with the less hazardous sodium azide, in situ then carrying on to react with a ketone 1.26 to 
form an aza-α-carbonyl compound 1.27. Any unreacted tosyl azide 1.25 could be quenched by a 
mixture of sodium hydroxide with acetylacetone. 
 
Scheme 1.7 Synthesis of aza-α-carbonyl compounds via the in situ formation of tosyl azide 1.25, 
preventing the use of preparing hazardous stock solutions.40 
Formation of hazardous reagents in situ is a commonplace practice for flow chemistry 
because of the ease in which reagent streams and reactor coils can be combined to existing setups. 
For example there have been multiple uses of generating gases in situ for laboratory scale 
applications, avoiding the more intensive task of installing a gas cylinder and the expense of a mass 
flow controller.80 
1.1.3 Multistep Synthesis of Pharmaceuticals Using Automated Flow Reactors 
The modular nature and small footprint of continuous reactors means that it is simple to 
integrate multiple equipment types into one reactor setup. Examples have been shown in the 
previous sections where multiple reaction steps have been integrated for synthesis of hazardous 
reagents40, 80 or desired organic compounds,56-58 however flow technology has advanced to allow 
sophisticated syntheses of organic compounds, all in a single continuous process. This not only 
includes coupling continuous reaction modules but also liquid/liquid separators,81-83 solvent 
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extractors,84-86 by-product scavengers,87 back pressure regulators,88 crystallisers89, 90 and filtration 
devices.91 
 
Scheme 1.8 Continuous flow synthesis of ibuprofen 1.32 by Bogdan et al.93 All steps were 
incorporated into a single process to produce crude 1.32a, which was recrystallised 
in batch. DIB = (diacetoxyiodo)benzene, TMOF = trimethyl orthoformate 
Ley and Baxendale used solid supported reagents and scavenging columns in the multistep 
continuous synthesis of compounds including complex alkaloids.92 This method required no 
isolation or purification steps, however the columns are too expensive to use in any realistic scale 
up and manufacturing process. A more attractive procedure is to optimise each single step to 
minimise excess waste or ensure that it will not interfere in any downstream reactions or processes. 
Bogdan et al. provided one of the first examples of this in their continuous synthesis of ibuprofen 
1.32.93 An excess of TfOH was used for the Friedel-Crafts acylation in the first step, and the DIB 
mediated 1,2-aryl migration in the second to yield the target compound in a 51% yield in 7 min 
(after batch recrystallisation, Scheme 1.8). Snead and Jamison pushed this synthesis further using 
neat reagents wherever possible, inline liquid-liquid separation, continuous crystallisation and 
novel process windows to produce pure 1.32 in an 83% yield in 3 min (Scheme 1.9).94 
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Scheme 1.9 Continuous flow synthesis of ibuprofen 1.32 by Snead and Jamison.94 The first step 
was quenched using aqueous HCl solution then product 1.30 extracted using 
continuous inline separation. The final step featured a combined ester hydrolysis and 
continuous crystallisation to produce pure 1.32b. TMOF = trimethyl orthoformate. 
The danger with multistep continuous flow synthesis is that it relies on the process running 
perfectly. In reality continuous flow can be fraught with potential pitfalls caused by variable 
reagent quality, equipment malfunction or material blockage.95 The best way to prevent this is to 
use intelligent control platforms to monitor equipment and have emergency shutdown procedures 
in case of malfunctions. Ingham et al. used this approach for the continuous synthesis of 
adamantine amino acid 1.38 (Scheme 1.10).  
 
Scheme 1.10 Continuous flow synthesis of oxazole intermediate 1.37. All steps were controlled by 
a computer platform which used online IR and webcam liquid level monitoring to 
stop and start each step. Amide 1.36 was collected as a filtrate in a solution with 
KOH, which was directly pumped into the next reactor to facilitate cyclisation to 
1.37. Adamantane amino acid 1.38 was synthesised in separate steps. 
The formation of the propargyl alcohol 1.35 from the solutions of adamantone 1.33 (in 
toluene and diethyl ether) and ethynyl magenesium bromide 1.34 (in THF), was monitored by 
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online infrared spectroscopy (IR) to control the quench stream of saturated ammonium chloride. 
Computer controlled liquid/liquid separation resulted in a solution of 1.35 in a mixture of organic 
solvents, which were evaporated and then acetonitrile was introduced to produce a solution of 1.35 
for which the level was controlled by webcam monitoring. This acetonitrile solution was reacted 
with sulfuric acid to produce amide 1.36, then quenched with potassium hydroxide. The by-product 
salt was filtered and the filtrate (containing KOH) was collected into a webcam monitored reservoir 
and then pumped through a reactor to induce the cyclisation to oxazole 1.37. Through the use of 
online IR analysis and monitoring of liquid levels using webcams, the synthesis of 1.37 was 
enabled in a fully automated continuous process with 10 separate unit operations. 
Whilst the combination of these technologies is impressive, there is a development and 
integration timescale to connect all the equipment together both physically and with computer 
communications. This configuration of equipment is specific to this process and requires setup and 
disassemble time. Adamo et al. developed a single reconfigurable automated reactor platform that 
was capable of synthesising 4 different formulated drug products: diphenhydramine hydrochloride, 
lidocaine hydrochloride, diazepam and fluoxetine hydrochloride (Figure 1.2).96 The platform was 
the size of a household refrigerator and contained computer controlled modules with online IR to 
monitor product formation and ultrasonic probes to quantify the concentration of solution phase 
parenteral and dermal doses (Figure 1.3). The time to reconfigure the system to synthesise different 
drugs varied from 15 min to 2 h and could produce up to 4500 doses over a 24 h period. 
 
Figure 1.2 Structures of pharmaceuticals manufactured by Adamo et al.96 Diphenyhydramine 
hydrochloride 1.8, lidocaine hydrochloride 1.39, diazepam 1.40 and fluoxetine 
hydrochloride 1.41. 
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Figure 1.3 Schematic of the reconfigurable automated reactor designed by Adamo et al., used 
for the synthesis of pharmaceuticals in Figure 1.3 Each unit could be 
interchanged/bypassed depending on the target product.96 
1.2 Online Analysis 
Analysis of reaction progress is not a new concept in chemical synthesis. For example, it is 
commonplace for standard batch laboratory reactions to be monitored offline by thin layer 
chromatography (TLC), gas chromatography (GC) or high performance liquid chromatography 
(HPLC). Typically, offline analysis requires neutralisation and possibly workup for the sample to 
be suitable for analysis. During these steps, reaction intermediates and crucial information about 
the reaction could be lost.  
Online analysis, describes the in situ analysis of a reaction, and can be used for a variety of 
applications, including reaction intermediate screening and gathering kinetic data. Techniques such 
as IR,97-104 Raman spectroscopy98, 99, 105 ultraviolet-visible light spectroscopy (UV-Vis)98, 100, 106 and 
nuclear magnetic resonance spectroscopy (NMR);107-110 HPLC111-113 and GC;114-116 as well as mass 
spectrometry117-119 have been used extensively to monitor reactions in flow reactors.  
1.2.1 Infrared Spectroscopy 
IR offers a convenient and non-destructive method for inline monitoring. The majority of 
applications of modern IR instruments for continuous monitoring utilise flow-through cells with 
attenuated total reflectance (ATR) technology and are capable of fast acquisition for near real-time 
monitoring. 
Fourier transform IR (FT-IR) monitoring of functional groups was used by Qian et al. in the 
telescoped flow synthesis of a δ-opioid receptor antagonist 1.45 (Scheme 1.11).104 Each step of the 
synthesis was carried out and optimised in individual reactor coils followed by polymeric 
scavenging columns to generate pure product without the need for work-up or purification.87 The 
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optimisation studies consisted of injecting sample loops containing the substrates and reagents, an 
online FT-IR was used to measure the presence of the intermediate, via the characteristic stretching 
frequency of the amide 1.44, so that the addition of the Burgess reagent stream could be 
synchronised. It was also possible to calculate the concentration and volume of reagent required 
using the IR spectra. 
 
Scheme 1.11 Telescoped synthesis of δ-opioid receptor antagonist 1.45. Online IR was used to 
observe the amide formation 1.44 and notify when to introduce the Burgess reagent 
for the dehydration.104 
Skilton et al. used the fingerprint region for online analysis of the O-methylation of n-
pentanol using dimethyl carbonate and a fixed catalyst bed containing γ-alumina.18 Calibration of 
the IR data was performed by correlation of non-convoluted peaks with calibrated GC data. The 
use of FT-IR significantly enhanced throughput compared to the GC experimentation. The average 
experiment time of 32 min when using GC was reduced to 3.5 min with FT-IR as the near real-time 
analysis could both detect steady state performance and much more rapidly quantify the outlet 
concentration of the desired product, enabling detailed scans of the parameter space. 
1.2.2 Nuclear Magnetic Resonance Spectroscopy 
NMR spectroscopy could be described as the go-to method for compound identification by 
synthetic organic chemists, but its inherent insensitivity generates spectra with low signal to noise 
ratios, especially with samples sizes of microlitres and smaller. Recent developments have been 
made into using microcoils and flow capillaries to reduce the signal to noise ratio.107, 108 Olson et al. 
demonstrated that microcoils and capillaries could be used to provide high resolution NMR 
spectroscopy for small quantities of material.107 Recently, miniaturised low-field NMR systems 
with permanent magnets have been developed for online analysis in the laboratory and production 
environments. These devices typically operate at field strengths of 2 tesla and up to 85 MHz 1H-
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frequency.120 This low field strength normally produces complex spectra and the magnetisation of 
the sample is influenced by the flow velocity and further complicated by the absence of deuterated 
solvents in process monitoring applications. Therefore, they are not ideally suited to detailed 
assignment of spectral features but can be readily used for near real-time analysis of reaction 
mixtures. However it may be impractical to accurately quantify low concentrations or systems 
containing a large number of compounds. 
Wensink et al. used a microcoil NMR at 60 MHz for generating a kinetic profile of an imine 
formation (Scheme 1.12) in continuous flow.108 Syringe pumps with the benzaldehyde and aniline 
in separate solutions of nitromethane-d3 were fed into the reactor. Clearly separated singlet signals 
of the aldehyde proton (CHO, δ 9.9 ppm) and the imine proton (Ar-CHN-Ar, δ 8.4 ppm) were 
chosen to monitor reaction conversion. Rate constants were collected and results shown to be 
comparable to offline measurements. Improvements were proposed, by adding multiple microcoils 
along a flow reactor; an approach later used by Ciobanu et al.110 
 
Scheme 1.12  A kinetic profile of the reversible imine formation was measured with NMR 
spectroscopy. Product formation and substrate degradation was easily monitored in 
crude spectra due to the distinctive changes in proton environments.108 
 
Scheme 1.13  Diels-Alder reaction between cyclopentadiene 1.49 and acrylaldehyde 1.50, 
catalysed by scandium triflate. The stereochemical ratio of the product was 
determined by deconvoluting 1H NMR spectroscopy.25 
The advancement of commercial low-field NMR spectrometers121, 122 has allowed researchers 
to monitor more challenging reactions by NMR. Sans et al. used online NMR to distinguish 
between two stereoisomer products of a Diels-Alder reaction between cyclopentadiene 1.49 and 
acrylaldehyde 1.50, catalysed by scandium triflate (Scheme 1.13).25 Deconvolution of the low 
resolution spectra was achieved by fitting Gaussian trends to the chemical shift peaks in the 
aldehyde region (δ 9.0 to 9.6 ppm). It was also possible to carry out structural characterisation of 
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the product of a fluorination reaction (Scheme 1.14) using 1H homonuclear correlated spectroscopy 
(COSY) and 1H13C heteronuclear single quantum correlated spectroscopy (HSQC) and 19F NMR. 
However, the machine used had a scan time of 10 s, which resulted in total acquisition times of 9 
min (COSY) and 38 min (HSQC) for the two techniques. 
 
Scheme 1.14  Fluorination of keto-ester 1.53 using Selectfluor. The product was identified using 
homo- and heteronuclear correlated spectroscopy.25 
Online NMR has also been used for monitoring the DIB mediated cyclopropanation of 
styrenes in flow, using a variety of different substrates. Geminal and vicinal correlations within the 
cyclopropane ring could be determined by using COSY with acquisition times of 10 min.123 
1.2.3 Ultraviolet-Visible Spectroscopy 
UV-Vis spectroscopy is conducted in the 200-800 nm wavelength range. It is especially 
applicable to compounds with high conjugation and active chromophores. Unlike NMR, IR and 
Raman Spectroscopy, UV/vis spectra consist of relatively broad absorption peaks due a multitude 
of electronic and vibrational levels, this makes quantification difficult in the majority of cases. 
Smith et al. showed the applicability of UV-Vis for measuring dispersion for product collection in 
a react and release system for the synthesis of triazoles.124 
1.2.4 Raman Spectroscopy 
Raman spectroscopy (RS) is another form of vibrational spectroscopy, which measures the 
inelastic scattering of light emission. RS, like ATR FT-IR spectroscopy, offers a convenient and 
non-destructive analytical technique for analysis of flow reactors. In particular, RS is particularly 
suited to systems containing water. A recent example by Chaplain et al. discussed the development 
of a Raman Flow Cell for the continuous Suzuki reaction shown in Scheme 1.15.125 
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Scheme 1.15  Suzuki reaction used to develop inline Raman spectroscopy using potassium 
carbonate base and a palladium on silica monolith catalyst. 
Quantitative analysis was achieved by partial least squares regression to obtain a calibration 
model which was validated using offline GC-MS analysis. Furthermore, kinetic profiles of the 
reaction could be compiled to give rate constants for reaction optimisation. This achieved 61% 
yield of the product. 
1.2.5 Near Infrared Spectroscopy 
Near Infrared Spectroscopy (NIRS) covers a spectral range between visible and mid-IR 
wavelengths (800-2500nm).  NIRS measures the absorption bands resulting from overtones or 
combinations of the fundamental mid-IR bands, mainly of –CH, -OH, -SH and –NH bonds.126 NIR 
spectra consist of many overlapped spectral features which necessitate the use of chemometrics to 
gain quantitative data regarding the composition of samples.127, 128 
Cervera-Padrell et al. used NIRS for the online monitoring of a Grignard reaction (Scheme 
1.16) in a tubular reactor.127 The Grignard reaction is a useful technique in organic synthesis for 
forming carbon-carbon bonds in functionalised compounds. It can be however problematic in scale 
up as it is incredibly fast, highly exothermic and therefore difficult to control. The increased heat 
transfer found in flow reactors has resulted in many Grignard transformations being scaled up in 
continuous reactors but heat spots are still observed at mixing sections,127 where it is assumed the 
reaction occurs.129 To counter these potential problems, the Grignard was introduced into the 
reactor through multiple entries. The reaction was sensitive to changes in the relative stoichiometry 
of the Grignard reagent and ketone, with increases in the former creating impurities, and the latter 
reducing the yield. NIRS was used to monitor the concentration of the substrates in the system, 
with a feedback loop controlling the pump ratios. 
 
Scheme 1.16  Formation of tertiary alcohol 1.59 by Grignard reaction with ketone 1.57. The 
reaction was sensitive to reactant stoichiometry and excesses of ketone and Grignard 
were monitored using online NIRS. 
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1.2.6 Gas Chromatography 
Chromatography separates compounds based on their differential affinity for mobile and 
stationary phases. It is commonly used as an accurate measure of purity as well as product 
identification, if compared with known standards, or combined with other analytical techniques 
(such as mass spectrometry). Chromatography is typically regarded as an at-line technique as 
sampling must be performed discretely with analysis results typically requiring 2-30 min, 
compared to the continuous real-time nature of most spectroscopy techniques. 
GC uses a gaseous mobile phase and has been successfully used in the online monitoring of 
reactions that produce extremely volatile products or by-products that are normally lost during 
work-up or extraction procedures. Online GC is typically conducted using a sample loop, a 
switching valve between two separate flow streams, which can introduce a small volume of the 
sampled stream into the carrier flow of the GC. Walsh et al. used online GC analysis to create an 
automated continuous system to analyse the formation of highly volatile short chain ether species 
in the solid acid catalysed etherification of short chain alcohols (Scheme 1.17) in supercritical 
carbon dioxide (scCO2) which could not easily be contained for offline analysis.114 O-Alkylations 
using short chain alcohols can be a greener alternative to their alkyl halide counterparts due to their 
non-toxicity. 
 
Scheme 1.17  Various reactions in the O-alkylation of alcohols using short chain alcohols (note, 
the etherification can be symmetrical or asymmetrical)114 
The symmetrical etherification of alcohols with methyl to n-pentyl chains was investigated 
and the results showed that the highest yield was achieved with n-propanol. It was proposed that 
the longer carbon chain increased the nucleophilicity of the alcohol, but for the longer butyl and 
pentyl chains, the elimination reaction was preferred. 
The implementation of online GC with an automated reactor resulted in a queue of 
experiments that could be run without any user intervention. GC was appropriate for analysing the 
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highly volatile short chain ether and alkene products. However GC is restricted to compounds that 
have significant volatility and has been estimated to be useful for only 20% of known organic 
compounds.130  
1.2.7 High Performance Liquid Chromatography 
HPLC separates materials based on their differing affinity to a pressurised liquid carrier and 
a column filled with a solid sorbent material (typically 2-50 micrometers particle size). Several 
different detectors can be fitted including UV/Vis, photodiode array or MS. HPLC has several 
advantages over GC, including: 
 A greater library of compounds that can be analysed. 
 A smaller diffusion coefficient, increasing the speed of analysis. 
 Higher viscosities of the mobile phase, reducing the diffusion coefficient. 
 Greater flexibility in changing the stationary and mobile phases. 
HPLC technologies have developed over the past few decades to improve the speed and 
efficiency of column separation. The newer technologies have been denoted as ultra-high 
performance liquid chromatography (UHPLC) or simply ultra-performance liquid chromatography 
(UPLC).131 Part of the advancement has been to decrease the theoretical plate height in a column, 
which is a measure of the resolution. The plates in a column are thought of as theoretical discrete 
steps that the compounds have to “climb” and the smaller the steps, the higher the number of these 
steps in a column and the better the separation. There are two particular methods that have been 
used to decrease the plate height: reduce the particle size to < 2 µm and change the particle 
composition to have partial porosity. The relationship between theoretical plate height, particle size 
and optimum flow velocity is calculated by the Van Deemter plot and shows that the optimum flow 
velocity is greater for smaller particle sizes (Figure 1.4).132, 133 The invention of core shell particles, 
with partial porosity reduce the longitudinal diffusion and therefore peak broadening.133, 134 
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Figure 1.4 Van Deemter plots showing the optimal linear velocities for HPLC columns with 
different particle sizes. Optimal linear velocity zones are highlighted by the dashed 
boxes. Smaller particle sizes result in higher linear velocities.132, 133 
At-line HPLC was used by Antes et al. to monitor the nitration of toluene in microreactors to 
assess the performance of a silicon microreactor.113  Silicon has high heat transfer properties and 
high resistance to acid corrosion. At-line HPLC was chosen for the speed and reliability of 
analytical feedback; plus the UV detector on the machine was suitable for the aromatic substrates 
and products. In this research they replaced the typical mixture of aqueous sulfuric and nitric acid 
with fuming nitric acid, removing the need to regenerate and purify the resulting nitrating acid 
mixture. The effective mixing and high heat transfer that is achieved in microreactors enabled rapid 
reaction with effective control of the reaction exotherms. The reactor was set up with three separate 
syringe pumps for toluene, fuming nitric acid and an ice water quench; with at-line HPLC sampling 
through a sample-loop. 
The nitration of toluene can generate a high number of different isomers (Scheme 1.18) but 
only mono-substituted products were targeted. During initial screening tests, the highest yields (89 
to 92%) of nitrotoluene were observed at residence times of 3 s, with isomer ratios of 53% ortho, 
3.5% meta and 44% para. Because the reaction time was so short, a quench stream was introduced 
before sampling, so that strict control over the reaction could be achieved. When the flow rate of 
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the quench stream was reduced the observed yield, by at-line HPLC, decreased by almost half, due 
to the reaction progressing to di-substituted products.  
 
Scheme 1.18  Different mono-isomers formed in the nitration of toluene.113 
1.2.8 Mass Spectrometry 
Online MS is a stand-alone technique that measures the molecular mass of compounds and 
their constituent fragments. MS is commonly coupled to chromatographic techniques (GC-MS, 
LC-MS) but has been used solely for online analysis in reaction monitoring and has several 
advantages over other techniques. It can directly detect metal species; and particular elements, such 
as chlorine and bromine can be identified by their isotope patterns. However it does come with 
some disadvantages. If structural isomers do not form different fragments, then they can only be 
identified with ion mobility,135 which is not readily available on most spectrometers. Different 
ionisation techniques are required for different compounds, so a compromise may have to be 
reached in the spectra obtained in terms of how many components can be characterised.  
Browne et al. capitalised on the speed of analysis and identification opportunities to monitor 
short lived and unstable intermediates formed in a tandem benzyne and Diels-Alder reaction 
(Scheme 1.19) using electrospray ionisation (ESI) MS.118  The reaction uses a nitride to convert the 
anthranilic acid 1.72 to a diazonium salt 1.73, which undergoes rapid loss of CO2 and N2 to yield 
the benzyne 1.74. Introduction of furan initiates a Diels-Alder reaction to form the epoxy 
naphthalene 1.76. 
This follows the traditional route to benzynes, which is no longer popular in batch processes 
because the diazonium intermediate is explosive if produced in large quantities or isolated to its 
pure crystalline form. The substrates have now been replaced with starting materials that introduce 
triflates and trimethylsilanes as leaving groups but these are expensive reagents that require 
multistep processes, generating more waste. The use of continuous processing offers a direct route 
because the low inventory of the hazardous intermediate can be handled safely. 
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Scheme 1.19  Single step benzyne generation and Diels-Alder reaction. Online MS was used to 
monitor intermediates and show evidence of competing reaction pathways.118 
Preliminary studies with the mass spectrometer showed that the explosive diazonium 
intermediate was still present in the out stream mass spectrum when the reactor was at room 
temperature, so sodium thiosulphate was added to the collection vessel to reduce the intermediate 
and thus minimise the risk of explosions. Further optimisation of the operating conditions using the 
mass spectrometer data enabled complete consumption of the explosive intermediate and prevented 
formation of undesired side products. 
1.3 Automated Optimisations using Flow Reactors 
1.3.1 Self-Optimisation 
Self-optimisation describes the use of automated reactors combined with online analysis and 
adaptive feedback algorithms to generate optimal conditions without the need for human 
intervention. The procedure depends on the algorithm used but will likely start with a set of 
conditions either user defined or calculated from the algorithm, which are carried out with the 
reactor, then the optimising target calculated from the online analytical data. Next, the algorithm 
will use the results of the experiments to predict new experimental conditions and this will continue 
in a cycle until the user stops the process or a tolerance limit is reached. 
  Flow systems are ideally suited for such experimentation, as integration of analytical 
equipment is facile and rapid measurement and adjustment of operating parameters such as flow 
rate, temperature and pressure can be accomplished quickly within a single reactor system. The 
concept was first used by Krishnadasan et al.11 for the synthesis of CdSe quantum dot nanoparticles 
 44 
using a microreactor, online UV and SNOBFIT algorithm.136 The reaction was optimised for a 
wavelength function that was termed the ‘dissatisfaction coefficient’, which assigned an error from 
the current to desired wavelength, which the SNOBFIT algorithm could minimise. This allowed the 
synthesis of highly tuned target-optimised CdSe quantum dot nanoparticles. 
SNOBFIT (Stable Noise Optimisation by Branch and Fit) is a branch and fit algorithm used 
in linear programming.136 It is so called because it will plot global (or exploratory) experimental 
points and then calculate polynomials based on the responses to find optimal (or local) points; 
essentially branching out and then finding a fit. The algorithm will continue to plot both 
exploratory and local points, as it continues to seek optima. 
McMullen et al. used the Nelder-Mead simplex (NMSim), steepest descent DoE and 
SNOBFIT algorithms for the optimisation of a Knoevenagel condensation in a microreactor 
equipped with at-line HPLC (Scheme 1.20).12 A 2-dimensional experimental space was selected 
using residence time and temperature as the variables; and optimised for a combined function of 
yield and production rate (also called Space Time Yield, STY). 
 
Scheme 1.20  Knoevenagel condensation used by McMullen for self-optimisation studies.12 
Simplex is an algorithm that will start by plotting 𝑛 + 1 experimental points, where 𝑛 is the 
number of variables, then ranking the results of the experiments from best to worst. A new point is 
created by reflecting the simplex shape from the worst point through the mid-point between the 
resultant points.137 There are various modifications to the simplex algorithm, including Nelder-
Mead, which can expand or shrink the simplex depending on the ranking of points.138, 139 
The boundary constraints for temperature and residence time were between 40 and 100 ºC, 
and 30 and 300 s respectively. Each algorithm found the same optimum conditions of 30 s and 100 
°C. The simplex algorithm quickly started merging towards short residence times and high 
temperatures; it reached the border range at 30 s and after trying to plot an experiment outside the 
defined constraints, started contracting as it moved towards 100 °C. The algorithm finished after 30 
experiments. The SNOBFIT algorithm required the highest number of experiments with 36, 
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however it created the highest amount of scatter across the experimental space and thus provided 
more confidence in the optimum conditions. The steepest descent algorithm started by plotting a 2-
level factorial design,a with 3 mid-point repeats. Analysis of the design by the algorithm showed 
that there was no quadratic curvature, then the algorithm calculated the gradient and progressed 
towards higher temperatures and lower residence times. When trying to plot an experiment outside 
of the design space, the algorithm changed the experiment to the constraint boundary and then 
terminated, after 13 experiments. Although the algorithm required the fewest number of 
experiments of the 3 tested, it relied on calculating the correct gradient after the first design, 
whereas the SNOBFIT algorithm will explore new space then re-evaluate the current model fit. 
Bourne et al. compared the approaches of standard and super modified simplex (SMSim) 
algorithms for the acid catalysed methylation of n-pentanol in supercritical CO2 (Scheme 1.21) 
using dimethyl carbonate (DMC).16 The reaction was optimised for yield using the parameters of 
temperature, pressure, CO2 flow rate; and equivalence of DMC. 
In the comparison between standard simplex and SMSim algorithms, it was shown that an 
optimum can be reached with the SMSim in fewer simplexes due to its ability to expand and 
contract as it moves towards the optimum. The self-optimisation technique was well suited to 
reactions in supercritical fluids because the solvent can be highly tuned by only slight changes in 
the temperature and pressure.140 This high level of precision would be difficult to achieve over a 
large experimental area, using other techniques. 
 
Scheme 1.21 Methylation of n-pentanol 1.60a in supercritical CO2 using dimethylcarbonate as a 
methylating agent and catalysed by γ-Alumina.15, 16 
In work that was either parallel or published subsequently to the start of experimental work 
in this thesis, the concept of “cloud chemistry” was introduced to the field of self-optimisation.22 
This used the concept of cloud networking, where any piece of equipment that is connected to a 
network can be remotely accessed from another location. Therefore, because almost all of the 
                                                 
a DoE factorial designs will be discussed in detail in Chapter 3 
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experiments are carried out by computerised control, the operating user does not actually need to be 
present at the equipment. Instead, the chemicals and equipment are prepared by a local technician 
and then the user remotely connects to the laboratory computer and controls all aspects of the 
automated optimisation until completion of the experiments, where the local technician then cleans 
and shuts down the reactor. The Poliakoff group at the University of Nottingham, UK managed to 
connect to remote operators at international campuses in Ningbo, China and Kuala Lumpur, 
Malaysia; as well as other institutions in Ethiopia (Addis Ababa University), Brazil (Universidade 
Federal do Rio Grande do Sul) and Turkey (Petkim Petrochemical Holding). Successful 
optimisations included the etherification of propanol and the γ-Al2O3, Nb2O5 and NbOPO4 
catalysed DMC methylation of butanol. 
 
Scheme 1.22  Symmetrical etherification of n-propanol 1.60b used for cloud controlled self-
optimisation.22 
The main advantage with cloud chemistry is that it makes available equipment that would be 
too expensive for some institutions, especially those in the developing world. The only challenges 
experienced with this technique were general local technological techniques, such as low 
bandwidth or poor weather limiting connection speeds. 
 
Scheme 1.23 Inorganic heterogeneous catalysed methylation of n-butanol 1.60c using 
dimethylcarbonate as a methylating agent. These reactions were optimised using 
cloud control self-optimisation.22 
There has also been considerable work towards integrating new forms of online analysis for 
self-optimisation. Previous techniques involving FT-IR require some form of chemometrics to 
deconvolute the output126 and some chromatographic methods can be up to an hour in length. As 
discussed above, NMR spectroscopy is a very good for product identification and requires very 
little effort in calibration due to the identical relative responses of products to an internal standard. 
 47 
The ability to reduce the spectral complexity by only monitoring specific nuceli (e.g. 19F) reduces 
the time spent developing methods. Sans et al. used a commercial NMR spectrophotometer for the 
self-optimisation of an imine condensation (Scheme 1.24), using a NMSim algorithm to maximise 
the STY.25 
 
Scheme 1.24  Imine condensation used for the maximisation of imine STY using online NMR and 
Nelder-Mead simplex algorithm (NMSim). 
1.3.2 Feedback Controlled Statistical and Kinetic Models 
Self-optimisation systems have typically used minimising algorithms in their feedback loops, 
however work by the Jensen group has replaced these algorithms with statistical and kinetic 
models. McMullen and Jensen aimed to optimise and scale up the Diels-Alder reaction between 
isoprene and maleic anhydride by using automated feedback controlled kinetic model 
determination and at-line HPLC (Scheme 1.25).13 
 
Scheme 1.25 Diels-Alder reaction between isoprene 1.81 and maleic anhydride 1.82 used by 
McMullen and Jensen for the automated feedback controlled kinetic model 
determination.13 
Four separate kinetic models (1.1 to (1.4) were proposed with varying orders with respect to 
the concentrations of the starting materials and reversible/irreversible reactions, where 𝐶𝐴 is the 
concentration of 1.81, 𝐶𝐵 is the concentration of 1.82, 𝐶𝐶 is the concentration of 1.83, 𝑟𝑖 and 𝑘𝑖 are 
the rates and rate constants of equation (1.𝑖), respectively. A Bayesian statistics approach was then 
used to discriminate between the different models and calculate a probability that each model 
describes the true reaction kinetics. Five separate experiments were carried out to determine which 
model was the most accurate and a sixth experiment confirmed that the best model was (1.1). Next 
a D-optimal DoE was carried out to find the kinetic parameters for model (1.1) (Arrhenius pre-
exponential constant 𝐴 and activation energy 𝐸𝐴) then these were used to predict the reaction 
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performance upon scale up from custom etched plate microreactor 120 µL to 60 mL Corning 
Advanced-Flow reactor (500 fold). 
 𝑟1 = −𝑘1𝐶𝐴𝐶𝐵 (1.1) 
 
 𝑟2 = −𝑘2𝐶𝐴
2𝐶𝐵 (1.2) 
 
 𝑟3 = −𝑘3𝐶𝐴𝐶𝐵
2 (1.3) 
 
 𝑟4 = −𝑘4,𝑓𝐶𝐴𝐶𝐵 + 𝑘4,𝑟𝐶𝐶  (1.4) 
 
The advantage with using kinetics to optimise a reaction is that an empirical kinetic model 
that accurately interpolates and extrapolates is obtained, which can thus be used to optimise any 
reaction metric. In this example the reaction is simple and the kinetic model only needs to 
incorporate 3 different species. If the example was a reaction that required multiple chemical 
species (e.g. metal catalysed cross coupling) then there could be potentially hundreds of kinetic 
models to distinguish between and the reaction could proceed down unpredicted impurity 
pathways. Black-box optimisation methods, such as minimising algorithms, only need to measure 
the target response and therefore can easily incorporate unpredictable reaction pathways. 
Further work by the Jensen group has used empirical statistical designs for automated 
reaction optimisation. Reizman studied the mono-alkylation of diamine (±)1.84 to optimise for 
solvent selection and continuous reaction conditions using online LC-MS and a feedback controlled 
DoE algorithm (Scheme 1.26).20 The feedback algorithm proceeded through the following steps: 
1. Initial fractional factorial design (FED) for each solvent. Fit models for each solvent. 
2. FED in smaller experimental area where the initial set of models predicted an 
optimum. 
3. Feedback G-optimal DoE search to minimise the uncertainty in the best performing 
solvent designs. 
4. Steepest descent gradient search optimising only continuous variables with the best 
solvent. 
 
Scheme 1.26 Amine mono-alkylation reaction used by Reizman and Jensen to carry out discrete 
and continuous feedback DoE optimisations.20 
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The solvents screened were: DMC, DCE, IPA, MeCN, THF, DME, pyridine, DMSO, 
toluene and DMF; and the continuous variables were: residence time, temperature and amine 
concentration. In the first step, 20 experiments were carried out at the least and most forcing 
conditions of the continuous variables for each of the 10 solvents screened (a 23-2 FED design). A 
response surface was fitted to each solvent design and was used to decrease the design space 
towards the predicted optimum conditions. Therefore the new least forcing conditions were the old 
centre-point and the new centre-point was scaled accordingly. A new set of 20 experiments (10 
FEDs) were carried out and the worst performing solvents were eliminated: MeCN, DME and 
DMC. 
Next the algorithm used response surface refinement to search through the continuous 
conditions using the resultant solvents. A G-Optimal design was used, which aims to minimise the 
maximum variance in the predicted models, i.e. carrying out experiments with solvents that have 
the highest error with the predicted optima. This search required a further 27 experiments before 
deciding that DMSO was the best performing solvent. The last step was a steepest descent gradient 
search optimising for only the continuous variables using DMSO as the reaction solvent. 
In total the optimisation required 97 experiments but there was no note of the overall 
optimisation time. The feedback DoE algorithm managed to optimise 10 discrete and 3 continuous 
variables to find the optimum conditions. The disadvantage with the approach is that the initial set 
of FED designs had a very low resolution and predicted optimum yields of 191 ± 121% and 
therefore possibly missed higher performing solvents that did not obtain a good initial model fit. 
Plus, the algorithm was custom written and required extensive statistical knowledge to implement, 
an expertise that is not commonplace amongst process chemists or engineers.  However the only 
way to screen the same number of discrete variables using existing self-optimisation techniques 
would be to carry out separate optimisations for each solvent, which would likely require much 
more than 97 experiments.b 
                                                 
b Further advantages and disadvantages with optimisation using DoE will be discussed in Chapter 4 
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1.4 Project Motivations and Thesis Outline 
A large part of pharmaceutical process development is the optimisation of each reaction step 
in order to maximise product yield and purity and minimise waste. This is often not a trivial 
problem and as such techniques including DoE and kinetic modelling are required to provide 
quantitative descriptions and optimum conditions. With the increasing development of continuous 
manufacturing steps in the pharmaceutical industry, it is perhaps a surprise that the ever-growing 
field of self-optimising flow reactors has not yet been applied to pharmaceutical process 
development. However self-optimisation is not without its problems. Some of the challenges are: 
 Chemical suitability – Self-optimisation has only currently been applied to model 
reactions and it is difficult to know if it would lend itself to much more complex 
substrates such as pharmaceuticals. 
 Conflicting with existing techniques – DoE is used extensively in process 
development and it could be hard to convince people to use new technologies that 
they are unfamiliar with. Even feedback DoE algorithms (as used by Jensen) are new 
and more work is required to combine the two techniques. 
 Analytical techniques – The existing analytical techniques for self-optimisation are 
primarily IR or chromatography and do not match the number of online analytical 
techniques available to process development scientists.141 
 Algorithm and target function – The algorithm and target function is incredibly 
important because different choices can deliver different results, not only for the 
target optimum but also about the chemical design space as a whole. 
 Material waste – A minimal amount of material is required for chemical analysis, 
however large quantities of material and pumped and simply discarded. Material is 
often a limited and precious resource in process development. 
The work in this thesis aims to address all of these points. This first chapter has reviewed the 
existing literature in the field of flow chemistry, online analysis of flow reactors and self-
optimisation techniques. Chapter 2 introduces the automated flow reactor and other automated 
techniques used in this thesis. Chapter 3 provides the first known example of using self-
optimisation to optimise the final bond-forming step in the synthesis of an API. It also shows how 
feedback controlled minimising algorithms can provide more information about a chemical system 
than just the optimum conditions. Chapter 4 discusses the possibility of obtaining empirical 
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response surface models, the same as obtained using DoE, from minimising algorithm data; 
therefore finding a way that existing optimisation techniques can be complimented by self-
optimisation. A new form of online quantitative analysis in self-optimising reactors is introduced in 
Chapter 5 – mass spectrometry. The chapter explores methods to quantify and calibrate the 
response with minimal manipulation or chemometric analysis of the raw data. Chapter 6 introduces 
practices to reduce the amount of material used during optimisations. This is covered by a two 
pronged approach of introducing sub-reactor volume reaction pulses and intelligent algorithms that 
can optimise for more than one target function at once. The final conclusions chapter summarises 
the significant contributions that have been made in this thesis and provides new directions for the 
future of automated self-optimising flow reactors. 
The ultimate desire for any pharmaceutical process development research is to obtain the 
maximum amount of data from the minimal amount of material in the minimal amount of time. It is 
believed that the work in this thesis can deliver towards this target by presenting novel research 
ideas combined with practical and interesting applications. 
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2. Description of Automated Reactor and Processes 
2.1 Reactor Description 
All automated flow experiments were carried out using a modular reactor containing 
commercially available equipment, which was monitored and controlled through a custom written 
program with graphical user interface (GUI). A generic diagram is shown in Figure 2.1; a detailed 
description of all components is in the following sections. Please note that these are general 
descriptions of how the equipment was set up and may vary in different chapters. 
 
Figure 2.1 Generic schematic of the automated reactor. SL – sample loop, BPR – back pressure 
regulator. 
Pumps 
All reagents were pumped using Jasco dual piston HPLC pumps (PU-980). The minimum 
flow rate for each pump was 0.02 mL/min, as this was measured as the lowest reliable flow rate 
against a total flow of 1 mL/min from the other pump(s). The pump heads were primed with 
isopropanol when left idle. 
Reactor 
Reactions were carried out using a Polar Bear Plus Flow Synthesizer (Cambridge Reactor 
Design) which has active heating and cooling. The specified temperature ranges from -50 to 150 
°C; however temperature testing showed that the reactor would not reach temperatures less than -
40 °C. Tubular reactors of various volumes were constructed by wrapping tubing around the 
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heating mantle. A Syrris 250 µL chip was used as a micro-reactor/mixer, with a pressure rating of 
30 bar but no temperature control module. 
Sample Injectors 
At-line HPLC and MS samples were acquired using a VICI Valco 4-port internal sample 
injector (Figure 2.2). Samples were delivered to the analytical mobile phase without prior quench 
or dilution. HPLC: CI4W.06 manual valve with a DCI4W.06 rotor, volume of 0.06 μL, and 
medium torque EUDA actuator. MS: CI4WE.06 manual valve with DCI4W.06 rotor, volume of 
0.06 µL, and high torque EUHA actuator. 
 
Figure 2.2 Schematic of a 4-port internal sample injector. Left – reaction mixture is pumped 
from the reactor, through the sample slot and then to waste (red). Right – the injector 
is rotated 90 °C and delivers the sample slot to the HPLC mobile phase (blue). 
Back Pressure Regulators 
Upchurch Scientific back pressure regulators (BPRs) were used and the pressure altered 
using replaceable cartridges (75, 100 and 250 psi). The pressure was kept constant through 
reactions at a value that would prevent boiling of the solvent. Pressure was kept constant 
throughout all experiments and therefore was not used as a variable. 
Tubing and Fittings 
Polyflon PTFE tubing (1/16” OD, 1/32” ID) was primarily used through the reactor. All 
connections and fittings to equipment were the individual brand (Jasco, VICI, Agilent etc.), all 
other tubing connections were Swagelok 316 stainless steel. Reagent feeds were mixed in mixing 
tees (Swagelok) unless otherwise stated. A Swagelok SS-2F-2 inline filter was fitted during some 
reactions to prevent particulates clogging the sample injector or BPR. 
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At-line HPLC 
At-line HPLC analysis was carried out using an Agilent 1100 system. All tubing between the 
pump head and UV detector outlet was green Agilent capillary tubing (ID 0.17 mm). Descriptions 
of the HPLC methods are in the experimental chapter. 
Online MS 
Online MS was carried out using an Advion Expression CMS operating in APCI mode. This 
was fitted with an APCI ionisation probe and corona discharge needle. The sample injector and 
ionisation probe was connected using red PEEK tubing (1/16” OD, 0.005” ID) with Rheodyne 
RheFlex fittings. Nitrogen was used for all gas feeds at a total flow rate of 4 L/min. The mobile 
phase was supplied using an Agilent G113A HPLC pump and made up of 50% H2O and 50% 
MeCN (0.1% formic acid). MeCN was purchased from commercial vendors at HPLC grade and 
H2O collected from departmental water purification module generating H2O at a resistivity of 18.2 
MΩ cm. 
Software and Communication 
Automated reactions were monitored and controlled using an in-house program written in 
MatLab, which ran on a conventional desktop PC (IBM running Windows 7). Control and 
monitoring of the HPLC was achieved using Agilent ChemStation (revision B.04.05-SP1) and the 
MS by Advion Mass Express (version 3.1.21.1). These software generated reports in .xls 
(ChemStation) and .cdf (Mass Express) file formats, and then scripts were written to transcribe the 
data from the reports into MatLab. All equipment command and monitoring signals were 
communicated through RS-232 (Jasco pumps and sample injectors), ethernet (Polar Bear reactor 
and HPLC) or USB (MS). Commands received from RS-232 controlled equipment were processed 
by Realterm.exe open source freeware. 
2.2 Automated Optimisation Process 
Automated optimisations typically proceeded according to the following set-up. All 
equipment was arranged to the desired configuration and connected with necessary tubing. HPLC 
software was launched and modules were turned on and allowed to equilibrate and the reactor was 
set to its minimum temperature whilst pump reservoir solutions were prepared. The pump heads 
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were primed through the priming valve and then allowed to pump at 1 mL/min until it was deemed 
the outlet tubing was primed to its next connection, typically 10 min. The operating program was 
launched (in MatLab) and all available communication lines to the equipment were connected. The 
optimisation control program was launched and all the necessary user inputs were entered. The 
optimisation was started. During this time, the only user actions required were replenishing the 
mobile phase and reagent reservoirs and emptying the HPLC and reactor outlet waste. 
2.2.1 Optimisation Control Program 
For each experiment, the optimisation control program would run according to the 
description in Figure 2.3. 
 
Figure 2.3  Flow diagram depicting the actions carried out by the optimisation control program. 
The program is split into 4 separate timers – optimisation, steady state, reaction and analysis. 
Timers are individual functions that can start and stop depending on various commands. In the 
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optimisation program, a new timer will not start until the existing one has finished. Firstly, the 
algorithm parameters are loaded from the user inputs entered into the program’s GUI (not shown 
on Figure 2.3). Next, the algorithm timer starts and calls the algorithm to calculate new conditions. 
The algorithm timer then stops and the program moves onto the steady state timer, which sets the 
reactor to its desired temperature and the pumps to their lowest values. Waiting for the reactor to 
cool is the greatest contributor to the overall optimisation time and with this approach the reactor 
only needs to cool once per cycle. Setting the pumps to its lowest values prevents unnecessary 
waste of material. 
Once the reactor has reached temperature, the reaction timer starts and the pumps are set to 
their desired flow rates. The time to reach steady state is calculated and the program continually 
monitors the equipment for clogging or malfunctions whilst it waits for analysis. When steady state 
is reached, the analysis timer checks that the analytical equipment is ready for a new sample, if not, 
it calculates when it will be ready and waits until a sample can be acquired. When a sample is 
acquired, the timer checks if it is the last experiment in the cycle. If this is the case, it waits for the 
analysis to finish and sets all the equipment to its minimum values. This prevents material waste 
and cools the reactor for the start of the next cycle. 
When the optimisation timer starts, it checks if there are any more experiments in the current 
cycle left to run. If there are more experiments, the new conditions are loaded and the steady state 
timer starts. If not, the timer calculates the responses to the existing experiments, checks to see if 
convergence has been reached then calls the algorithm to calculate new conditions. Once 
convergence is reached, the program stops. 
2.2.2 HPLC Automated Calibrations 
HPLC calibration curves were obtained with high precision and low error using an 
automated procedure. Two separate reservoir solutions were prepared, the first with the analyte and 
internal standard at known concentrations, the second with internal standard at the same 
concentration as the first. The solutions were fed into two separate pumps, mixed in a micro-mixer 
before entering the sample loop. The flow rates were adjusted to change the analyte concentration 
whilst maintaining constant internal standard concentration. The example in Figure 2.4 shows a 
solution of analyte (1.0 mol L-1) and internal standard (IS, 0.2 mol L-1) feeding pump A and a 
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solution of internal standard (0.2 mol L-1) feeding pump B. The total flow rate through the micro-
mixer always equals 1 but the flow ratio, and therefore concentration of analyte, varies. The 
concentration of internal standard remains constant throughout. The example assumes a 10 min 
HPLC cycle and turns off the pumps during analysis to prevent unnecessary material usage. HPLC 
samples are acquired at the end of each pump pulse. 
 
Figure 2.4 Schematic of the automated calibration procedure. Top shows the equipment setup, 
left shows flow rate vs time, right shows analyte and IS concentration vs time. 
The relative response factors (𝑓𝑅𝑅) were calculated  
 𝐴𝑥
𝐴𝐼𝑆
= 𝑓𝑅𝑅 (
𝐶𝑥
𝐶𝐼𝑆
) (2.1) 
where 𝐴𝑖 is the HPLC area of species 𝑖 at a given wavelength, 𝐶𝑖 is the known concentration of 
species 𝑖, 𝑥 is the analyte and 𝐼𝑆 is the internal standard. For a linear response, a plot of 𝐴𝑥/𝐴𝐼𝑆 vs 
𝐶𝑥/𝐶𝐼𝑆 gives a straight line of best fit with gradient 𝑓𝑅𝑅. If this plot showed a non-linear trend then 
the calibration was repeated at a wavelength that provided a linear trend. An alternative would be 
to use a more dilute solution. However, during reactions, this approach would require an extra 
dilution/quench stream after the reactor – increasing the engineering complexity – or running the 
reaction at lower concentrations – compromising on the kinetics. 
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2.3 Description of Optimising Algorithms 
2.3.1 Genetic Algorithm 
The genetic algorithm optimises a process using the same rules of natural selection in 
evolution.142, 143 Algorithm cycles are described as generations, containing populations instead of 
conditions. The initial population can either be assigned by the user or chosen by the algorithm at 
random. Populations are ranked by their response and the best individuals are chosen as parents to 
create children for the next generation, falling into three types: elite, crossover and mutated. Elite 
children are carried through without any modification. Crossover children are generated from two 
parents by sharing their vectors, much like how genetic information is shared between parents 
during reproduction. A parent can be selected to create more than one child with the same or 
different parent. Mutated children are created by a random mutation of a vector from the parent 
(Figure 2.5).144 
 
Figure 2.5 The creation of elite, mutated and crossover children in the genetic algorithm. 
2.3.2 Pattern Search 
Pattern Search (PS) is a derivate-free algorithm based on the OVAT approach to 
optimisation. New points are generated by only changing one variable at a time and the size of the 
distance between the points changes throughout.145, 146 A base point (or initial point) is generated by 
the user and the procedure of going from the base point to the next point is called a move. If the 
response at the new point is better, then the move is considered a success. If no improvement is 
made then the move is a failure. 
The MatLab process for PS optimisation147 (Figure 2.6) plots a user defined initial point (or 
base point), followed by points that are a single step size away only varying one condition at a 
time. If a successful move occurs, the step size (or mesh) is doubled and the successful point 
Elite
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Mutation
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becomes the new base point. If a successful move is no longer possible, the mesh is halved. The 
mesh can expand and contract until it is too small to initiate any significant change in the response, 
in which case the optimisation is terminated. 
The initial mesh size is calculated based on the upper and lower bounds of the algorithm: 
 
𝑚𝑒𝑠ℎ = 2
𝑙𝑜𝑔2|𝐵𝑜𝑙|+𝑙𝑜𝑔2|𝐵𝑜𝑢|
2  (2.2) 
 
where 𝐵𝑜𝑙 and 𝐵𝑜𝑢 are the lower and upper bounds, respectively. 
 
Figure 2.6 Flow chart following the key decisions made during the MatLab version of the 
pattern search algorithm.147 
2.3.3 Super-Modified Simplex 
The super-modified simplex (SMSim) is an algorithm adapted from the simplex algorithm.137 
In a classic simplex algorithm, a simplex is created with the number of vertices, 𝑛 + 1 where 𝑛 is 
the number of variables. Each vertex (or point) is ranked based on its response, and a new vertex is 
created by reflecting from the worst vertex through the midpoint of the resulting vertices, thus 
creating a new simplex. The new point, and the resultant points make up a new simplex and then 
the points are reranked to form a new vertex and subsequent simplex The process continues until 
the optimum is surrounded by simplicies (Figure 2.7).137 
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Figure 2.7  (a) The variables of temperature and stoichiometry are selected and three initial data 
points are plotted with three different conditions (N=2, N+1=3). (b) The three data 
points are ranked (1=worst, 2=middle, 3=best) for how close they reach to the 
optimum and a vertex is plotted from the lowest ranked point, through the midpoint 
between the top two ranked points and finishes at a new point generated by the 
algorithm. (c) A new simplex is formed between points 2, 3 and 4 and then these 
points are re-ranked. A new vertex is generated from the lowest ranked point to the 
newest point, 5; points 3, 4 and 5 form the new vertex. (d) The process is continued 
forming new simplexes until the optimum point is reached.137, 148 
The SMSim algorithm139 (Figure 2.8) follows the same rules to calculate the reflected vertex 
as the simplex algorithm. However the response of the mid-point (vertex ?̅?, response ?̅?)c is also 
calculated and a curve is fitted between the worst (𝑊), reflected (𝑅) and midpoint vertices to 
calculate an expansion coefficient (𝑌𝑜𝑝𝑡) subject to either a polynomial fit 
 
𝑌𝑜𝑝𝑡 =
𝑤 − ?̅?
𝑤 − 2?̅? + 𝑟
+ 0.5 (2.3) 
or Gaussian fit: 
 
𝑌𝑜𝑝𝑡 =
𝑙𝑛𝑤 − 𝑙𝑛 ?̅?
𝑙𝑛𝑤 − 2 𝑙𝑛 ?̅? + 𝑙𝑛 𝑟
+ 0.5 (2.4) 
where 𝑤 and 𝑟 are the responses for vertices 𝑊 and 𝑅 respectively. The expansion coefficient is 
used to calculate an improved reflected vertex (𝑂)149 
                                                 
c For all formulae during the simplex sections, 𝑖 is the response of vertex 𝐼  
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 𝑂 = 𝑌𝑜𝑝𝑡?̅? + (1 − 𝑌𝑜𝑝𝑡) ×𝑊 (2.5) 
The value of 𝑌𝑜𝑝𝑡 is bound by constraints and must be between the values of -1 and 3 so that the 
simplex doesn’t grow more than twice the size of the original.150 The initial value of 𝑌𝑜𝑝𝑡 is 
normalised so that the distance between 𝑊 and ?̅? is 1. 
If a boundary is reached, a boundary coefficient (𝑌𝑎) is introduced 
 
𝑌𝑎 =
𝐵𝑜𝑗 − ?̅?𝑗
?̅?𝑗 −𝑊𝑗
+ 1 (2.6) 
where 𝐵𝑜𝑗 is the boundary value for variable 𝑗. The value of 𝑌𝑎 is set to 0.5 if 𝑌𝑎 < 1.5 to ensure 
reasonable spacing between 𝑅, ?̅? and 𝑊 and that the simplex doesn’t shrink more than half the size 
of the original.150 Once a boundary is reached a new value for 𝑌𝑜𝑝𝑡 is calculated, which for a 
polynomial fit takes the form 
 
𝑌𝑜𝑝𝑡 =
(𝑌𝑎
2 − 𝑌𝑎)
2
𝑤 − ?̅?
𝑤(𝑌𝑎 − 1) − 𝑌𝑎?̅? + 𝑟
+ 0.5 (2.7) 
and for a Gaussian fit: 
 
𝑌𝑜𝑝𝑡 =
(𝑌𝑎
2 − 𝑌𝑎)
2
𝑙𝑛𝑤 − 𝑙𝑛 ?̅?
𝑙𝑛𝑤 (𝑌𝑎 − 1) − 𝑌𝑎 𝑙𝑛 ?̅? + 𝑙𝑛 𝑟
+ 0.5 (2.8) 
which is subject to additional conditions. When 𝑌𝑎 > 1, ?̅? must be greater than 
𝑟+𝑤(𝑌𝑎−1)
𝑌𝑎
 (for 
polynomial fit) or 𝑟1/𝑌𝑎𝑤(1−1/𝑌𝑎) (for Gaussian fit), otherwise 𝑌𝑎 is set to -1. When 𝑌𝑎 ≤ 1, ?̅? must 
be less than 
𝑟+𝑤(𝑌𝑎−1)
𝑌𝑎
 (polynomial) or 𝑟1/𝑌𝑎𝑤(1−1/𝑌𝑎) (Gaussian), otherwise 𝑌𝑎 is set to 3.
149 
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Figure 2.8 Transformations during the SMSim. Points W, N and B make up the original 
simplex and are ranked best (B), worst (W) and other (N). Point R is created by 
reflecting through the mid-point P̅ from W. The WP̅ distance is equal to P̅R distance; 
WO distance (Yopt) and position of O is calculated by fitting a polynomial or 
Gaussian curve between W, P̅ and R. 
2.3.4 Nelder-Mead Simplex 
The Nelder-Mead Simplex138 (NMSim) algorithm follows the same initial rules as the 
classical simplex algorithm where a reflected vertex 𝑅 is created. If 𝑟 is better than 𝑏, an expanded 
vertex (𝐸), which is reflected twice as far as 𝑅, is calculated:151 
 𝐸 = 2𝑅 − ?̅? (2.9) 
If 𝑒 (response of 𝐸) is better than 𝑟 then vertex 𝐸 is retained. If 𝑟 is not an improvement on 
the optimum then a new 𝑅 is calculated, reflecting from the next worse vertex, and this process 
continues until 𝑟 is an improvement on the optimum. If 𝑟 never improves then the current simplex 
must surround the true optimum and will start to contract. The first contraction vertex (𝐶1) occurs 
from 𝑊: 
 
𝐶1 =
𝑊 + ?̅?
2
 
(2.10) 
If 𝑐1 is better than 𝑤 then 𝐶1 replaces 𝑊 in the new simplex, otherwise a second contraction vertex 
(𝐶2) is calculated, which contracts from 𝑅. 
 
𝐶2 =
𝑅 + ?̅?
2
 (2.11) 
If 𝑐2 isn’t better than 𝑤 then the simplex must shrink towards 𝐵, and a new vertex 𝑆 is calculated: 
 
𝑆 =
∑ 𝑁𝑖𝑖
𝑖
 (2.12) 
where 𝑁 is any vertex that isn’t 𝐵,𝑊, 𝑅, 𝐸 or 𝐶 and 𝑖 is the number of those vertices. It should be 
noted that the cycle is refreshed upon iteration and the simplex can still reflect and expand after a 
contraction or shrink.  Figure 2.9 shows geometric representations of the transformations. 
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Figure 2.9 Transformations that occur during NMSim algorithm: (a) reflection through 
midpoint P̅ to new point R; (b) expansion of R to new point E; (c) contraction from 
W to new point C1 or from R to new point C2; (d) shrinking towards point B to make 
new point S. During a reflection, expansion or contraction the conditions of midpoint 
P̅ are calculated but not its response. During a shrink, both the conditions and 
response of P̅ are calculated. 
2.3.5 SNOBFIT 
SNOBFIT (Stable Noisy Optimisation by Branch and Fit) is a branch and fit algorithm used 
in linear programming for a computationally expensive function.136 The algorithm starts by plotting 
random points until it has enough to fit a polynomial surface. It will then plot exploratory and local 
points to improve the surface fit and find optimal points. The algorithm will continue to plot both 
exploratory and local points as it continues to seek optima. 
Each algorithm cycle contains a property called 𝑛𝑟𝑒𝑞, which is the number of requested 
points and is a user input at the beginning of the optimisation. Other user inputs include call, the 
number of total 𝑛𝑟𝑒𝑞, dx, the precision of each variable, the upper and lower boundaries, and prob, 
the probability of exploring empty space. Each experimental data point is assigned one of 5 types: 
1. Global minimum 
2. Secondary minima 
3. Local point to improve the polynomial fit 
4. Random exploratory point 
5. Initial scatter if there is insufficient data to fit a polynomial 
Typically, the first 2-3 𝑛𝑟𝑒𝑞 only contain type 5 points in order to gain more information 
about the system. Afterwards, per cycle, the algorithm will plot a single type 1 point and, if 
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applicable, a single type 2 point. The number of type 4 points is determined by the value of 𝑝𝑟𝑜𝑏 
and any resultant points in the cycle are filled with type 3 points. Sometimes the algorithm will 
increase the value of 𝑛𝑟𝑒𝑞 to increase the number of type 3 points and improve the polynomial fit. 
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3. Optimising the Continuous Synthesis of a Pharmaceutical 
Intermediate using a Self-Optimising Flow Reactor 
3.1 Introduction 
To achieve effective optimisation of a reaction process, careful consideration is needed of 
the various synergistic interactions that occur between reaction variables such as temperature, 
reaction time and reagent concentrations. It is important to ensure that suitable parameter-defining 
experiments have been carried out during the course of process development to deliver a robust 
process that can be easily transferred to a manufacturing facility. Design of experiments (DoE) is a 
commonly used approach which implements statistical methods to screen and optimise a reaction, 
particularly for problematic steps and has been used in the synthesis of many pharmaceutical 
products.2 
A DoE is traditionally constructed using a full factorial design (FFD), which requires 
experiments at the minimum and maximum of each variable split across each level in all possible 
combinations, plus centre-points.152 Centre-points are used to show curvature in the response 
between the variable extremes and are repeated to show how reproducible the model results are. 
The number of experiments for a full factorial is calculated by: 
 𝑛𝑘 +𝑚 (3.1) 
where 𝑛 is the number of levels, 𝑘 is the number or variables and 𝑚 is the number of centre-
points.153 This number increases exponentially with increasing variables and can be too large to 
carry out efficiently for a high number of variables. Table 3.1 shows the number of experiments per 
number of variables for 2- and 3-level full factorial designs. 
A 2-level full factorial will show which of the variables (or main effects) contribute most to 
the response, as well as interactions between variables. For example, temperature and time could be 
an interaction as reactions are faster at higher temperature and vice versa. Interactions can occur 
between 2-, 3- and up to 𝑘-variables. 
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Table 3.1 The number of experiments in full factorial experiments. 
No. of variables 
No. of experiments 
2-level 3-level 
2 22 = 4 32 = 9 
3 23 = 8 33 = 27 
4 24 = 16 34 = 81 
5 25 = 32 35 = 243 
6 26 = 64 36 = 729 
7 27 = 128 37 = 2187 
8 28 = 256 38 = 6561 
 
A fractional factorial (FED) reduces the number of experiments required by at least half.154 
The number of experiments in an FED is calculated by: 
 𝑛𝑘−𝑓 +𝑚 (3.2) 
where 𝑓 is the factor that the design is reduced (i.e. half=1, quarter=2, either=3 etc.). 
 
Figure 3.1 Example of a 2-level 3-variable FFD (A) and 1/2 FED (B). The tables show how the 
design is constructed. The vector of c is calculated from the product of ab (e.g. exp 
1, 1×1=1; exp 2, -1×1=-1 etc.) 
 
2-level 3-variable 
full factorial
Exp a b c
1 + + +
2 - + +
3 + - +
4 - - +
5 + + -
6 - + -
7 + - -
8 - - -
9 0 0 0
10 0 0 0
2-level 3-variable 
½ fractional factorial
Exp a b c=ab
1 + + +
2 - + -
3 + - -
4 - - +
5 0 0 0
6 0 0 0
A
B
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The reduction in experiments is achieved by replacing (or confounding) a main effect with 
an interaction (Figure 3.1B). This means that it is impossible to distinguish between a main effect 
and its confounded interaction. As the number of variables in an interaction increases the 
coefficient of that interaction (i.e. how much it contributes to the model) decreases. Therefore a 
main effect will be confounded with the highest available interaction. If a design has a lot of 
variables then the reduction in experiments is justified as it would be uncommon for an interaction 
of greater than 3 variables to contribute anything towards the fit of the model. However as the 
variables increase, or the degree of the FED decreases, the chance of a main effect confounding 
with an interaction with a large coefficient is high. In Figure 3.1B, the highest available interaction 
is a 2-variable interaction, which results in 𝑐 being confounded with 𝑎𝑐. It may not be clear if a 
high coefficient for 𝑐 is a result of the 𝑎𝑐 interaction. 
The resolution of an FED describes the amount and extent of confounding in the model: 
 Resolution III: main effects are confounded with 2-variable interactions 
 Resolution IV: main effects are not confounded with 2-variable interactions; 2-
variable interactions are confounded with other 2-varibale interactions. 
 Resolution V: main effects are not confounded with 2-variable interactions; 2-
variable interactions are confounded with 3-variable interactions etc. 
The FED shown in Figure 3.1 was constructed by setting 
 𝑐 = 𝑎𝑏 (3.3) 
If both sides are multiplied by 𝑐: 
 𝑐2 = 𝑎𝑏𝑐 (3.4) 
or 
 𝐼 = 𝑎𝑏𝑐 (3.5) 
where 𝐼 is the generator. The resolution of a design is determined by the shortest possible 
generator. For this example the FED is a resolution III half factorial, otherwise notated as 2III3-1. 
Table 3.2 shows how the confounding changes for models of different resolution for designs with 3 
to 6 variables. 
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Table 3.2 Construction of 2-level fractional factorial designs for 3 to 6 variables of differing 
resolution154, 155 
Variables 2III3-1 2IV4-1 2V5-1 2III5-2 2IV6-2 2III6-3 
a a a a a a a 
b b b b b b b 
c ab c c c c c 
d - abc d ab d ab 
e - - abcd ac abc bc 
f - - - - bce ac 
No. exps 4 8 16 8 16 8 
 
The final step of the synthesis of the Src kinase inhibitor saracatinib (3.3 AZ), a nucleophilic 
aromatic substitution between a fluoroanilidine and an alcohol (Scheme 3.1),156 was optimised 
using a fractional factorial DoE154, 155 due to a poor isolated yield. The key issues upon scale up 
were: increased impurity formation at temperatures higher than 90 °C, a high charge of alcohol was 
required for acceptable reaction times and the unknown role of water in the reaction that appeared 
to increase the reaction rate and improve selectivity. The design carried out was a two level 
resolution IV design of four reaction variables (stoichiometry of base, water and alcohol 3.2; and 
temperature) totalling 10 experiments (2 centre-points). 
 
Scheme 3.1 Final step SNAr reaction in the synthesis of saracatinib 3.3.156 
The results of the design revealed four key findings: an excess of base above 2.2 eq did not 
affect the reaction; water stoichiometry higher than the equivalents of base greatly reduced the 
reaction rate; higher temperatures improved the rate but increased impurity formation and 
increasing the equivalents of alcohol 3.2 improved the rate although this would be undesirable due 
to the cost implications. 
The disadvantage with FEDs is that extra experimentation might be required to distinguish 
between a main effect and interaction, and no 2-level factorial designs (FFD and FED) can be used 
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for accurate prediction because only linear coefficients are included. A different design is required 
to predict and define process parameters, called a response surface method (RSM, Figure 3.2).153, 
157, 158 
 
Figure 3.2 Experimental plots of 3-variable RSM designs. The blue points are experimental 
data points, axial “star” points (central composite) are highlighted in green, centre-
points are highlighted in orange. 
A troublesome step in the synthesis of an antibiotic (GSK) was the deprotection of silyl ether 
3.4 to alcohol 3.5.3 Lactone 3.6 is formed from the product 3.5 and the compounds were found to 
co-crystallise upon isolation. The reaction was optimised using RSM with the aim to improve the 
yield of 3.5 (>75% by HPLC area), reduce the presence of 6 in the crude product (<2% by HPLC 
area, which would translate to <0.5% isolated product) and minimise the amount of TREAT-HF for 
cost purposes.  
 
Scheme 3.2 Deprotection of silyl ether 4 in the synthesis of 3.5 towards an antibiotic. Lactone 3.6 
is an undesired impurity (TREAT-HF = Et3N•3HF, NMP = N-methyl pyrolidine). 
A four variable central composite circumscribed design157, 158 was carried out using 
temperature, time, volumes of NMP and molar equivalents of TREAT-HF as variables with a total 
of 30 experiments. The model predicted different regions where the alcohol yield was maximised 
and the lactone yield was minimised. However, superimposing these conditions generated an 
operating region that fulfilled the criteria of alcohol yield >93% and lactone yield <2%. These 
3-level 3-variable
full factorial
2-level 3-variable
central composite
3-level 3-variable
Box-Behnken
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conditions increased the alcohol yield during manufacture from 68% to 94% whilst still 
maintaining low levels of impurities in the final product. 
However, further experiments were required to verify the model and ensure sufficient 
robustness of manufacture. An additional 6 experiments were carried out to confirm the conditions 
predicted from the model. Whilst this number is not excessive it adds to the overall experiment 
number and therefore increases the time and resources required. 
The study suggests a route for choosing an experimental design for progression from 
uncertain process conditions to robust manufacture (Figure 3.3). Initial scoping experiments 
provide boundary limits for each variable. The screen shows key main effects and interactions and 
can be used to eliminate variables from the design for the next optimisation step. This step adds 
curvature to the model allowing a response surface to be fitted which can be used to predict 
responses. The final robustness step shows how far away from the optimum the response will be 
and is the basis of operating limits for manufacture. 
 
Figure 3.3 Recommended steps for selecting experimental designs to choose conditions for 
manufacture. Blue points are experimental data points, axial “star” points (central 
composite) are highlighted in green, centre-points are highlighted in orange, the 
optimum point is highlighted by the star.3 
The scope might seem a trivial step and could be eliminated in order to progress to the screen 
where more information is obtained. However, the variable limits are decided in this step and are 
incredibly important to obtain a good overall fit. Models are generated by fitting a polynomial to 
the responses of the experimental data points. Polynomial curves are very poor at fitting sharp 
changes in response, especially over a broad range. Instead it is sensible to choose limits where the 
maximum change in response is happening over the minimum change in a variable. Figure 3.4 
shows how a polynomial fit can be improved by reducing the variable limits. 
Screen
factorial design
Optimise
central composite
Scope Robustness
Plackett-Burman
 71 
 
 
Figure 3.4 Examples of how the fit of a polynomial can improve between different limits. The 
blue line shows a polynomial fit over the whole data range, the red line shows a 
polynomial fit in the shaded section only. The red polynomial shows a better fit over 
the shaded area; the polynomial is extended to outside this space to show how poorly 
it will extrapolate. 
The disadvantages of reducing the variable limits range might not seem apparent as the 
model will optimise and deliver manufacturing conditions within this limit. However, developing a 
process for the manufacture of an active pharmaceutical ingredient (API) requires focus on more 
than just yield as control of impurities is crucial. This can involve synthesising sufficient quantities 
of an impurity to characterise and asses any toxicological hazards. Therefore the ability to screen 
and optimise in a larger experimental space than that available in DoE is highly advantageous. 
A self-optimising reactor with adaptive feedback algorithm can explore a larger experimental 
space than DoE. The rejection of points that contribute to a lower response means that only the 
important main effects and interactions are explored thus providing the same information as a full 
factorial in fewer experiments. The algorithms also generate a more concentrated scatter of points 
around the optimum illustrating the robustness of the reaction. Therefore a single self-optimisation 
can provide all the information that required 4 separate steps by using a DoE. 
However, the choice of algorithm is very important. Some algorithms will directly move 
towards the optimum region but not provide additional information about experimental space that 
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does not lie between the starting point and optimum. If an exploratory algorithm, such as 
SNOBFIT (stable noisy optimisation by branch and fit), is used then the data will be spread across 
all of the experimental space and can still provide a replica of a response surface. 
The SNOBFIT algorithm is a branch and fit algorithm that will generate random scatter 
across the experimental space until it has enough data points to fit a polynomial. It will then plot 
points that simultaneously target improving the optimum, the polynomial fit and exploring empty 
space. It does not suffer from the poor polynomial fit demonstrated in DoE as the concentration of 
points around the optimum will naturally improve the fit, and therefore predicted response, in that 
area. The exploration of empty space means that the scatter can show how the response changes in 
areas of poorer response and can also find and distinguish between local and global optima. 
 
Scheme 3.3 Synthesis of acrylamide 3.10, the freebase of the AZD9291 API. Aniline 3.7 is 
treated with acid chloride 3.8 to give unisolated intermediate 3.9, which undergoes 
base mediated elimination to generate 3.10. 
There is motivation to develop adaptive feedback control technologies to explore a greater 
area of experimental space than DoE, providing optimum response and robustness. An automated 
flow reactor is ideally suited for such an initiative as monitoring and control of reaction variables, 
such as flow rate, temperature and pressure can be achieved rapidly within a single system.8, 9, 53, 54, 
159 This chapter explores the applicability of using this technology in process development by 
optimising a model reaction then transferring the knowledge gained towards the final bond forming 
step in the synthesis of AZD9291 (osimertinib, 3.10), an irreversible epidermal growth factor 
receptor (EGFR) tyrosine kinase inhibitor with T790M mutation, developed for treating non-small 
cell lung cancer (Scheme 3.3).160-162 
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3.2 Model Optimisation Study 
A model reaction study was carried out, using the same chemical transformation as in the 
AZD9291 synthesis but with a commercially available substrate. With this approach, an 
experimental set-up could be developed without wasting high value material. The reaction carried 
out was the telescoped synthesis of acrylamide 3.13, which proceeded via an amidation between 
aniline 3.11 and acid chloride 3.8, to form the unisolated β-chloroamide 3.12, followed by base 
mediated elimination (Scheme 3.4). 
 
Scheme 3.4 Telescoped synthesis to acrylamide 3.13 via the unisolated intermediate β-
chloroamide 3.12 
3.2.1 Initial Reaction Screening 
The aim of the initial reactions was to minimise the amount of solvent by pumping neat 
triethylamine and acid chloride with the aniline dissolved in acetonitrile, but the high 
concentrations resulted in clogging in the tee-piece from the resultant triethylammonium chloride 
(TEAC). The acid chloride was diluted with anhydrous acetonitrile but it was only possible to 
pump without clogging when water was added to the aniline reservoir. 
A temperature profile was carried out using an acetonitrile:water mixture (7:2, v:v) for the 
aniline solution (0.25 mol L-1, 4.4 mmol L-1 biphenyl IS), anhydrous acetonitrile for the acid 
chloride solution (2.2 mol L-1) and neat triethylamine. The flow rates were adjusted to correspond 
to 1.05 eq acid chloride and 10 eq triethylamine, with a 2.5 min residence time. The high excess of 
base was to ensure the HCl byproduct was quenched and prevent corrosion of the stainless steel 
reactor parts; and to encourage high yields of acrylamide 3.13.  
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Figure 3.5 Reactor setup for the model compound study. SL – sample loop 
The results of the temperature profile (Figure 3.6) show that the first step in the reaction is 
very fast, as full conversion of 3.11 to 3.12 is achieved after 2.5 mins at all temperatures. The 
second elimination step is slower and requires higher temperatures to maximise the yield of 3.13 
under the conditions for the temperature ramp. An unknown impurity (imp1) was formed that had a 
higher yield at lower temperatures and decreased with increasing temperature. This could be 
rationalised by three explanations: imp1 is formed from the chloroamide, which is at higher 
concentrations at lower temperatures; the desired reaction route is faster at higher temperatures; or 
imp1 is formed in an equilibrium which favours the reactants at higher temperatures. No other 
major impurities were identified at this stage, but the conversion of 3.12 was incomplete so more 
impurities could form at longer residence times. 
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Figure 3.6 Temperature profile of the continuous reaction shown in Scheme 3.4. Reaction 
conditions were 1.05 eq 3.8, 10 eq NEt3 and 2.5 min. The product composition is 
measured by HPLC area % after removing the internal standard peak. 
3.2.2 Reaction Optimisation 
The reaction yield, measured using at-line HPLC, was optimised using the SNOBFIT 
algorithm, with the flow rate of the aniline 3.11 (pump A), molar equivalents of acid chloride 3.8 
(pump C - wrt aniline), triethylamine (pump B – eq, wrt acid chloride) and the reactor temperature 
as variables. The pump reservoir solutions were diluted from those used in the temperature profile 
so that the volumetric flow rates were similar and all the TEAC would be in solution. The real-time 
yield was calculated from the ratio of the HPLC peaks of 3.13 and biphenyl internal standard; the 
algorithm was set to find conditions to maximise this value. The boundary condition limits and 
reservoir concentrations are displayed in Table 3.3. The temperature range was decreased from the 
temperature profile as the increased dilution resulted in the reaction boiling and it was decided that 
a lower maximum temperature was preferable to increasing the pressure of the BPR. 
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Table 3.3 Optimisation boundary limits for the conditions of the model aniline reaction 
Limit Pump A / 
 mL min-1 
Pump B / 
mol eq 
Pump C / 
mol eq 
Temperature / 
°C 
Minimum 0.100 4.5 0.9 0 
Maximum 0.500 20 2.1 130 
Pump A reservoir 0.241 mol L-1 aniline 3.11, 0.0156 mol L-1 biphenyl, pump B reservoir 3.73 mol L-1 
triethylamine, pump C reservoir 1.00 mol L-1 acid chloride 3.8. 
The results of the optimisation are displayed in Figure 3.7. The optimum conditions are 0.1 
mL min-1 3.11, 117.8 °C, 1.7 equivalents of 3.8, 16 equivalents of triethylamine and a residence 
time of 12.2 min, generating 3.13 in a 92% yield. A low aniline flow rate correlates to an increase 
in the residence time and higher yields are achieved at higher temperatures. The excess of 3.8 is 
likely to compensate for the competing hydrolysis reaction and high equivalents of triethylamine 
are possibly required to accelerate the slower elimination step. Further scrutiny of the HPLC 
chromatograms show >99% conversion of 3.11 in all experiments with the other main component 
being the intermediate 3.12, highlighting that the elimination step is probably rate limiting. In the 
optimum chromatogram, complete conversion of 3.11 is achieved with the resulting impurities 
totalling 8% (2.7% 3.12). 
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Figure 3.7 Multi-dimensional plot of the optimisation of acrylamide 3.13. The 3-axis plot show 
the aniline 3.11 flow rate (x-axis), acid chloride 3.8 eq (y-axis) and temperature (z-
axis). The size of the point represents the eq of NEt3, and the colour represents the 
product yield. The optimum conditions: 12.2 min, 118 °C, 16 eq NEt3, 1.7 eq 3.8 are 
highlighted by the star. 
3.2.3 Impurity Identification and Optimisation 
Using the optimisation data, it was possible to create multi-dimensional plots for all the 
significant impurities observed by HPLC, and find the experimental space where impurity yield is 
high (Figure 3.8). This is important, not only to find operating conditions where impurities are 
minimal for manufacture but to find where impurity formation is high in order to synthesise it for 
characterisation. The US Food and Drug Administration (FDA) guidelines dictate that any non API 
compounds present in the drug substance above 0.05%d must be identified.163 The ability to use 
automated equipment that can track substance composition in experimental space is a great asset 
for impurity identification  
Impurities in the optimisation were identified using offline LC-MS and by comparing the 
relative retention times with known impurity standards in the API HPLC method. An impurity 
                                                 
d Impurity threshold of 0.05% for drug products with a daily dose of >1 g; 0.1% for drug products with a 
daily dose of ≤1 g.  For more information see reference 18. 
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(imp1) had already been observed during the temperature profile but did not match anything in the 
API HPLC method. An impurity of particular concern in the current API synthesis was known to 
be a dimer. In this model system, a dimeric impurity with a molecular weight equivalent to two 
monomers of 3.13 was also detected. Two potential mechanisms were proposed that could lead to 
dimeric species: nucleophilic substitution between 3.11 and 3.12 followed by amidation with 3.8 
and subsequent elimination to give 3.15a; or a Rahut-Currier mechanism164 (a variation on the 
Baylis-Hillman reaction)165-167 via the enolate 3.14 to give dimer 3.15b (Scheme 3.5). In the LC-
MS analysis, imp1 had a mass of m/z 309 and further LC-MS-MS analysis showed a fragment of 
m/z 208 in the second MS spectrum. These data suggest that imp1 is the enolate 3.14 and from the 
potential mechanistic motifs proposed in sub-chapter 3.2.1, it is proposed that formation of the 
enolate 3.14 is reversible. 
 
Scheme 3.5 Proposed mechanisms to dimers 3.15a and 3.15b. The observation of a peak 
corresponding to 3.14 favours the Rahut-Currier mechanism to 3.15b. All observed 
peaks from offline LC-MS are displayed. 
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Figure 3.8 Multi-dimensional plots showing the compositions of the major impurities: aniline 
3.11 (a), β-chloroamide 3.12 (b), enolate 3.14 (c) and dimer 3.15 (d). The maximum 
composition for each compound is highlighted by the star. 
A further optimisation was then run in order to maximise the amount of 3.14, and find 
experimental regions where the impurity formation is high. The yields of by-product 3.14 from the 
original optimisation (Figure 3.7) were inputted to SNOBFIT as preliminary data and the algorithm 
continued from the last data set using the same boundary limits (Table 3.3).  
It should be expected that the optimum region for the formation of 3.14 (Figure 3.9) is 
similar to that of the acrylamide 3.13, as the acrylamide is a precursor for the formation of the 
enolate. However, 3.14 is formed in higher yields at much lower temperatures, suggesting two 
possibilities for its formation. Firstly, it could be that increased temperatures favour the onward 
reaction of 3.14 with another molecule of 3.13, resulting in the formation of the dimer 3.15b. 
Secondly, as the reaction from 3.13 to 3.14 (Scheme 3.5) is likely to be reversible, it is possible that 
increased temperatures favour the acrylamide 13 in the equilibrium. However, any mechanistic 
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assumptions would need to be confirmed with further kinetic experimentation. It was hoped that 
these optimal conditions for 3.14 could be used for its full characterisation but attempts to isolate 
the compound were unsuccessful. 
 
Figure 3.9 Multi-dimensional plot, showing the results of the optimisation of enolate 3.14. The 
3-axis plot show the aniline 3.11 flow rate (x-axis), acid chloride 3.8 eq (y-axis) and 
temperature (z-axis). The size of the point represents NEt3 eq, and the colour 
represents the product yield. The optimum conditions: 0.1 mL min-1 3.11, 117.8 °C, 
1.5 eq 3.8, 15.2 eq NEt3 and 12.7 min are highlighted by the 5-pointed star. The 
optimum conditions of 3.13 are highlighted by the 6-pointed star. 
Further LC-MS-MS analysis was carried out using samples acquired from the optimisation 
to find a reasonable explanation of the dimer structure. The presence of enolate 3.14 favours the 
Rahut-Currier route to 3.15b. LC-MS-MS of the dimer peak (m/z 437, [M+Na]+) showed a 
fragment of m/z 230, which is assumed to be a sodium adduct. Each dimer can produce that 
fragment, but the C-N disconnection of dimer 3.15a looks more probable than the C-C of 3.15b. 
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Scheme 3.6 Proposed adduct fragments of dimers 3.15a and 3.15b. The final adducts assume that 
the respective radical is quenched by a hydrogen radical and undergoes no further 
isomerisation or elimination. It should be noted that only one of the radical 
intermediates will be quenched to form an adduct after a single fragmentation. 
3.3 Optimisation of AZD9291 Freebase 
The data obtained from the model compound was used for optimising the final bond forming 
step of AZD9291.160-162 Phase I clinical trials showed an encouraging response to the drug, which 
prompted the FDA to award it breakthrough status for fast track through Phases II and III.168 
Therefore rapid development and optimisation was required to meet the demands put in place by 
the regulatory bodies, something that a self-optimising reactor would be highly suitable for. 
3.3.1 Optimisations Using AZD9291 Free Aniline 
Under the batch conditions developed at AZ, a slurry of aniline 3.7 is cooled to 0 °C before 
addition of acid chloride 3.8. The presence of a tertiary alkyl amine on the starting material 
facilitates the first amidation step without requiring base. Next, triethylamine is added and the 
reaction is heated at reflux to undergo elimination to acrylamide 3.10 (AZD9291 freebase, Scheme 
3.7). It had been observed at AZ that the impurities were forming during the heating gradient to 
reflux and the model optimisations showed that selectivity and yield of the eliminated product was 
greater at elevated temperatures. Therefore, it was proposed that the reaction would benefit from 
the safer operation of elevated temperatures and excellent heat transfer in flow reactors to increase 
the selectivity of the reaction and minimise impurity formation. 
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Scheme 3.7 Synthesis of acrylamide 3.9, the freebase of the AZD9291 API. Aniline 3.7 is treated 
with acid chloride 3.8 and triethylamine to yield unisolated intermediate 3.9, which 
undergoes base mediated elimination to generate 3.10. 
3.3.2 Development of Process Conditions for the Continuous Synthesis of AZD9291 
Acrylamide 
One of the challenges of transferring the process from batch to continuous was the low 
solubility of 3.7 in the solvent mixture. The reactor pumps require homogeneous solutions, and 
dissolution of 3.7 was only achieved with 60 relative volumes (RV) of solvent. This would not be 
suitable for a manufacturing process due to the excess of solvent. Therefore a brief solvent screen 
compared the solubility of 3.7 in methanol, acetone, ethyl acetate, anisole, diethyl carbonate, 
dioxane and tetrahydrofuran. Saturated solutions of 3.7 in each solvent were filtered and then the 
absorbance of the filtrate was measured using HPLC-UV/Vis; a solubility model was built using 
DynoChem software.169 This was coupled with separate thermodynamic solubility calculationse and 
both studies showed that anisole was an attractive replacement to aqueous acetonitrile. 
In anisole, aniline 3.7 dissolved in 25 RV, which is higher than ideal for manufacture but is a 
lot lower than the existing solvent mixture. Anisole also scores more favourably than acetonitrile in 
solvent comparison studies based on safety, environmental and occupational health factors.170 
However, the reaction was much slower and multiple experiments over a period of time resulted in 
accumulation of solids and clogging. Anisole was replaced with acetonitrile in the triethylamine 
reservoir to improve the reaction kinetics but the reaction was still slow and it required addition of 
water to prevent clogging. The water content was only 10% (v:v) in the triethylamine reservoir but 
this coalesced to a biphasic mixture upon leaving the reactor, which could incur problems for 
HPLC sampling if aqueous material was sampled rather than organic. 
                                                 
e Thermodynamic solubility calculations were carried out using COSMOTherm software by S. Tomasi, 
AstraZeneca 
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Instead, a solution of the hydrochloride salt of 3.7 (0.8 eq HCl) was prepared, which would 
dissolve in 15 RV of the aqueous acetonitrile mixture. Sub-stoichiometric equivalents of acid were 
used to maintain a non-acidic pH thus preventing corrosion of stainless steel within the reactor. The 
boundary limits were adjusted from the initial AZD9291 optimisation to explore a larger chemical 
space. In particular, the temperature range was increased from the model reaction as poor 
conversion of 3.7 was achieved during initial experiments at lower temperatures. The optimisation 
limits are displayed in Table 3.4, the flow rates of which correspond to a calculated residence time 
between 4 and 22 minutes. The optimisation results are shown in Figure 3.10. 
Table 3.4 Optimisation boundary limits for the AZD9291 aniline reaction 
Limit Pump A / 
mL min-1 
Pump B / 
mol eq 
Pump C / 
mol eq 
Temperature / 
°C 
Minimum 0.080 2.2 0.75 80 
Maximum 0.150 15 3.0 150 
Pump A reservoir 0.136 mol L-1 aniline 3.7, 0.0255 mol L-1 biphenyl, pump B reservoir 1.20 mol L-1 
triethylamine, pump C reservoir 0.500 mol L-1 acid chloride 3.8. 
The optimum conditions (0.11 mL min-1 7, 2.65 eq 3.8, 10.5 eq NEt3, 123.9 °C, 9.36 min in 
89%) are slightly different to that of the model compound, with higher equivalents of triethylamine 
and 3.8, resulting in a shorter residence time than the free aniline, but this could be a consequence 
of the higher concentration resulting in a higher reaction rate. 
The flow rate of 3.7 is not at the minimum boundary and it exhibits a clear interaction with 
temperature. As the flow rate of 3.7 is increased there is a concurrent increase in temperature 
required to achieve high yields as the residence time decreases. The decrease in residence time 
could also be a result of improved mixing. Whilst this was proposed in the initial optimisation, this 
system involves an extra pre-equilibrium step to deprotonate the HCl salt of 3.7, which could be 
mixing sensitive. Further analysis of the HPLC chromatographs for each experiment show that the 
relative composition of 3.7 is typically higher than 3.9 indicating that the elimination is faster and 
the pre-equilibrium is most likely the rate limiting step. Unfortunately there is no way to identify 
the degree of protonation of 3.7 by HPLC and further kinetic experimentation would be required to 
support this hypothesis. 
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Figure 3.10 Multidimensional plot of the optimisation of acrylamide 3.10. The 3 axis flow rate 
shows the aniline 3.7 flow rate (x-axis), acid chloride 3.8 eq (y-axis) and temperature 
(z-axis). The size of the point corresponds to the triethylamine eq, the colour is the 
yield. Optimum conditions: 9.36 min, 123.9 °C, 10.5 eq NEt3, 2.7 eq 3.8 are 
highlighted by the star. 
The equivalents of triethylamine across the two optimum conditions vary significantly from 
10.57 to 16. It could be that each reaction requires different concentrations of base but there could 
be an alternate explanation. The flow rate of each pump controls the respective concentrations of 
the reaction components but also the overall residence time. The residence time wasn’t a main 
variable but was confounded from the flow rate of aniline and the equivalents of triethylamine and 
3.8. Therefore it could be proposed that the concentrations of aniline and 3.8 and the residence time 
were the most important factors, ignoring temperature, and the effect of the changes in equivalents, 
and subsequently flow rate, of triethylamine has more impact as an adjustment of residence time 
and concentration of 3.7 than as a concentration of triethylamine. 
3.4 Conclusions 
Presented is the novel application of implementing a self-optimising flow reactor for the 
continuous optimisation of the final bond forming step in the synthesis of an active pharmaceutical 
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ingredient. The concept was first tested on a model reaction to develop the experimental set up and 
data analysis for the ultimate optimisation of the API. The model optimisation was the telescoped 
synthesis of acrylamide 3.13 from aniline 3.11. Initial reaction conditions were developed by 
carrying out a temperature profile, where impurity formation was first observed. With the reaction 
set up in hand, the yield of acrylamide 3.13 was optimised using the SNOBFIT algorithm, 
providing conditions for its formation in 92% yield. The model optimisation also provided enough 
information to predict a mechanistic route to and possible structures for the impurities enolate 3.14 
and dimer 3.15. 
The final optimisation of 3.10 required 42 separate experiments, which used 10 g of material 
and lasted 37 hours (average of ~240 mg per experiment) providing the desired product in 89% 
yield. The overall time would have been less but clogging resulted in some periods of down time 
before the reactor could be restarted. One of these events occurred at 1 am and therefore was not 
noticed until the following morning. Fortunately, an automatic trip written into the optimisation 
program prevented wasteful continuous pumping of material by stopping all the pumps. Had the 
reactor pumped continuously without clogging through its whole operation, the optimisation would 
have finished in 26 hours. The impracticalities of performing the reaction in flow influenced the 
decision to carry out the reaction in batch for the manufacturing route. Ultimately, neither the work 
in this chapter, nor the complementary work by the AZ flow chemistry team could develop a 
reliable set-up where the reaction could be pumped continuously without problems. 
Nevertheless, the use of self-optimising systems allowed swift exploration and process 
optimisation even of multistage reaction systems without human intervention. The data obtained 
not only provided optimum regions of high product yield but aided the identification and 
mechanistic route to impurities. Crucially, this technology enables a shift in focus towards the 
scientifically challenging aspects whilst the automated system performed the routine 
experimentation. 
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4. Empirical response surface models generated using self-optimising 
algorithmsf 
4.1 Introduction 
Multivariate optimisation describes the changing of more than one variable at a time to track 
the change in response and ultimately find optimum conditions. This method has multiple 
advantages over only changing one variable at a time (OVAT) because the systematic approach to 
carrying out experiments does not lead to an increase in the number of total experiments and does 
not omit inter-variable interactions. 
Design of experiments (DoE) is the common approach, where statistical analysis is carried 
out on a predetermined grid of experiments (design). The result is an empirical model, which can 
predict the behaviour of the process within the limits for the variables studies. This differs from a 
conclusive model, which can predict all outcomes across all condition ranges. The information 
acquired from the model depends on the type of design: a linear design (screen) can show the 
important main effect variables and interactions; a quadratic design can show curvature in the 
model and can be used to interpolate, predict responses and optimise. 
Quadratic designs are typically labelled response surface methodology (RSM) because the 
curvature of the model allows a surface to be plotted using the terms generated from the model.157, 
158 Common designs for RSM include 3-level full factorial, central composite and Box-Behnken. 
Each of these designs feature 3 levels which allow the quadratic fit. The number of experiments per 
design depends on the number of factors, but it follows the order: Box-Behnken ≤ central 
composite << full factorial. 
All three of these designs have at least three levels and require experiments at the minimum 
and maximum extremes of each variable, either in the corners, edges or faces of the experimental 
cube. However, there are a few examples of using RSM with data that does not follow a 
conventional factorial design. The data generated from exploratory algorithms, such as SNOBFIT, 
provides a scatter across the experimental space but is used solely for optimising purposes rather 
than for acquiring information about a chemical system.136 There are examples of optimisation by 
                                                 
f The work in this chapter was carried out in collaboration with MChem student M. Jeraal. The Author and 
MJ carried out the experimental optimisations and all model and data analysis was carried out by the Author. 
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algorithm with multiple target functions,26, 171 but it is typical for an optimisation to be run for a 
single function and repeated for a new target or metric.17, 64, 172 Some algorithms will only generate 
new experiments with the aim of improving the existing optimum. Therefore only providing 
information about the reaction system in experimental space that lies between the initial and 
optimum points. It is hypothesised that RSM models can be fitted to data obtained from exploratory 
algorithms in order to provide more information about the chemical process and find optimum 
conditions for new single or compound target functions. This will be carried out by fitting quadratic 
models using commercially available DoE software and then applying statistical treatments and 
analysis that result in accurate models with good fit. 
4.2 Response surface model generation 
4.2.1 Example: Claisen-Schmidt condensation 
The reaction studied was a Claisen-Schmidt condensation between benzaldehyde 4.1 and 
acetone 4.2 to yield benzylideneketone 4.3 (Scheme 4.1). The reaction proceeds with NaOH base 
catalysis and will readily form the bis adduct, dibenzylideneacetone (DBA, 4.4), under mild 
conditions.173 A SNOBFIT optimisation was carried out to optimise the yield of the kinetic product, 
ketone 4.3, by varying the flow rate of benzaldehyde, molar equivalents of acetone, flow rate of 
base catalyst and reactor temperature. The flow reactor setup (Figure 4.1) consisted of three pumps, 
6 mL tubular reactor, inline filter and 6 bar back pressure regulator. The pump reservoirs contained 
benzaldehyde (1.95 mol L-1) and biphenyl internal standard (0.032 mol L-1) in ethanol, sodium 
hydroxide (0.2 mol L-1) in ethanol, and neat acetone. Online analysis was carried out using HPLC 
and the algorithm limits are displayed in Table 4.1. 
 
Scheme 4.1 Base catalysed Claisen-Schmidt condensation between benzaldehyde and acetone. 
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Figure 4.1 Reactor setup for the Claisen-Schmidt condensation. SL – sample loop 
Table 4.1 Boundary limits for the Claisen-Schmidt condensation optimisation 
Limits 4.1 flow rate /  
mmol min-1 
NaOH flow rate / 
mmol min-1 
4.2 /  
mol eq 
Temperature /  
°C 
Minimum 0.4  0.008 1 10 
Maximum 2.0 0.100 7 80 
 
 
Figure 4.2 Optimisation plot for the SNOBFIT optimisation of ketone 4.3. x-axis = 4.1 flow 
rate; y-axis = acetone eq; z-axis = temperature; size of the point denotes NaOH flow 
rate; colour of the point denotes yield . The optimum point is denoted by the star: 0.4 
mmol min-1 1, 7.0 eq acetone, 0.25 mmol min-1 and 35.8 °C. 
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The algorithm generated optimum conditions of 0.4 mmoL min-1 4.1, 7.0 eq acetone, 0.25 
mmol min-1 and 35.8 °C (Figure 4.2). The spread of data is scattered across the experimental space 
but generally concentrated towards low benzaldehyde flow rates and high acetone equivalents. 
4.2.2 Basic model generation 
The percentage yield of compounds 4.1, 4.3 and 4.4 were used as the responses for three 
separate quadratic models. Saturated models were generated by including all square and interaction 
terms and fitted using multiple linear regression (MLR). The model can be written as 
 ?̂? = 𝛽0 + 𝛽1𝑥1 + 𝛽2𝑥2 + 𝛽3𝑥3 + 𝛽4𝑥4 + 𝛽11𝑥1
2 + 𝛽22𝑥2
2 + 𝛽33𝑥3
2 + 𝛽44𝑥4
2 
+𝛽12𝑥1𝑥2 + 𝛽13𝑥1𝑥3 + 𝛽14𝑥1𝑥4 + 𝛽23𝑥2𝑥3 + 𝛽24𝑥2𝑥4 + 𝛽34𝑥3𝑥4 
(4.1) 
where ?̂? is the model response, 𝛽𝑖 is the coefficient of each term, 𝑥𝑖. The terms are displayed in 
Table 4.2. 
Table 4.2 Description of terms from equation (4.1) 
Term Variable Abbreviation 
𝑥1 Flow rate of 1 P1 
𝑥2 Acetone eq Ace 
𝑥3 Flow rate of NaOH  NaOH 
𝑥4 Temperature Temp 
 
Following construction of the model, the success of the fit can be quantified according to 
two terms 𝑅2 and 𝑄2. 𝑅2 measures how well the model fits the existing data, and is calculated by 
 
𝑅2 = 1 −
𝑆𝑆𝐸
𝑆𝑆𝑇
 
(4.2) 
 
where 𝑆𝑆𝐸 is residual sum of squares and 𝑆𝑆𝑇 is the total sum of squares 
 
𝑆𝑆𝐸 =∑(𝑦𝑖 − ?̂?𝑖)
2
𝑛
𝑖=1
 
(4.3) 
 
 
𝑆𝑆𝑇 =∑(𝑦𝑖 − ?̅?)
2
𝑛
𝑖=1
 
(4.4) 
 
where ?̂?𝑖 is the modelled (or predicted) response, 𝑦𝑖 is the experimental (or observed) response and 
?̅? is the mean experimental response. 𝑄2 measures how well the model will predict the response of 
new data, and is calculated by 
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𝑄2 = 1 −
𝑃𝑅𝐸𝑆𝑆
𝑆𝑆𝑇
 
(4.5) 
 
where 𝑃𝑅𝐸𝑆𝑆 stands for the prediction error sum of squares, and is calculated by refitting the 
model with a point 𝑖 removed, then calculating 𝑆𝑆𝐸 when predicting the response of the 𝑖
th point, 
?̂?(𝑖) 
 
𝑃𝑅𝐸𝑆𝑆 =∑(𝑦𝑖 − ?̂?(𝑖))
2
𝑛
𝑖=1
 
(4.6) 
 
4.2.3 Methods to improve the fit 
A model will have the maximum 𝑅2 value when all possible interaction and square terms are 
included because the degrees of freedom (DF) of the model (the number of terms subtracted from 
the total number of points) is low. The 𝑅2 fit can also be increased by removing data points that 
have a large deleted studentized residual when plotted as a normal distribution, which also 
decreases DF. The deleted studentized residual (DSR) measures the ratio of a residual (𝑒𝑖 = 𝑦𝑖 −
?̂?𝑖) by the estimation of its standard deviation (SD). In conventional DoE it is typical to repeat an 
anomalous experiment rather than remove it but in this case the spread of data and number of data 
points (high initial DF) allows deletion. However, reducing the DF too much can result in a poor 
model. 
The total DF is a measure of how much the data can vary without changing the model and is 
calculated by 𝑛 − 1, where 𝑛 is the number of experiments. For example, a survey of the details of 
a group of people is carried out and a model generated, which shows the average height of a male 
adult is 180 cm. The heights of four adult males are measured and they are 170, 180 and 190 cm. 
For the model to be correct, the height of the fourth man must be 180 cm. Therefore the model has 
3 DF; the heights of the first three men can be anything but the height of the final must be a value 
that supports the hypothesis. In this case, an average height of 180 cm. The complexity can be 
increased by adding an additional term so that the average height and weight of an adult male is 
180 cm and 85 kg, respectively. The model now has 2 DF; the height of the fourth man and weight 
of the third must be values that support the hypothesis. If it is discovered that the first man is not a 
fully grown adult, they must be removed from the model. Now the model only has 1 DF, meaning 
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only one data point can have any variation. Therefore it is important to increase the DF to generate 
a more robust model. 
The model is improved by removing terms where the potential to contribute to the model is 
calculated to be zero. This generally does not greatly decrease the 𝑅2 value but will increase the 
DF and 𝑄2 value because the model is better at predicting with fewer terms and higher DF. 
The saturated model (4.1) for ketone 4.3 is shown in Figure 4.3 with all coefficients, normal 
probability vs deleted studentized residuals plot and 𝑅2 and 𝑄2 values. The model had an average 
fit (𝑅2 = 0.753) but poor predictability (𝑄2 = 0.495). However, as described above, there were 
steps to be taken to improve the fit. 
 
Figure 4.3 Model coefficients (left) and normal probability distribution (centre) and 𝑹𝟐 and 𝑸𝟐 
(right) for the saturated model of ketone 3. 
The normal probability plot showed an S-shape fit, which demonstrated that the data was not 
normally distributed and also showed that experiment 26 had high residual error. Removing this 
experiment, along with a further 7, improved the 𝑅2 and 𝑄2 values to 0.961 and 0.907, 
respectively. It is standard procedure to repeat anomalous results in a DoE, however the high 
number of experiments obtained during the SNOBFIT optimisation justified their removal. The 
anomalous experiments could be caused by faulty pumps or integration error with HPLC analysis. 
The statistical significance of a coefficient is measured by its 𝑝-value, which is a measure of 
whether the null hypothesis of the model should be rejected.174 A 𝑝-value of >𝛼 (for 95% 
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confidence interval, 𝛼 = 0.05) shows significance towards the null hypothesis and can therefore be 
rejected from the model. Coefficients with 𝑝-values of >𝛼 had error bars that overlapped the x-axis 
(Figure 4.3), stating that their contribution to the model was potentially zero, and were removed 
from the model. After a coefficient was removed, the model was re-fitted and the p-value could 
change. Therefore it was important to only remove a single coefficient at a time and reassess the 𝑝-
values of each coefficient. Figure 4.4 shows the model coefficients and summary of fit for the 
improved model. Removing insignificant coefficients and anomalous experiments improved the 
overall fit and predictability as well as the normal distribution of the data. 
 
Figure 4.4 Model coefficients (left) and normal probability distribution (centre) and 𝑹𝟐 and 𝑸𝟐 
(right) of the model for ketone 4.3 after removing anomalous experiments and non-
significant coefficients. 
4.2.4 Transformations 
The model for ketone 3 had the advantage of good initial 𝑅2 and 𝑄2 values, requiring only 
slight modification of the model to improve both fits. However the model for benzaldehyde 4.1 
needed much more treatment. The 𝑅2 value for the initial saturated model (4.1) was only 0.55 and 
the 𝑄2 was 0.06 (Figure 4.5). 
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Figure 4.5 Monitoring how the 𝑹𝟐and 𝑸𝟐 values change with treatments to improve the fit of 
model for aldehyde 4.1. Sat. = saturated; trans. = transformed; untrans. = 
untransformed; coeffs. = coefficients. 
All of the experiments were within ±4 SD on the normal probability plot; however five 
points were deleted, which resulted in a spread of data where all points were within ±3 SD. As 
shown in Figure 4.5 (remove anomalies), this greatly improved the fit but no further improvements 
were witnessed after removal of coefficients.  
Next, the model was investigated to see if it could be a good candidate for a transformation, 
where the response is treated with a mathematical transformation such as a logarithm or indices.175, 
176 Transformations are calculated according to  
 
𝑦(𝜆) = { 
𝑦𝜆          𝑖𝑓 𝜆 ≠ 0
𝑙𝑜𝑔(𝑦)   𝑖𝑓 𝜆 = 0
 (4.7) 
for 𝑦 > 0 where where λ is a parameter that defines the transformation and 𝑦(𝜆) is the transformed 
response. λ is determined using the maximum likelihood estimation (MLE, 𝐿𝑚𝑎𝑥(𝜆)), of the 
regression of transformed responses 
 
𝐿𝑚𝑎𝑥(𝜆) = −
1
2
𝑛 𝑙𝑛 (
𝑆𝑆𝑅,𝜆
𝑛
) + (𝜆 − 1)∑𝑙𝑛 (𝑦𝑖)
𝑛
𝑖=1
 (4.8) 
Where 𝑛 is the number of experiments and 𝑆𝑆𝑅,λ is calculated by 
 
𝑆𝑆𝑅,𝜆 =∑(𝑦(𝜆)𝑖 − ?̅?)
2
𝑛
𝑖=1
 (4.9) 
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A plot of 𝐿𝑚𝑎𝑥(𝜆) vs different values of λ (Box-Cox plot)
175 will show the best recommended 
transformation, which can be approximated within a  (1 − 𝛼) confidence region using 
 
𝐿𝑚𝑎𝑥(𝜆
∗) − 𝐿𝑚𝑎𝑥(𝜆) <
1
2
𝜒𝐷𝐹𝜆
2 (𝛼) (4.10) 
where λ∗ is the value that supports the best transformation, χ𝐷𝐹𝜆
2  is the chi-squared distribution for 
the degrees of freedom of 𝜆 and 𝛼 is the confidence interval (for 95%, 𝛼 = 0.05). Transformations 
are typically calculated for −2 ≤ 𝜆 ≤ 2, a summary of which are displayed in Table 4.3. 
Table 4.3 – Summary of common transformations based on the MLE 𝝀 value 
MLE 𝜆 value Transformation 
-2 𝑦(λ) =
1
𝑦2
 
-1 𝑦(λ) =
1
𝑦
 
0 𝑦(λ) = ln (𝑦) 
0.5 𝑦(λ) = √𝑦 
1 
𝑦(λ) = 𝑦 
No transformation 
2 𝑦(λ) = 𝑦2 
 
The Box-Cox plot for the aldehyde 1 model supports a logarithm transformation because the 
λ value is closest to zero (Figure 4.6). The 𝑄2 value decreased after the transformation, however 
when the non-significant terms were removed a greater 𝑅2 was achieved with transformation than 
without (Figure 4.5) (after trans.). The transformation also supported an improvement in the in 
normal distribution of the data (Figure 4.7). 
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Figure 4.6 Box-Cox plot for benzaldehyde 1 model. The 𝑳𝒎𝒂𝒙(𝝀
∗) value is approximated to 
95% confidence interval. 
 
Figure 4.7 Comparison of the normal probability distribution for the transformed (left) and 
untransformed (right) benzaldehyde 1 models. The transformed data fits a straight 
line and shows an improved normal distribution.  
A design feature of some response surface methods is that they are rotatable, which means 
that the variance in each experimental point is constant for points that have the same distance from 
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the centre-point, regardless of their location.177 Constant variance is simple to determine for 
conventional RSM models, such as central composite or Box-Behnken, as it is easy to calculate 
experiments with the same distance. It is simple to see visually that these models have rotational 
symmetry. The data generated from SNOBFIT is much more random and if there is more than two 
data points with the same distance from the centre-point, they would be difficult to spot visually. 
However, constant variance can be qualitatively confirmed by looking at the spread of DSR against 
each variable. A random spread of data shows constant variance, whereas a trend that follows a 
shape such as cone or curve can be the result of a missing model term or non-constant variance. 
The initial untransformed model showed a cone shape for the benzaldehyde flow rate variable vs 
DSR, indicating non-constant variance. As shown in Figure 4.8, the randomness of the variable vs 
DSR increases after transformation. 
 
Figure 4.8 Comparison of deleted studentized residuals vs flow rate of 4.1 for the transformed 
(left) and untransformed (right) models of benzaldehyde 4.1. 
4.2.5 Analysis of variance and lack of fit 
The quality of fit has been described above as having high values for 𝑅2 and 𝑄2, however 
these quantities do not completely explain all aspects of the model. A method of quantifying the 
model in terms of testing the null hypothesis is by using analysis of variance (ANOVA). This 
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separates the total sum of squares (𝑆𝑆𝑇) associated with the model into regression error (𝑆𝑆𝑅), due 
to the model fit and residual error (𝑆𝑆𝐸), due to the noise 
 𝑆𝑆𝑇 = 𝑆𝑆𝑅 + 𝑆𝑆𝐸  (4.11) 
where 
 
𝑆𝑆𝑅 =∑(?̂?𝑖 − ?̅?)
2
𝑛
𝑖=1
 (4.12) 
The total degrees of freedom (𝐷𝐹𝑇) can also be separated into regression and residual so that 
 𝐷𝐹𝑇 = 𝐷𝐹𝑅 + 𝐷𝐹𝐸  
= (𝑘) + (𝑛 − 𝑘 − 1) 
= 𝑛 − 1 
(4.13) 
where 𝑘 is the number of coefficients in the model. The model null hypothesis is tested by 
calculating the 𝐹0 value 
 
𝐹0 =
𝑆𝑆𝑅 𝐷𝐹𝑅⁄
𝑆𝑆𝐸 𝐷𝐹𝐸⁄
=
𝑀𝑆𝑅
𝑀𝑆𝐸
 (4.14) 
which looks at the ratio between the regression and residual errors, where 𝑀𝑆 is the mean square. 
As the 𝐹0 value greatly increases above 1, the regression error is much larger than the residual error 
and a poorly fitting model will be due to problems with the model itself rather than random noise. 
The null hypothesis can be accepted or rejected by calculating the p-value of the F-distribution 
having degrees of freedom 𝐷𝐹𝑅 and 𝐷𝐹𝐸. This p-value calculates the probability of a 𝐹0 value that 
is greater than the observed value and the null hypothesis is rejected if the p-value is less than the 
significance level for the confidence interval (𝛼). 
Further scrutiny of the data looks at how well the model fits the trend of the data, which is 
tested using lack of fit. Lack of fit measures the error variance 𝜎2 in the replicate experiments, 
which could be caused by instrument, analytical and human random error. It is measured by first 
partitioning the residual sum of squares into two components 
 𝑆𝑆𝐸 = 𝑆𝑆𝑃𝐸 + 𝑆𝑆𝐿𝑂𝐹 (4.15) 
where 𝑆𝑆𝑃𝐸 is sum of squares due to pure error and 𝑆𝑆𝐿𝑂𝐹 is sum of squares due to the lack of fit. 
This is measured based on the replicate experiments in the model, the experiments with the same 
conditions where the responses are measured separately of each other (i.e. not one experiment 
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measured multiple times). For every replicate level 𝑖 = 1,2…𝑚 there will be 𝑗 = 1,2…𝑛𝑖 replicate 
responses, such that the (𝑖, 𝑗)th residual is 
 𝑦𝑖𝑗 − ?̂?𝑖 = (𝑦𝑖𝑗 − ?̅?𝑖) + (?̅?𝑖 − ?̂?𝑖) (4.16) 
 Squaring and summing for all values of 𝑖 and 𝑗 converts (4.16) to 
 
∑∑(𝑦𝑖𝑗 − ?̂?𝑖)
2
𝑛𝑖
𝑗=1
𝑚
𝑖=1
=∑∑(𝑦𝑖𝑗 − ?̅?𝑖)
2
𝑛𝑖
𝑗=1
𝑚
𝑖=1
+∑𝑛𝑖(?̅?𝑖 − ?̂?𝑖)
2
𝑚
𝑖=1
 (4.17) 
where the left hand side of equation (4.17) is 𝑆𝑆𝐸, the first summation term on the right hand side is 
𝑆𝑆𝑃𝐸 and the second summation term is 𝑆𝑆𝐿𝑂𝐹. If the error due to lack of fit is higher than the pure 
error then there is a significant lack of fit in the model, possibly caused by a missing term or lack of 
transformation. The 𝐹0 test for lack of fit is 
 
𝐹0 =
𝑆𝑆𝐿𝑂𝐹 𝐷𝐹𝐿𝑂𝐹⁄
𝑆𝑆𝑃𝐸 𝐷𝐹𝑃𝐸⁄
=
𝑀𝑆𝐿𝑂𝐹
𝑀𝑆𝑃𝐸
 (4.18) 
Models with a high reproducibility can sometimes result in a lack of fit because the pure error is so 
low. The reproducibility is calculated as such 
 
𝑅𝑒𝑝𝑟𝑜𝑑𝑢𝑐𝑖𝑏𝑖𝑙𝑖𝑡𝑦 = 1 −
𝑀𝑆𝑃𝐸
𝑀𝑆𝑇
 (4.19) 
Therefore the 𝑆𝑆𝐿𝑂𝐹 may not be of a magnitude that would lead to a lack of fit, but the 𝑆𝑆𝑃𝐸 is so 
low that the model appears to have a high lack of fit. This can sometimes be highlighted in the 
model validity, which gives a measure of lack of fit. The validity is calculated such that a model 
with a p-value for lack of fit (𝑝𝐿𝑂𝐹) that is less than the confidence interval (𝛼 = 0.05) will total < 
0.25. Any model that has a high validity will have no lack of fit. 
 𝑉𝑎𝑙𝑖𝑑𝑖𝑡𝑦 = 1 + 0.57647 × 𝑙𝑜𝑔 (𝑝𝐿𝑂𝐹)  (4.20) 
The summary of fit for models 4.1, 4.3 and 4.4 shows how the high reproducibility can result in a 
poor model validity (Figure 4.9). The model for ketone 4.4 was fitted and treated according to the 
techniques described in sections 4.2.2 and 4.2.3 and did not require a transformation. 
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Figure 4.9 Summary of fit for the benzaldehyde 4.1, benzylideneketone 4.3 and 
dibenzylideneacetone 4.4.Green - 𝑹𝟐, blue - 𝑸𝟐, yellow – model validity and 
turquoise = reproducibility. 
4.2.6 Optimisations and predictions 
The addition of square terms is a feature of RSM that gives the model curvature and means 
that interpolation and optimisation can be carried out. Optimisations are carried out by minimising 
or maximising a response within a user defined value using the Nelder-Mead simplex algorithm.138 
This is achieved by calculating a desirability function (𝑑𝑘) for all of the included models, which 
normalises the response 𝑦 to the range  
0 ≤ 𝑑𝑘 ≤ 1 
and searches for the variables that predict responses that are closest to the desired targets. If there 
are multiple model responses then the desirability function will compromise between each target 
equally.178 In such a case the compromise is expressed as an overall desirability function 
 
𝑑𝑠 = (∏𝑑𝑘
𝑚
𝑘=1
)
1
𝑚
 (4.21) 
where 𝑑𝑠 is the overall desirability function, 𝑚 is the number of responses, 𝑑𝑘 is the 
desirability function for each model 𝑘 = 1,… ,𝑚 . Optimum conditions are achieved by minimising 
the value of 𝑑𝑠. The desirability function has different notation depending on the optimisation 
requirements.179, 180 If the response 𝑦 is to be maximised 
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𝑑 = {
0                  𝑦 < 𝐿       
(
𝑦 − 𝐿
𝑇 − 𝐿
)
𝑟
    𝐿 ≤ 𝑦 ≤ 𝑇
1                  𝑦 > 𝑇       
 (4.22) 
where 𝑟 is the user defined weight of the desirability function (0 < 𝑟 < 1). If 𝑟 = 1 then the 
function is linear, if 𝑟 > 1 then the function concentrates on being closer to the target value, 
choosing a value of 𝑟 < 1 places less emphasis on this response. If the response 𝑦 is to be 
minimised 
 
𝑑 = {
0                  𝑦 < 𝑇       
(
𝑈 − 𝑦
𝑈 − 𝑇
)
𝑟
    𝑇 ≤ 𝑦 ≤ 𝑈
1                  𝑦 > 𝑈       
 (4.23) 
If the target value (𝑇) is between the lower (𝐿) and upper (𝑈) tolerances, the desirability function is 
defined as 
 
𝑑 =
{
  
 
  
 
0                  𝑦 < 𝑇       
(
𝑦 − 𝐿
𝑇 − 𝐿
)
𝑟
     𝐿 ≤ 𝑦 ≤ 𝑇 
(
𝑈 − 𝑦
𝑈 − 𝑇
)
𝑟
    𝑇 ≤ 𝑦 ≤ 𝑈
1                  𝑦 > 𝑈       
 (4.24) 
 
The models were used to predict an optimum yield of ketone 3 by maximising the response 
of 3 (lower tolerance 65%) and minimising 4.1 and 4.4 (upper tolerance 5%). Optimum conditions 
were calculated that satisfied the tolerances for responses 4.1 and 4.4: 1.56 mmol min-1 4.1, 7.0 eq 
acetone, 0.11 mmol min-1 NaOH and 80.0 °C, generating 4.3 in a 64% yield. These conditions did 
not match the yield optimum observed by the SNOBFIT algorithm of 0.4 mmol min-1 4.1, 7.0 eq 
acetone, 0.099 mmol min-1 and 35.8 °C, generating 4.3 in a 66% yield. When the model for ketone 
4.3 was used to predict the response from the SNOBFIT optimum conditions, it predicted a yield of 
61%.  
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Figure 4.10 Response contour plot for the model of ketone 4.3 where NaOH flow rate (0.11 
mmol min-1) and temperature (80.0 °C) are fixed. The black cross-hair shows the 
predicted optimum conditions to maximise 4.3 and minimise 4.1 and 4.4. 
A contour plot of fixed temperature and NaOH flow rate shows a strong interaction between 
benzaldehyde flow rate and equivalents of acetone. The model shows that for a constant response, a 
reduction in benzaldehyde flow rate leads to a corresponding increase in equivalents of acetone 
required, which was not initially observed from the SNOBFIT results. In addition the maximum 
yield the model predicts is at high flow rate and eq, whereas the algorithm optimisation found the 
highest yields at low flow rate and high acetone eq. 
Further scrutiny of the SNOBFIT optimum data point showed that there is a significant rise 
in yield compared to points in close vicinity. For maximum values of acetone eq and NaOH flow 
rate, there are a lot of points that are ~59 ±2% creating a plateau that the polynomial of the RSM 
possibly has difficulty fitting. This, coupled with the disagreement in optima between the two 
techniques prompted some further experimentation to study the reproducibility of the algorithm 
optimum. Three further experiments were carried out at the optimum conditions, which generated 
4.3 in a mean yield of 64.4% ± 0.3% (arithmetic mean ± 1 SD). This shows that the previous 
optimum value was possibly caused by an integration error from HPLC analysis. It was decided to 
carry out a second self-optimisation, expanding on the existing experimental space. 
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4.3 Improved experimental space 
The SNOBFIT algorithm was restarted using the existing data points within the new 
boundary limits (Table 4.4). The new optimisation required 36 further experiments with an 
optimum point of 0.76 mmol min-1 4.1, 14 eq acetone, 0.15 mmol min-1 and  43 °C, generating 4.3 
in a 67% yield (Figure 4.11). The new optimum is close to the centre of  benzaldehyde 1 flow rate 
and temperature limits, indicating that the new experimental space is an improvement over the 
original. 
Table 4.4 New boundary limits for the second Claisen-Schmidt condensation optimisation 
Limits 4.1 flow rate /  
mmol min-1 
NaOH flow rate / 
mmol min-1 
4.2 /  
mol eq 
Temperature /  
°C 
Minimum 0.4  0.01 5 10 
Maximum 1.0 0.15 14 60 
 
The data collected over the two optimisations were collated into a new data set that included 
experiments within the ranges shown in Table 4.5. This was an attempt to include as many 
experiments as possible in an experimental space that would deliver good fitting and accurate 
models. 
Table 4.5 Boundary limits for the second generation RSM models 
Limits 4.1 flow rate /  
mmol min-1 
NaOH flow rate / 
mmol min-1 
4.2 /  
mol eq 
Temperature /  
°C 
Minimum 0.4 0.008 1 10 
Maximum 1.0 0.15 14 60 
 
New MLR models were fitted according to the techniques discussed in Section 4.2. No 
transformations were required and each model either had values for all summary of fit terms that 
were either an improvement over the first models, or within the same magnitude. The exception is 
for the model validity, which saw a large improvement for all three models, with models 4.1 and 
4.3 no longer showing evidence for lack of fit (Figure 4.12). 
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Figure 4.11 Plot for the SNOBFIT optimisation of ketone 4.3 using an improved experimental 
space. x-axis = 4.1 flow rate; y-axis = acetone eq; z-axis = temperature; size of the 
point denotes NaOH flow rate; colour of the point denotes yield. The optimum point 
is denoted by the star: 0.76 mmol min-1 1, 13.9 eq acetone, 0.15 mmol min-1 and 43.0 
°C generating 3 in a 67% yield. 
The new models were used to predict an optimum yield by maximising 4.3 and minimising 
4.1 and 4.4 with the conditions 0.57 mmol min-1 4.1, 12.3 acetone eq, 0.09 mmol min-1 NaOH and 
50 °C, generating ketone 4.3 in a 63% yield. These optimum conditions were in greater agreement 
with the SNOBFIT optimum when compared to the original experimental space. This re-enforced 
that the new boundary limits had improved the experimental space explored.  
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Figure 4.12 Comparisons of summary of fit terms for the original (solid colour) and extended 
(faded colour) experiment spaces. Green - 𝑹𝟐, blue - 𝑸𝟐, yellow – validity, turquoise 
– reproducibility. 
4.3.1 Reaction metrics 
It is possible to try and increase the yield of ketone 4.3 by increasing the limits for acetone 
eq and NaOH flow rate, however it is worth considering if the increase in reagent eq would be 
worth the financial and material cost, especially for reaction scale up. Especially as doubling the eq 
of 4.2 only resulted in an increase of 1% yield. Although yield was the target function for the 
optimisations so far, previous research has shown how yield is not the best target and other metrics 
such as E-factor, process mass intensity (PMI), material cost and reaction productivity can be a 
better target for an efficient manufacturing process.12, 17, 18, 27, 181 The advantage of a statistical 
model means that additional responses can be calculated and new models fitted without carrying 
out further experiments, whereas algorithm optimisations need new experiments to find new 
optima. 
Therefore, metric analyses were carried out by calculating the values for different metrics 
from the experiments used to fit the existing models. The new metrics were PMI, a measure of the 
total chemical resource per mass unit 
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𝑃𝑀𝐼 =
∑ 𝑄𝑚(𝑖)
𝑛
𝑖=1
𝑄𝑛(𝟒. 𝟏) 𝑌 𝑀𝑊(𝟒. 𝟑)
 (4.25) 
where 𝑄𝑚 is mass flow rate, 𝑄𝑛 is molar flow rate, 𝑌 is yield and 𝑀𝑊 is molecular weight;
182 
Space time yield (STY), the mass of product per unit volume per unit time 
 
𝑆𝑇𝑌 =
𝑄𝑛(𝟏)𝑀𝑊(𝟑)
𝑉
 (4.26) 
where 𝑉 is reactor volume; and material cost per mass unit of ketone 4.3 produced 
 
𝐶𝑜𝑠𝑡 =
∑ 𝑄𝑣(𝑖) £(𝑖)𝐶0(𝑖)
𝑛
𝑖=1
𝑄𝑛(𝟒. 𝟏) 𝑌 𝑀𝑊(𝟒. 𝟑)
 (4.27) 
 
 
Figure 4.13 Summary of fit for the new metrics. Green - 𝑹𝟐, blue - 𝑸𝟐, yellow – validity, 
turquoise – reproducibility. 
New models for these metrics were fitted using MLR with R2 values of 0.93 (PMI), 0.92 
(STY) and 0.90 (cost); and Q2 values of 0.86 (PMI), 0.86 (STY) and 0.83 (cost). Each model also 
had high reproducibility (> 0.9) and no evidence of lack of fit (Figure 4.13). 
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Table 4.6 Effect of different metrics on the product composition of compounds 1, 3 and 4 
Metric target 4.1 / % 4.3 / % 4.4 / % PMI /  
kg kg-1 
STY /  
g L-1 h-1 
Cost /  
£ kg-1 
Yield 3.22 65.62 3.01 18.48 633.20 33.45 
PMI 4.54 47.90 6.02 13.81 614.36 27.92 
STY 3.06 62.15 4.45 19.11 872.69 34.50 
Cost 4.15 58.81 4.13 14.30 798.39 26.72 
Yield PMIa 4.28 55.32 4.70 13.99 729.52 26.91 
PMI Costb 2.96 64.81 3.66 16.35 769.93 29.57 
The first column shows the metric target, responses are shown in the rows. Maximized values are highlighted 
in bold, minimized values and highlighted in italics. Unformatted values display the models’ predicted 
values. amaximize the yield of 3, minimize the PMI; bminimize both PMI and cost. 
Table 4.6 shows how the model responses change with optimum conditions for different 
metric targets. The maximum yield has poor responses for PMI, STY and cost, showing that high 
yielding reactions are wasteful and unproductive. The optimum response for PMI is the least 
productive and predicts the lowest yield of ketone 4.3. There is good correlation between the 
responses of PMI and cost for all the metric targets. This should be expected as they are calculated 
by the ratio of product to substrates and reagents. The raw material cost calculation aims to put bias 
on reducing the excess of expensive material, although this reaction example is perhaps not the best 
to show this as all substrates are relatively inexpensive. It should be noted, however, that lower cost 
promotes a higher yield rather than lower PMI, indicating that raw material cost could be the most 
important metric, assuming that a cheaper reagent does not increase the complexity, and therefore 
cost, of work-up and purification. 
The conditions for the optimal responses are shown in Table 4.7. The flow rate of 4.2 is 
towards its upper limits for every target which reduces the residence time, therefore increasing the 
reaction productivity (STY). The acetone equivalents are generally lower than the self-optimisation 
thus limiting the reagent waste (PMI and cost). Strict temperature control is required to both 
maintain the high yields of 4.3 and minimise polymer formation. 
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Table 4.7 Predicted conditions for the optimum responses to different metric targets 
Metric target 4.1 flow rate / 
 mmol min-1 
NaOH flow rate / 
mmol min-1 
4.2 /  
mol eq 
Temperature /  
°C 
Yield 0.741 0.112 12.4 47.2 
PMI 0.846 0.044 6.0 44.1 
STY 1.000 0.150 13.9 42.2 
Cost 0.986 0.067 9.2 47.1 
Yield PMIa 0.915 0.055 7.5 45.5 
PMI Costb 0.998 0.096 10.5 46.8 
amaximize the yield of 3, minimize the PMI; bminimize both PMI and cost. 
4.4 Conclusions 
The yield of ketone 4.3 in a Claisen-Schmidt condensation was self-optimised using an 
automated flow reactor equipped with an at-line HPLC system and feedback loop with SNOBFIT 
algorithm. With the data obtained from the self-optimisation, response surface models were fitted 
to the main compounds of interest in the reaction (4.1, 4.3 and 4.4). After analysis of the models 
and self-optimisation data, it was decided to carry out further optimisations in a larger chemical 
space. The second experimental optimisation improved upon the yield of 4.3 and the increased 
correlation between the new optimum and surrounding experimental points, provided a greater 
range of conditions at which optimal yields could be obtained. The subsequent statistical models of 
the extended optimisation predicted similar optimal conditions and exhibited an overall improved 
model fit.  
It should be noted that the choice of algorithm in the initial self-optimisation step is critical 
to achieving a good fit to the RSM. The simplex algorithm and modifications thereof,137-139, 183 is a 
popular choice in self-optimising systems.12, 14-17, 23, 25, 27 However, during its operation it will only 
execute experiments with an improved predicted response therefore not providing any information 
about experimental space that does not lie between the initial and optimum points. The execution of 
random conditions and exploration of free space offered by SNOBFIT provides a scatter of data, 
without which the additional response surface fitting would not be possible. In this study, the 
increased robustness resulting from the additional experimental points around the optimum would 
also have been forfeited with a simplex approach. 
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Because the experimental optimum was identified at the edge of the initial optimisation 
space, prediction of the optimum via the statistical model was compromised due to its inability to 
fit a polynomial to changes induced by the cliff edge. The experimental self-optimisation, however, 
freely explored the edge of the optimisation space to identify the point of maximum yield. For 
these reasons, it can be concluded that self-optimisation is the superior technique for chemical 
process optimisation. However, when used in tandem the subsequent response fitting of self-
optimisation data can predict the responses of different species and even alternate metrics without 
additional experimentation. It therefore follows that self-optimisation and DoE can be 
interdependent, rather than conflicting techniques, which can combine to provide a wealth of 
information in the scale-up and process optimisation of chemical systems. 
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5. Adaptive feedback controlled optimisations using at-line 
quantitative mass spectrometry7 
5.1 Introduction 
Online analysis describes the in-situ monitoring of a chemical reaction by any analytical 
technique without any manual intervention from the user. This can be separated into two distinct 
categories: at-line analysis, which describes the automated extraction of a reaction aliquot for 
analysis; and inline analysis, which describes the direct analysis of the whole reaction by the 
analytical equipment. 
Quantitative online analysis is a requirement for the optimisation of reactions using an 
adaptive feedback loop. Self-optimisation has been carried out using UV-Vis,11 IR18, 27, 97, 184 and 
NMR spectroscopy;25 and gas15-18, 23 and liquid chromatography.12, 14, 21, 172, 185 Depending on the 
self-optimising setup, the analysis time can have the highest contribution to the overall optimisation 
time, especially if using an algorithm where the results of the previous experiment are required 
before calculating a new one.18 The criteria for the ideal analytical techniques are: 
 Quantitative – must be able to accurately calculate the response 
 Short method lengths – minimising the amount of time that the reactor is left idle 
 Simple data analysis – allows fast acquisition of experimental response from the 
analytical data file 
 Minimal method development – reduces the time it takes to develop the analytical 
method, enabling an easier process for the user 
 Easy (or no) calibration of response – reduces the equipment setup time prior to 
starting the optimisation 
 Minimal data analysis by chemometrics required – analytical data provides the 
discrete composition of all species, without requiring complex deconvolution 
 Can monitor unknown species – provides information about the composition of by-
products and/or impurities 
                                                 
7 Themes from this chapter appear in: N. Holmes, G. R. Akien, R. J. D. Savage, C. Stanetty, I. R. Baxendale, 
A. J. Blacker, B. A. Taylor, R. L. Woodward, R. E. Meadows and R. A. Bourne, React. Chem. Eng., 2016, 1, 
96-100.  
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 Can identify unknown species – provides information about the structure of by-
products and/or impurities 
In a laboratory environment, online analytical equipment is typically denoted as “benchtop” 
and is designed to have a smaller footprint, thus making it easier to fit into a fumehood and 
integrate with existing equipment. Benchtop machines typically generate data at a lower resolution 
to their offline counterparts but are easier to use for a non-specialist. As is shown in Table 5.1, 
there is not an existing analytical technique that satisfies all the criteria, however mass 
spectrometry (MS) satisfies most. Despite this, it is surprising that online MS is sparingly used to 
monitor reactions. Existing examples in flow reactors are only qualitative27, 118, 186-188 and 
quantitative monitoring has required the use of specialist spectrometers.189-191 
Table 5.1 Properties of online analytical techniques 
 UV IR NMR GC HPLC MS 
Quantitative ● ● ● ● ● ● 
Short method length ● ● ●   ● 
Simple data analysis   ● ● ● ● 
Minimal method development ● ● ●   ● 
Easy calibration   ● ● ●  
No requirement for chemometrics    ● ● ● 
Monitor unknown species    ● ● ● 
Identify unknown species  ● ●   ● 
UV – ultraviolet/visible spectroscopy, IR – infrared spectroscopy, NMR – nuclear magnetic resonance 
spectroscopy, GC – gas chromatography, HPLC – liquid chromatography, MS – mass spectrometry. N.B. all 
criteria are applied to general benchtop specification and might change depending on the reaction case study. 
MS is an analytical technique that measures the mass of a charged compound and can 
separate multiple species according to their mass to charge ratio (m/z). A compound is charged by 
ionisation, which is achieved using a variety of techniques. Electrospray ionisation (ESI) is the 
most common technique for measuring the mass of organic compounds and therefore is the most 
available for benchtop spectrometers. ESI generates ions by injecting the liquid sample through a 
nebulising needle into an electrically charged chamber, creating a mist of positively charged 
droplets. The chamber is exposed to hot dry gas, which evaporates solvent from the droplets. As 
the amount of solvent evaporates, the repulsive electrostatic forces exceed the surface tension of 
the droplet and it desorbs into the gas phase, where it is attracted to pass through a negatively 
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charged capillary and into the mass analyser (Figure 5.1). ESI can sometimes create multiply 
charged species and is best used for large polar molecules. 
 
Figure 5.1 a) Diagram of ESI ion source. Liquid sample is injected through needle and 
nebulised to produce a spray. Hot N2 gas aids desorption of the spray to create a 
positively charged mist that is attracted to the capillary tube and fed to the mass 
analyser. b) Desorption of sample to produce a positively charged analyte mist. 
Figures adapted from ref 192. 
Atmospheric pressure chemical ionisation (APCI) is a similar ionisation technique to ESI. 
The liquid sample is heated to very high temperatures using a hot nebulising gas stream, which 
transfers the sample into the gas phase. The gas particles are then charged by being exposed to 
electrons that are generated from a corona discharge needle. Like ESI, these charged gas particles 
are then attracted through a capillary into the mass analyser. APCI generally does not create 
multiply charged species and it best used for smaller polar and non-polar compounds that will not 
undergo thermal degradation.  
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Figure 5.2 Diagram of APCI ion source. Liquid sample is nebulised using a hot gas stream and 
the gaseous particles are then charged with electrons from a corona discharge needle. 
Adapted from ref 192. 
Both APCI and ESI are classified as soft ionisation sources because they generate a large 
quantity of molecular ions with minimal fragmentation ions. ESI is typically used for molecules 
with a high polarity and large molecular weight because of its ability to generate multiple 
positively charged species. APCI is suited to compounds with a lower polarity and molecular 
weight.192-195 The molecular weight range is much lower for APCI because the high temperatures 
during its ionisation procedure can make it unsuitable for thermally labile compounds (such as 
enzymes and proteins). As a result ESI generally performs better at ionising cationic or anionic 
compounds whereas APCI is better at neutral or basic compounds.195 
The main reason for the lack of examples using online quantitative MS is due to the 
difficulty in calibrating a signal that has a variable sample matrix. Existing analytical techniques 
use a calibration curve where a number of samples are prepared at different concentrations then a 
plot of response vs concentration will have a straight line fit. However this is not representative of 
the signal when using MS due to a phenomenon called “matrix effects”.196 The sample matrix 
describes everything else in the sample that is not the desired analyte (e.g. reaction solvent, mobile 
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phase solvents and modifiers, reagents, substrates, by-products, impurities etc.) and these can 
supress the response of the analyte resulting in an unpredictable response that changes with 
reaction conditions197-199 and MS method.186 
There are several examples of inline MS analysis of flow reactions, where the reactor outlet 
is fitted to capillary tubing directly into the spectrometer, resulting in full destruction of the 
sample;200-208 and using multiple ionisation techniques that are unfortunately unavailable with 
commercial benchtop spectrometers.117 This technique also means that reactions have to be 
performed at very low concentrations and therefore are not representative of kinetics at 
manufacturing scales. 
One of the first examples of monitoring a reaction at process relevant concentrations using 
atmospheric pressure ionisation (AtmPI) MS was reported by Dell’Orco et al. for the Knoevenagel 
condensation to produce an intermediate 5.3 towards eprosartan, an angiotensin II receptor 
antagonist, using a batch reactor (Scheme 5.1).209 The MS setup featured a series of HPLC pumps 
to sample the reaction then quench and dilute by 3000 fold before ESI-MS analysis. The work was 
used to identify reaction intermediates and propose a mechanism, which aided separate kinetic 
investigations. The MS data was not used to determine the kinetic parameters due to the difficulties 
in calibrating all species, some of which were only stable in solution. 
 
Scheme 5.1 Knoevenagel condensation reaction to intermediate 5.3 towards eprosartan 
Quantitative MS analysis was achieved by Owen et al. for the base catalysed esterification of 
butyl acetate 5.7 from acetic anhydride 5.4 (Scheme 5.2).191 The reaction was carried out at two 
different scales using batch reactors and was monitored online by ATR-IR and ESI-MS and offline 
by GC. Calibration of the MS signal was carried out by applying a least squares linear regression fit 
to the reaction data from the response of the pure components of acetic anhydride, acetic acid, butyl 
acetate, butanol, pyridine, ethanol and ethyl acetate. 
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Scheme 5.2 Base catalysed hydrolysis and esterification of butyl acetate. 
Zhu et al. monitored a Michael addition between 2-phenylethylamine 5.9 and acrylonitrile 
5.10 to form 3-phenethylamino-propionitrile 5.11 using APCI-MS (Scheme 5.3).190 The reactants 
were placed in a syringe then infused (using a syringe pump) through a 4-port microvolume 
internal sample injector, replicating a batch reaction that continually refreshes the sample delivered 
to the MS. Quantification of the MS signal was achieved by preparing stock solutions and binary 
mixtures of the starting amine and product at concentrations ranging from 0.165 to 1.65 mol L-1. 
These calibration curves showed a linear response across the experimental range covered and could 
be used to show the change in concentration of the two species over the course of the reaction. 
 
Scheme 5.3 Michael addition between 2-phenylethylamine 5.9 and acrylonitrile 5.10 to form 3-
phenethylamino-propionitrile 5.11. 
The above quantitative techniques are possible due to the availability of pure compounds, the 
linearity of the response and, most importantly, the predictable composition of species in the 
reaction. Other calibration techniques require the first two points but not the final. For example, 
when monitoring a reaction by chromatography, where the compounds of interest have been 
calibrated by calculating relative response factors, the response from the machine does not change 
with the amount of reagent or catalyst added to the reaction; and therefore the calibration does not 
need to be recalculated for changing reaction conditions. However, in the Michael addition by Zhu, 
the amount of acrylonitrile is kept constant throughout the reactions. Whilst the compound is not 
detected by the MS, it is likely that it is still ionised and therefore its concentration in the reaction 
will change the potential for the other compounds to be ionised thus changing their response. 
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Moreover, both quantified techniques have been carried out using modified analytical equipment, 
which would be daunting for a non-specialist to use. 
5.1.1 Aims and objectives 
It is the aim of the work in this chapter to use a benchtop MS for quantitative analysis of the 
automated optimisation of the amidation of methyl nicotinate 5.12 with methylamine to form N’-
methyl nicotinamide 5.13 (Scheme 5.4). The cheapest commercial source of methylamine is 
available in an aqueous solution, which promotes the hydrolysed nicotinic acid 5.14 as an impurity 
in the reaction. The presence of the pyridine group should provide a good site for ionisation and 
high loadings of methylamine may cause suppression of the MS response. 
 
Scheme 5.4 Amidation of methyl nicotinate 5.12 with methylamine in methanol and water to 
form the desired N’-methyl nicotinamide 5.13 or the hydrolysed nicotinic acid 5.14. 
The objectives for this work were: 
 Develop a method to use fast sample acquisition (<1 min) to identify steady state 
within the reactor. 
 Calibrate the MS response and calculate response factors for the three compounds of 
interest (5.12-5.14). 
 Optimise the reaction using adaptive feedback controlled minimising algorithm. 
5.2 Mass spectrometry and reactor setup 
5.2.1 Equipment 
The reactor was configured as shown in Figure 5.3; three pumps were used to deliver the 
ester 5.12, methylamine and methanol. Pump reservoir solutions were prepared to concentrations of 
1.45 mol L-1 ester 5.12 in methanol and 5.77 mol L-1 of methylamine in water (unless otherwise 
stated). A length of tubing equalling 3 mL was fitted to the reactor. A detailed description of the 
equipment used is available in the equipment chapter; preparation of pump reservoir solutions is 
available in the experimental chapter. 
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Figure 5.3 Reactor set-up for the optimisation of N’-methyl nicotinamide 13. 
 
Figure 5.4 Comparison of sampling frequency for ESI+ (A) and APCI+ (B) over a 3 minute 
period. 
The spectrometer used for all online analysis was an Advion expression CMS210 operating 
using APCI+ ion source. The machine is capable of operating with either ESI± or APCI+, and 
whilst a higher frequency of sampling was possible with ESI, APCI was chosen for its reduction in 
baseline noise (Figure 5.4), higher mobile phase flow rate tolerance, increased signal strength and 
reduced likelihood of ion suppression.199 Reaction aliquots were introduced to the mobile phase 
using a 4-port VICI micro-volume sampling valve. It is possible to sample MS quasi-continuously 
using a mass rate attenuator,211, 212 which delivers aliquots of volume 20 to 300 nL at a frequency of 
up to 2 Hz at a constant sample concentration. The advantage with this approach is that real-time 
monitoring is achieved with the continuous sampling; however it is difficult to detect accumulation 
of analyte within the spectrometer. 
A mobile phase of 1:1 (v:v) MeCN:H2O with 0.1 % formic acid modifier was pumped using 
an agilent G1311A quaternary pump module. Agilent stainless steel capillary tubing (green, 0.17 
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mm ID) delivered the mobile phase to the sample loop and PEEK tubing (red, 0.005” ID) from the 
sample loop to the spectrometer. All other equipment is described in the equipment chapter. 
A 2:5 flow splitter was created by connecting 6.5 and 16.5 cm PEEK tubing (red) to a PEEK 
microvolume tee-piece (rheodyne), where the input was sample in mobile phase. The shorter tubing 
was directed to waste and the longer tubing to the APCI input. The change in pressure drop 
between the different tubes was used to control the flow ratios. The mobile phase flow rate to the 
MS was calculated to be 0.057 mL min-1, based on a flow rate of 0.200 mL min-1 from the pump 
(0.200 mL min-1 ×
2
7
= 0.057 mL min-1). 
Assuming that the sample injection into the mobile phase is the same as two fluid streams 
meeting in a tee-piece with a total flow rate of the mobile phase flow rate, the maximum 
concentration of 5.12-5.14 can be calculated 
 
𝐶𝑋 =
𝐶𝐴𝑞𝑋
𝑄
 
(5.1) 
 
where 𝐶𝑋 is the concentration of analyte (mol L
-1), 𝐶𝐴 is the concentration of nicotinic species in 
the reactor (mol L-1), 𝑞𝑋 is the theoretical flow rate from the sample loop injection (L min
-1) and 𝑄 
is the total flow rate of mobile phase. Assuming that the reservoir of 5.12 is pumped without any 
other pump streams, the analyte concentration is calculated 
𝐶𝑋 =
1.45 mol L−1 × 0.06 × 10−3𝑚𝐿 𝑚𝑖𝑛−1
0.200 𝑚𝐿 𝑚𝑖𝑛−1
= 4.35 × 10−4𝑚𝑜𝑙 𝐿−1 
and when accounting for the split ratio 
𝐶𝑋 =
2
7
× 4.35 × 10−4𝑚𝑜𝑙 𝐿−1 = 1.24 × 10−4 𝑚𝑜𝑙 𝐿−1 
The concentration of the analyte within all reactions will depend on the ratio of methylamine 
flow rate to ester 5.12 flow rate. For example, if the ester and methylamine pumps are set to the 
same flow rate, the total of all nicotinic species in the reactor (𝐶𝐴) will be 0.725 mol L
-1 and the 
analyte concentration will thus be 6.21 × 10-5 mol L-1. 
Product composition from MS is determined from two separate chromatograms: total ion 
chromatogram (TIC), which calculates the total number of ions detected over a time period; and 
extracted ion chromatogram (XIC), which calculates the number of ions for a specific mass over 
 118 
the same time period. The composition of a product is calculated from the ratio between the XIC 
and TIC. Advion Mass Express software was used to record all chromatograms and the program 
would bin mass peaks to the nearest 0.5 mass unit (Dalton, Da) and then create a data report in a 
.cdf format. Data could be extracted from the .cdf file using MatLab commands and a script was 
written to calculate the XIC for a particular mass over all of the sample range. A percentage yield 
was calculated from the ratio between the desired XIC and the XIC for all known compounds. 
5.2.2 Steady state determination 
In a batch reactor the relative concentrations of species in the reactor change with respect to 
time. In a plug flow reactor, the relative concentrations change with respect to the length of the 
reactor tubing or channel.213-215 Therefore, a sample acquired at a fixed point in a continuous 
reactor will have constant composition, assuming the conditions remain constant throughout the 
reactor’s residence time. This concept is known as steady state and is fundamental for the 
performance of a reaction in flow. The time to reach steady state depends on the physical 
dimensions of the reactor, which firstly affects the dispersion, where the frictional forces from the 
walls of the reactors result in a non-uniform flow velocity across the tube; and secondly the 
residence time distribution, which describes the average amount of time the fluid spends in the 
reactor.213 
 It is typical for the material from the first two reactor volumes to be disposed of before 
analysis of the reaction is carried out, which obviously creates a large amount of waste. Online IR 
has been used to detect the steady state of a reactor due to its fast acquisition time. It is 
hypothesised that the same approach can be achieved with MS. 
To test this, the reactor was set up according to the configuration shown in Figure 5.3, with 
methanol replaced with isopropyl alcohol. Ester 5.12 was prepared to 0.787 mol L-1 in methanol, 
and methylamine was used as a 40 % (w/v) aqueous solution without any modification. The reactor 
was set to 30 °C then 5.12 pumped at 0.200 mL min-1 and methylamine pumped at 0.023 mL min-1 
(2 mol eq) for 30 min; MS acquisition was set to a period of 1 min. Solvent was then pumped for 
10 min at 0.500 mL min-1 to clean the reactor, prevent accumulation in the MS and check that the 
MS response returns to zero. This cycle was then repeated using 3 and 4 mol eq of methylamine 
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(full conditions shown in Table 5.2). The mobile phase was as stated above but without the splitter, 
resulting in a total flow rate of 0.200 mL min-1. 
Table 5.2 – Conditions screened to test steady state 
12 flow / 
 mL min-1 
MeNH2 flow /  
mL min-1 
IPA flow /  
mL min-1 
Duration /  
min 
Time from start /  
min 
0.200 0.023 0 30 30 
0 0 0.500 10 40 
0.200 0.034 0 30 70 
0 0 0.500 10 80 
0.200 0.046 0 30 110 
0 0 0.500 10 120 
 
The results from the steady state test (Figure 5.5) showed that linearity of the MS signal was 
reached when the standard deviation in the internally normalised data (0-100) was less than 1.5 %, 
corresponding to an analytical error of ± 0.75%. 
 
Figure 5.5 Test for steady state monitoring by MS. The graph shows change in MS ion count 
for compounds 5.12-5.14 over total time. The reactor was initially filled with 
solvent, and then pumped with the desired reagents. The signal of all three 
compounds changes as the reactor reaches the outlet (~20 min). Linearity is reached, 
indicating steady state, then the signal for all three compounds drops when the 
reactor is flushed with solvent (30-40 min). This cycle is repeated a further two 
times. 
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If steady state was calculated based on 2 reactor then this would be 27 min (1st experiment), 
26 min (2nd) and 24 min (3rd). However Figure 5.5 shows that linearity in the signal, and therefore 
the true reactor steady state, is reached before these calculated values; indicating that time can be 
saved by detecting when the reactor reached steady state rather than calculating it. Using this data it 
was possible to construct a steady state function to run during the automated optimisations (Figure 
5.6). Development of optimum split ratio and mobile phase flow rate resulted in an MS method of 
25 s allowing a sampling period of 40 s during optimisations. 
 
Figure 5.6 Flow chart showing the optimisation process with steady state function (dashed 
lines) 
5.3 Calibration 
Quantitative MS response was achieved by calibrating against HPLC. The MS spectra of 
each compound showed peaks corresponding to both [M+H]+ and [M+MeCN+H]+ adducts, but the 
response was only calibrated to the [M+H]+ peaks as the [M+MeCN+H]+ adduct for the acid 14 
had a m/z peak of 149, which can be a plasticiser contaminant.216 It was assumed that the degree of 
acetonitrile adduct formation would be constant throughout all reaction conditions because its 
source is the mobile phase. 
5.3.1 Isotope deconvolution 
The molecular weight of the ester 5.12 and amide 5.13 is only separated by one mass unit 
(Dalton, Da) and it is therefore possible that full conversion of 5.12 is achieved but cannot be 
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detected due to the presence of a 13C [M+H]+ peak of 5.13. Therefore the isotopic abundance of 
carbon in each compound was calculated so it could be accounted for in the calibration. 
MS spectra will normalise the highest peak to 100%, so the peak corresponding to the 
highest isotope abundance must also be normalised to the same value. 
 𝐼𝐸𝑛 =
𝑥𝐸𝑛
𝑥𝐸0
 (5.2) 
 
where 𝐼𝐸𝑛 is the isotope composition of element 𝐸 isotope 𝑛, 𝑥𝐸𝑛 is the molar ratio of element 𝐸 
isotope 𝑛, and 𝑥𝐸𝑛 is the molar ratio of the most abundant isotope of element 𝐸. For example, the 
molar ratio of 12C:13C in carbon is 0.9893:0.0107, which means the percentage isotope composition 
of 13C is: 
𝐼𝐶13 =
0.0107
0.9893
= 1.1% 
according to the IUPAC defined molar ratios.217 Therefore, for every atom of carbon in a molecule, 
the [M+1+H]+ isotope peak will increase by 1.08%. The ester 5.12 has a molecular formula of 
C7H7NO2, therefore the size of the +1 isotope peak, 𝑃𝐼+1 can be calculated by the abundance of 
13C 
in the compound: 
𝑃𝐼+1 = 7𝐼𝐶13 = 7.7% 
because all other elements in the compound have negligible abundance in their +1 isotopes. The 
acid 5.14 has a formula of C6H5NO2 and therefore a calculated isotope peak of 6.6%. Using these 
values, the response of each compound was calculated using the following equations: 
 𝐸𝑠𝑡𝑒𝑟(𝟓. 𝟏𝟐) = (𝑃137 − (𝑃138 × 0.077)) × 1.077 (5.3) 
 
 𝐴𝑚𝑖𝑑𝑒(𝟓. 𝟏𝟑) = 𝑃138 × 1.077 (5.4) 
 
 𝐴𝑐𝑖𝑑(𝟓. 𝟏𝟒) = 𝑃124 × 1.066 (5.5) 
 
5.3.2 Calibration of relative response factors 
Firstly calibration solutions were prepared to 1.4 mol L-1 in methanol for compounds 5.12 
and 13 and to 0.49 mol L-1 dimethylsulfoxide for compound 5.14. The acid 5.14 was sparingly 
soluble in most solvents and so the lower concentration calibration solution was justified as its 
formation in high quantities would clog the reactor. Calibrations were carried out by preparing 
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samples at concentrations of 0.14 to 1.4 mol L-1, in 0.14 mol L-1 increments, and analysis by HPLC 
analysis at 254 nm. A plot of HPLC peak area vs concentration showed a linear response. 
Next a single stock solution containing all three compounds was prepared to a concentration 
of 0.332 mol L-1 and HPLC samples were prepared at dilutions of 1/2, 1/4, 1/8 and 1/16, 
corresponding to concentrations of 0.332, 0.166, 0.083 and 0.042 mol L-1. Response factors for the 
compounds were calculated from the gradient of regression analysis of a plot of HPLC peak area vs 
concentration.  
Table 5.3 Boundary limits for the optimisations by algorithm and design of experiments 
Limits 5.12 flow / mL min-1 MeNH2 eq Temperature / °C 
Upper 0.100 1 0 
Lower 0.400 10 130 
 
 
Figure 5.7 Comparison between HPLC and MS responses. Individual points are shown for the 
ester 12 (blue), amide 13 (green) and acid 14 (red). Linear regression analysis is 
shown for all three compounds combined (grey). 
MS calibration was carried out by running experiments at the upper and lower extremes for 
each variable. A central composite faced (CCF) design of experiments (DoE) was carried out, 
analysing by both HPLC and MS, according to the limits shown in Table 5.3. 
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The HPLC was analysed by internal normalisation of the peaks of compounds 5.12-5.14 
after correcting the areas from the response factors. MS was analysed by internal normalisation of 
the intensity of the [M+H]+ peaks for compounds 5.12-5.14, corrected for isotope deconvolution. A 
new MS response was calculated by multiplying the existing response by a response factor, initially 
set to 1, and internally normalising the results. The difference between the two techniques was 
calculated using a sum of squares approach 
 
𝐸𝑟𝑟𝑜𝑟 = ∑(𝑅𝑖,𝐻𝑃𝐿𝐶 − 𝑅𝑖,𝑀𝑆)
2
3
𝑖=12
 (5.6) 
 
where 𝑅𝑖 is the response of compound 𝒊 after treatment with necessary response factors and 
deconvolution calculations. This error was then minimised by changing the MS response factors 
using a generalised reduced gradient non-linear algorithm from the solver function in Microsoft 
excel. Comparison between the HPLC and MS responses are shown in Figure 5.7. 
5.4 Automated optimisations 
Automated optimisations were carried out using the SNOBFIT algorithm136 and response 
surface methodology (RSM) of a CCF DoE157 using the boundary limits shown in Table 5.3. The 
optimum function was to maximise the yield of amide 5.13, the actual experimental limits for the 
equipment are shown in Table 5.4. For each experiment, the reactor was set to the desired 
temperature and methanol pumped at 0.5 mL min-1 and the other pumps at 0.02 mL min-1 to 
minimise reagent usage, clean the reactor and prevent accumulation in the MS during temperature 
changes. During experiments the methanol pump was set to 0.001 mL min-1 because a value of zero 
would trigger the safety trips included within the program code. It was not anticipated that these 
low values would affect the results of the experiments. 
Table 5.4 – Conversion of limits shown in Table 5.3 into experimental limits 
Limits Pump 1 flow / mL 
min-1 
Pump 2 / mol 
eqa 
Pump 3 flow / mL 
min-1 b 
Temperature / °C 
Upper 0.100 1 0.001 0 
Lower 0.400 10 0.002 130 
Pump 1 – ester 5.12, pump 2 – MeNH2, pump 3 – MeOH. a) Flow rate for pump 2 was calculated as a ratio 
of the flow rate for pump 1. b) The MeOH pump was used to clean the reactor between algorithm cycles and 
prevent accumulation in the MS 
 124 
When the reactor reached the set temperature the reagent pumps were set to their desired 
flow rates and allowed to pump for 1.1 residence times. Next the steady state function (Figure 5.6) 
monitored the last three samples and when variation of the % yield of the amide 5.13 was less than 
a deviation of ± 0.75% the system is deemed to be at steady state. The composition of the fluid was 
then recorded and the next experiment conditions are set and the process above repeated. 
5.4.1 SNOBFIT optimisation 
Optimum conditions were reached in 21 experiments, which corresponded to less than 12 
hours of overall experiment time. The optimum conditions generated 5.13 in 93% yield (Ester 5.12 
flow rate 0.1 mL min-1, MeNH2 10 eq, 10.6 °C). 
 
Figure 5.8 Optimisation plot for the SNOBFIT self-optimisation of amide 5.13. Optimum point 
highlighted by the star, ester 5.12 flow rate 0.1 mL min-1, MeNH2 10 eq, 10.6 °C. 
The flow rate of the ester 5.12 is inversely proportional to the residence time, therefore the 
optimum conditions have the minimum flow rate of 5.12 in order to maximise the residence time. 
The minimum flow rate of 5.12 was also matched by a maximum 10 equivalents of methylamine. 
Whilst this number is excessive, the optimum function was only looking at maximising the yield of 
13 rather than minimising waste. The optimum temperature was low, possibly to reduce the amount 
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acid 5.14 produced because the high loadings of methylamine would increase the concentration of 
water in the reaction and the maximum acid yields were recorded at high temperatures.  
5.4.2 Response surface optimisation 
A CCF design was used to construct RSM models for compounds 5.12-5.14. A central 
composite circumscribed design was not possible as it would create scientifically impossible 
experiments (negative flow rates) and it was thought that an inscribed design would not cover 
enough experimental space. 
The reaction conditions were ranked into blocks of ascending temperature and then 
randomised within these blocks. Traditionally, statistical experiments require full randomisation to 
eliminate systematic errors that can create bias in the results.3 However it has been found that 
results within the same analytical error were obtained for the same design carried out in both 
ranked and fully randomised orders. Heating and cooling of the reactor is the biggest contributor to 
the overall optimisation time, therefore it was decided to proceed with the higher intensification of 
experiments that could be achieved with ascending orders of temperature. The responses of each 
model are shown in Figure 5.9. 
RSM models were fitted using multiple linear regressions (MLR), and the model coefficients 
determined by creating saturated models with all square and interaction terms and then manually 
removing any non-significant coefficients.218 Non-significant terms were determined as those 
where the probability that the coefficient contributes zero to the overall model (p-value) was 
greater than 5%. The response for the acid 5.14 was transformed, because of a non-normal 
distribution of the data, according to the 𝐿𝑚𝑎𝑥(λ) value of the Box-Cox plot. This measures the 
maximum likelihood of the data supporting a transformation (MLE) vs the type of transformation 
(λ).175 The MLE value (0.234) was rounded to the nearest integer to give a value of zero, which 
suggested a logarithm transformation (𝑦(λ) = log10(𝑦), where 𝑦 is the original response and 𝑦(𝜆) 
is the transformed response). Box-Cox plots of the ester 5.12 and amide 5.13 models did not 
recommend transformations (Figure 5.10). 
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Figure 5.9 Yield of compounds 5.12 (a), 5.13 (b), and 5.14 (c) for each experiment in the CCF 
design. 
a)
b)
c)
 127 
 
Figure 5.10 Box-Cox plots for the original responses from the CCF design. The 𝑳𝒎𝒂𝒙(𝝀) value 
(L. max) suggests improved transformations to the original response. The 𝑳𝒎𝒂𝒙(𝝀) 
value is close to 0 for the acid and therefore suggests a logarithmic transformation. 
The 𝑳𝒎𝒂𝒙(𝝀) values for the amide and ester are close to 1 and therefore does not 
recommend a transformation.175 
After the treatment, all the models had R2 and Q2 values of 0.99 and 0.977 for ester 5.12, 
1.00 and 0.98 for amide 5.13 and 0.90 and 0.74 for acid5.14, as shown in the summary of fit 
(Figure 5.11). The fit of models 5.12 and 5.13 are excellent, no doubt attributable to the high 
reproducibility achievable with automated reactors and precise measurements recorded by the MS 
through the steady state function. This shows the benefit of such a setup to all synthetic chemistry 
fields and that the technological barrier to building such equipment is worth the effort. 
It is probable that the acid 5.14 model has lower fit values because the spread of data across 
the experimental space is only between 3 and 40%, whereas the ester 5.12 and amide 5.13 models 
are between 2 and >90%. In addition the higher acid yields are at the more extreme conditions and 
a non-uniform spread of data can lead to a poor overall fit. The summary of fit also gives values for 
the model validity and reproducibility. The model reproducibility is measured by how consistent 
the responses of the centre-points are in each model, and a very high reproducibility can lead to low 
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model validity.8 All three models have excellent reproducibility because the automated equipment 
allows for very high consistency. As a consequence the value for model validity suffers.  
 
Figure 5.11 Summary of model fit for the acid 5.14, amide 5.13 and ester 5.12.  
The choice of CCF model allowed for prediction of optimum yield conditions by maximising 
the response of amide 5.13 and minimising the responses of ester 5.12 and acid 5.14. The optimum 
conditions calculated were 0.1 mL min-1 ester 5.12, 9.7 eq MeNH2 and 7 °C, which are consistent 
with the SNOBFIT optimisation conditions of 0.1 mL min-1 ester 5.12, 10 eq MeNH2 and 10.6 °C. 
However the ability to plan experiments before carrying them out resulted in an overall run time of 
5.5 hours compared to the 12 hours for SNOBFIT. 
5.5 Conclusions 
Online MS has been explored for monitoring and quantifying the response of an amide bond 
forming reaction in flow. A calibration model was generated by minimising the regression error 
between HPLC and MS analysis of identical sample matrices. This calibration model was then used 
to calculate the yield of desired amide in optimisations using the minimising SNOBFIT algorithm 
                                                 
8 DoE model terms are explained in more detail in Chapter 4 
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and CCF response surface model. The optimum conditions generated by both techniques were 
highly consistent, showing the high reproducibility and low error associated with online MS. 
The online analysis for self-optimisation requires fast, quantitative and sensitive data 
acquisition, which is simple to set up, carry out and analyse. IR has had a lot of success in the 
online monitoring of flow reactions, exemplified by the commercialisation of the Mettler Toledo 
ReactIR and FlowIR and its fast data acquisition.219 However IR data analysis can be increasingly 
difficult as the structure of the desired compounds becomes more complex or multiple impurities or 
intermediates are generated. HPLC can discretely separate crude mixtures and quantify individual 
components but typically requires a chromophore for UV detection and the total acquisition time is 
often greater than 5 min rather than <1 min achievable with spectroscopic methods. 
It is possible that MS can fill the void generated between these two forms of analysis 
because of its inherent separation of compounds based on their molecular weight, fast data 
acquisition and simple data analysis. However calibration of online MS can be difficult due to 
suppression of signal caused by the sample matrix. Whilst quantification techniques have been 
reported prior to this work,190, 191 the calibration has been carried out after the experimental work 
was completed. In the work carried out in this chapter, the calibration model was created first, 
allowing for rapid automated feedback controlled optimisations using fast and efficient MS 
analysis.  
For MS to be used routinely for reaction monitoring then the method of calibration needs to 
be simplified. All existing methods, including this work, have been calibrated for all components of 
the reaction by either comparing the response under the same reactions conditions of different 
analytical methods, or by preparing calibration solutions of mixtures of numerous components. 
These approaches assume that only the compounds screened during the calibration will be present 
in the sample matrix and therefore no further impurities or by-products are formed. These 
assumptions are valid for simple reactions involving monofunctional compounds, however this is 
not true of most synthetic transformations. Synthetic routes to pharmaceutical compounds involve 
the stepwise increase in complexity of a molecule, therefore increasing the numbers of undesired 
impurity routes. The ability to detect an impurity using the mass or isotope pattern is an advantage 
of analysing by MS, however quantification is not possible if it has not been included during 
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calibrations. It may also interfere with the response of compounds that are included, reducing the 
calibration accuracy. 
A possible way around this is to include an internal standard (IS), which the responses of all 
known and unconfirmed compounds can be normalised to. This would allow quantified analysis of 
reactions without having to carry out full calibration beforehand. The difficulty with this approach 
is confirming that the IS response remains a constant ratio to its concentration in the sample and a 
change in measured product composition is reflected by the reaction conditions and not due to 
differing suppression effects between compounds relative to the IS in the matrix. 
Nevertheless, MS analysis is a very strong asset to online reaction monitoring due to its high 
sensitivity, inherent separation of compounds and fast data acquisition. Obtaining quantitative 
signal response is not without its challenges, however as more calibration techniques are developed 
its use for reaction monitoring will surely increase. This chapter exemplifies how a benchtop MS 
can be easily integrated into a flow reactor setup and can replace HPLC for fast on-demand data 
analysis and reaction optimisation. 
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6. Reducing Material Consumption in Automated Flow 
Optimisations 
6.1 Introduction 
Preparative chemical research requires countless hours of manual, unskilled tasks. Reactions 
are carried out via the transfer of chemicals from containers into reaction vessels, which are 
exposed to various physical conditions, samples are acquired for analysis and then the desired 
component(s) are extracted through a variety of techniques such as liquid-liquid separation, 
induced precipitation, trituration, filtration, solvent evaporation, purification, distillation and 
crystallisation. Multiple reactions are required for methodology, in order to find combinations of 
reagents, solvents, catalysts etc., which can then undergo extended scopes to show how the reaction 
changes with different substrate functionalities. Reaction understanding requires multiple screens 
of different concentrations and temperatures to determine the kinetic parameters of the associated 
chemical transformation, and the optimisation of continuous variables to find and verify optimum 
conditions again requires considerable experimentation. 
The ability to use the data acquired from analysis to understand the key components of 
chemical transformations and then decide which follow up experiments are needed is the main 
focus of chemical research. However a large proportion of a researcher’s time is spent carrying out 
unskilled, labour intensive tasks that could be replaced by automated technology.53 Sometimes only 
the data from a reaction is required and the final mixture is simply disposed of, at high cost.22 
Therefore chemical research generates a lot of waste: not only material but the time of a highly 
trained and educated workforce. 
It should be expected that chemical reaction development and the associated technologies are 
increasingly employing automation and becoming data rich environments.  Automated reaction 
platforms are now routinely used for discovering new chemical transformations,220-223 synthesising 
known compounds,96, 224-226 high throughput screening227-229 and optimising novel or existing 
synthetic pathways.14, 15, 20, 172, 215 
Online analysis and automation are widely applied to microfluidic flow reactors because the 
integration of this technology is simple.9, 10, 53, 54, 159, 185 The nature of continuous plug flow means 
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that at steady state, the chemical composition changes with the distance of the reactor but for any 
fixed point the composition is constant. Therefore, if analysis is carried out at a fixed point at the 
end of the reactor, the whole contents of that reactor are pumped to waste before the composition 
under new reaction conditions reaches the analysis point. It can take anywhere between 1.5 to 3 
reactor volumes to reach steady state under these new conditions.230 
A way to circumvent these problems is to use segmented flow, where a small amount of 
reaction mixture is carried through the reactor using either a miscible or non-miscible fluid. Below 
is an abridged list of different gas and liquid flow regimes that result in controlled separation 
between the two fluid compositions, described in terms of dispersed and continuous phases (Table 
6.1 and Figure 6.1). 
Table 6.1 Description of microfluidic multiphase flows 
Description Dispersed phase Continuous phase 
Pulsed flow Liquid Miscible liquid 
Segmented/Slug flow Liquid Non-miscible fluid or PFC 
Compartmentalised flow Liquid PFC followed by non-miscible fluid 
Double emulsion PFC within organic liquid Aqueous 
fluid –  gas or liquid, PFC – perfluorinated compound 
Interesting phenomena can occur using the different flow regimes. In segmented flow, the 
individual segments can act as individual reactors allowing increased mixing through physical 
collisions caused by surface tension between the segments.231 In double emulsion flow, the bead of 
PFC within a segment also increases the physical mixing.232 In continuous flow, reactions can 
suffer from dispersion, where the increase in friction of the walls of the reactor causes the flow 
profile shape to become parabolic, resulting in non-constant flow velocities across the cross 
sectional area of the reactor and uncertainty in the residence time. The surface tension between 
plugs in segmented flow is generally greater than the frictional forces and therefore dispersion is 
minimised.231, 233 
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Figure 6.1 Schematic of different flow regimes where the dispersed phase is red, continuous 
phase is yellow and PFC is blue: a) pulsed flow, b) segmented flow, c) 
compartmentalised flow, d) double emulsion flow. 
The only existing examples using segmented flows in the feedback controlled optimisation 
of automated flow reactors has been reported by Reizman et al. who used slug flow for the 
selective alkylation of diamines20 and Suzuki-Miyaura cross couplings.21, 185 The authors used a 
series of fractional factorial (FED) experiments to screen discrete variables then used feedback 
controlled response surface methodology (RSM) to optimise continuous variables for a target 
function. FEDs were used in order to test if there was disproportionate response across 
experimental space with the different discrete parameters. An automated liquid handler prepared 
the reagent solutions which were introduced to the reactor as 14 µL slugs using a sample injection 
loop and carried using N2 gas. The amine and base solutions were introduced to the slug through 
tee-pieces and the reaction quenched the same way using acetic acid. After quenching, the reaction 
was diluted before analysis using at-line HPLC-MS. 
In the first example (Scheme 6.1), DMSO provided the best yield of the desired mono adduct 
6.3 out of all the solvents screened: DMF, pyridine, DCE, THF, DMC, MeCN, iPrOH, DME and 
toluene. The feedback RSM then optimised the reaction to generate 6.3 in a 62% yield. 
a)
b)
c)
d)
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Scheme 6.1 Asymmetric alkylation of trans-1,2-diaminocyclohexane (±)6.1 with 4-
methoxybenzyl chloride 6.2 to form the desired mono adduct 6.3. 
In the second example (Scheme 6.2), pre-catalysts were prepared using a variety of 
phosphine ligands (Figure 6.2) and used to screen and subsequently optimise the synthesis of four 
different compounds 6.8-6.11 for turnover number (TON) of the catalyst (mol of substrates 
converted to product per mol of catalyst). The optimum TONs ranged from 17 (35% yield) for 6.9 
to 89 (90% yield) for 6.11. 
 
Scheme 6.2 Suzuki-Miyaura cross-coupling between heteroaryl 6.5 and boronic ester 6.6 or 
boronic acid 6.7. 
 
Figure 6.2 Ligands screened in the Suzuki-Miyaura cross-coupling optimisation (Scheme 6.2) 
Effective optimisation of discrete and continuous variables in both examples was achieved 
using this method, which greatly benefitted from the segmented flows approach. The reactor 
volume was 240 µL, which would have required at least 360 µL of material pumped to reach 
steady state. However each reaction was contained within a 14 µL segment requiring only 4% of 
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the material when operating under continuous flow. These calculations assume a steady state of 1.5 
reactor volumes. 
The main disadvantage with the approach is that the reactor set-up suffered from over 
complexity. Photosensors were fitted either side of the tee-pieces and sample loops to control the 
addition of amine and quench solution as well as at-line HPLC-MS sampling. The rig also 
contained 7 individual sample injection loops that all needed individual programming as well as 4 
syringe pumps, vacuum pump, mass flow controller, reactor, HPLC-MS and custom designed 
automated liquid handler. The use of a liquid handler also meant that any discrete reagents had to 
be liquid or in solution, thus meaning that solvents and reagents must be prepared in all 
combinations of reagent/solvent solutions if they are to be screened simultaneously. A common 
problem for discrete variable screening in automated flow reactors. 
This chapter will explore the use of pulsed flows in self-optimising reactors to reduce the 
amount of material required to complete an optimisation vs. continuous flow. It was decided to use 
pulsed flows as they can be introduced into the existing reactor set-up with minimal disruption and 
is therefore less technologically complex than the segmented flow setup used by Reizman et al.20, 21, 
185 The main disadvantage with pulsed flows is that the reactor can suffer from dispersion, however 
these effects can be minimised or completely removed if the residence time distribution is 
characterised before optimisations commence. 
Pulsed flow is routinely used in chemical development by industry and academia alike to 
reduce the amount of material consumed in reactions. The Uniqsis FlowSyn234 and Vaportec R-
Series235 are fitted with 6 port sample injection loops of various sizes, which can be loaded with 
reagent and/or substrate and the machines can switch between pumping continuously from a stock 
solution and carrying the injection loop pulse with solvent. Selected examples include, but are not 
necessarily limited to, organic functional group transformations123, 236, 237 using gaseous238-241 and 
organometallic reagents;242-244 multistep synthesis;238, 239, 245, 246 packed bed reactors238, 247-249 and 
photochemistry.250, 251 
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6.2 Calculating Dispersion and Residence Time Distribution 
Continuous flow is often described as plug flow, which is an engineering model term to 
describe an ideal continuous reactor where no fluid mixes back against the flow direction. A plug 
flow reactor (PFR) can be thought as of as cross-sectional discs of infinitely small thickness that 
are all stacked together and move in unison in the direction of flow. In reality, a continuous reactor 
contains non-uniform flow patterns caused by differences in frictional forces across the tubing or 
oscillations from mechanical motion of the pumps (Figure 6.3). These non-uniform regimes result 
in uncertainty in the residence time, which can be characterised by residence time distribution.213 
 
Figure 6.3 Comparison between the flow patterns of an ideal PFR (left) and realistic reactor 
suffering from dispersion (right). 
Residence time distribution (RTD) calculations were carried out using a 3 mL PTFE tubular 
reactor with internal dimensions (ID) 1/32” (0.79 mm) and external dimensions 1/16” (1.59 mm) 
and length 6.25 m. A pulse of a biphenyl solution was pumped through the reactor by alternating 
between two pumps, one containing the solution and one with just solvent and dispersion was 
measured at 1 and 3 min residence times. For residence times of 1 min, the solvent pump was set to 
3 mL min-1 for 1 min, then stopped and the biphenyl pump was set to 3 mL min-1 for 1 min. This 
was repeated for a total duration of 50 min. During this time, the sample loop was set to acquire a 
HPLC sample at a frequency of 125 s. This resulted in 25 chromatograms displaying the 
composition of biphenyl at 5 s intervals along the 1 min repeated pulse.60 For residence times of 3 
min, the solvent pulse was set to 1 mL min-1 for 3 min, then the biphenyl pump set to 1 mL min-1 
for 3 min. This was repeated for a duration of 216 min with HPLC sampling frequency of 370 s. 
This resulted in 36 points displaying the composition of biphenyl at 10 s intervals across the 3 min 
repeated pulse (Figure 6.4). 
t = 0 t = ∞ t = 0 t = ∞
Ideal PFR Realistic dispersion
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Figure 6.4 Plots of HPLC area of biphenyl vs time for the dispersion experiments. Residence 
times of 1 min (left) and 3 min (right). 
The dispersion is determined by calculating the parameter 𝐷, which is the longitudinal 
dispersion coefficient and characterises the amount of back mixing in continuous flow. This can be 
converted to the dimensionless term 
𝐷
𝑢𝐿
, where 𝑢 is the flow velocity and 𝐿 is the length of tubing. 
For 
𝐷
𝑢𝐿
 values of 0, there is perfect plug flow but as 
𝐷
𝑢𝐿
 approaches infinity there is large dispersion 
and mixed flows. Typically any value of 
𝐷
𝑢𝐿
< 0.01 can be fitted to the dispersion model for a PFR. 
The experiments as described in the previous chapters generated a tracer pulse of HPLC area 
vs. time of pulse (Figure 6.4). This response of the pulse is normalised to create a 𝐶 curve 
 
𝐶 =
𝐶𝑖(𝑡)
𝐶𝑚𝑎𝑥
 
(6.1) 
 
where 𝐶 is the normalised HPLC response, 𝐶𝑖(𝑡) is the HPLC area at time 𝑡 and 𝐶𝑚𝑎𝑥 is the 
maximum HPLC area across the time span. The time was normalised so that 𝐶𝑚𝑎𝑥 occurs at 𝜃 = 1 
 
𝜃 =
𝑡
𝑡̅
 
(6.2) 
 
 
Next, an 𝐸 curve was calculated, which fits the data to a Gaussian trend depending on the value of 
𝐷
𝑢𝐿
. For small deviations from plug flow (
𝐷
𝑢𝐿
< 0.01), the tracer shape is symmetrical and the 𝐸 
curve calculated by 
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𝐸𝜃 =
1
√4𝜋 (
𝐷
𝑢𝐿)
𝑒𝑥𝑝(−
(1 − 𝜃)2
4 (
𝐷
𝑢𝐿)
) 
(6.3) 
 
The 𝐸 curve was normalised in order to calculate the error (𝑆𝑆𝐸) between the 𝐶 and 𝐸 curves 
 𝑆𝑆𝐸 =∑(𝐶𝑖(𝜃) − 𝐸𝜃(𝜃))
2
 (6.4) 
 
The shape of the two tracer pulses are not true Gaussian but have a plateau of 𝐶𝑚𝑎𝑥 values, that 
distort the shape of a fit across all the data points. To rectify this, fitting was carried out on only the 
right hand side of the tracers because the trailing of a peak is a better indication of dispersion, 
especially for non-symmetrical curves.213 
The last point of the plateau was denoted as 𝐶𝑚𝑎𝑥 (𝜃 = 1) and the 𝐸 curve was fitted to the 𝐶 
curve by minimising the error 𝑆𝑆𝐸 using generalised reduced gradient non-linear algorithm as part 
of the Microsoft Excel solver function. 
 
Figure 6.5 𝑬 curve fit layered over 𝑪 curve for 1 min residence time distribution experiment 
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Figure 6.6 𝑬 curve fit layered over 𝑪 curve for 3 min residence time distribution experiment 
The 𝐸 curve fits are shown for RTD 1 min experiments in Figure 6.5 and for 3 min 
experiments in Figure 6.6. Both of the 𝐸 curve fits show a value for 
𝐷
𝑢𝐿
 that is greater than 0.01, 
indicating that there were deviations from plug flow in the tubular reactor constructed. If this is the 
case then the 𝐸 curve is calculated using a different equation from that shown in (6.3) 
 
𝐸𝜃 =
1
√4𝜋 (
𝐷
𝑢𝐿)
𝑒𝑥𝑝(−
(1 − 𝜃)2
4𝜃 (
𝐷
𝑢𝐿)
) 
(6.5) 
 
However when this expression was used there was minimal change to the overall 𝐸 curve fit and 
value for 
𝐷
𝑢𝐿
.Therefore it was assumed that there was minimal variation from plug flow and 
therefore minimal dispersion in the reactor. 
6.3 Self-Optimisation Using Pulsed Flows 
To test the material savings achievable with pulsed flows, a nucleophilic aromatic 
substitution (SNAr, Scheme 6.3) was optimised using at-line HPLC and pattern search algorithm.147 
2,4-difluoronitrobenzene 12 can undergo rapid substitution with morpholine to form the desired 
regioisomer ortho 13 and undesired para 14. Base was required to quench the hydrofluoric acid 
generated in situ, so triethylamine was added to ensure that all of the morpholine was used as a 
reagent and not a base.252 Both isomers 13 and 14 can undergo double addition to form the di-
substituted 15, however previous research within the group has shown that the para 14 undergoes 
this transformation faster than 13.60 
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Scheme 6.3 SNAr reaction between difluoronitrobenzene 6.12 and morpholine to form the 
desired ortho 6.13 and undesired para 6.14, which can both undergo double 
substitution to form di-substituted 6.15. 
Three pumps were used with reservoirs of nitrobenzene 6.12 (2.03 mol L-1) and biphenyl 
internal standard (0.10 mol L-1) in EtOH, morpholine in triethylamine (4.17 mol L-1, 1.1 mol eq 
NEt3) and neat EtOH. The same 3 mL PTFE tubular reactor was fitted, as was used during the 
dispersion experiments, as well as a 100 psi BPR (Figure 6.7). The EtOH pump was used to modify 
the concentration of nitrobenzene species (6.12-6.15) during reactions and as the carrier solvent 
during solvent pulses. 
 
Figure 6.7 Reactor schematic for the SNAr self-optimisation. SL = Sample loop 
6.3.1 Pulse Volume 
Firstly it was important to determine the size of reactor volume (RV) pulse that would be 
used during optimisations. It was hypothesised that 0.5 volumes would be sufficient but this needed 
to be tested. Several reactions under the same conditions were carried out but differing sizes of 
reaction pulses were pumped, with ethanol as the miscible solvent carrier. 
The flow rates and duration of reaction and solvent pulses were calculated according to the 
centre of the reaction pulse being at the end of the reactor when a HPLC sample was taken. This 
6.12
6.13-6.15
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would ensure the centre of the reactor pulse would be at the sample loop when a sample was taken. 
4 experiments were carried out for each volume and the analytical response averaged after removal 
of anomalous results. 
To make it easier to calculate the duration of reaction and solvent carrier pulses, the pulses 
were separated into reaction pulse 𝑅 and solvent pulses 𝐴 and 𝐵 (Figure 6.8). 𝐴 is the first solvent 
pulse, which is followed by reaction pulse 𝑅 then solvent pulse 𝐵. The flow rate of all pulses 
remain constant and the duration of each pulse is calculated 
 
𝑅 = 𝑅𝑉𝑝𝑢𝑙𝑠𝑒𝑡𝑅𝑒𝑠 (6.6) 
 
𝐵 = 𝑡𝑅𝑒𝑠 −
𝑅
2
 (6.7) 
 
𝐴 = 𝑡𝑒𝑛𝑑 − (𝑅 + 𝐵) ≥ 0 (6.8) 
where 𝑅𝑉𝑝𝑢𝑙𝑠𝑒 is the size of reactor volume pulse, 𝑡𝑅𝑒𝑠 is the residence time and 𝑡𝑒𝑛𝑑 is the time for 
the analysis acquisition to be ready, typically the sample frequency time. 
 
Figure 6.8 Notation of the solvent pulses A and B and reaction pulse R 
The change in percentage composition of compounds 6.12-6.15 shows that unreliable 
responses are recorded at volumes less than 0.5 (Figure 6.9). This means that for pulses of less than 
0.5 RV, dispersion was an overriding factor and prevented the expected reaction kinetics. The 
margin for error for each RV of 0.5 and lower was calculated from the values recorded at RVs 1-2. 
Firstly the mean response of RVs 1-2 was calculated, then the residual error for the other RVs. For 
example, the residual error for ortho 6.13 at 0.5 reactor volumes 
𝑆𝑆𝐸,(𝟔.𝟏𝟑,0.5) =∑(𝑌𝑖,(𝟔.𝟏𝟑,0.5) − ?̅?𝟔.𝟏𝟑,0.5)
2
= 5.58 
where 𝑌𝑖 is the yield for experiment 𝑖. Next the standard deviation of the residual error for the 3 
experiments was calculated 
AB R
tend t0Flow direction
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𝜎(𝟔.𝟏𝟑,0.5) = √
5.58
3
= 1.36 
For a confidence interval of 95%, the Z table value for 0.475 (0.95/2) is 1.96 which means the 
margin for error was 
 𝑒𝑟𝑟𝑜𝑟 = 𝑍
1−
𝛼
2
(
𝜎
√𝑛
) 
= 1.95 × (
1.36
√3
) = 1.54 
(6.9) 
 
 
Figure 6.9 Summary of HPLC areas for compounds 6.12-6.15 for changing reactor pulse 
volumes. 
A summary of the yields of all the experiments, along with margins for error, is shown in 
Table 6.2. The reactions performed in a RV pulse of 0.5 showed a margin for error of < 1.6 %, 
however part of this error must have been from irreproducibility from equipment as well as 
analytical error. It could be assumed that these factors were solely responsible for the margins for 
error for RVs 1-2. If this was the case then the error associated with dispersion can be calculated by 
subtracting the average margin for error for RV 1-2 from the overall margin for error for 0.5 RV, 
giving a value of ~ 1%. This low margin for error showed that 0.5 RVs was a suitable pulse 
volume for optimisations. 
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Table 6.2 HPLC % area of compounds 6.12-6.15 for different rector volume pulses 
Reactor 
volumes 
Nitrobenzene 6.12 Ortho 6.13 Para 6.14 Di 6.15 
2 34.9 (± 0.790) 62.6 (± 0.765) 2.26 (± 0.021) 0.21 (± 0.006) 
1.5 35.0 (± 0.440) 62.5 (± 0.422) 2.26 (± 0.013) 0.21 (± 0.007) 
1 34.9 (± 0.538) 62.5 (± 0.524) 2.25 (± 0.011) 0.21 (± 0.005) 
0.5 36.37 (± 1.59) 61.2 (± 1.54) 2.17 (± 0.104) 0.27 (± 0.089) 
0.2 51.72 (± 19.0) 46.6 (± 18.0) 1.59 (± 0.760) 0.00 (± 0.241) 
0.1 77.92 (± 48.6) 22.0 (± 45.8) 0.00 (± 2.555) 0.00 (± 0.241) 
0.05 94.10 (± 66.9) 5.9 (± 64.1) 0.00 (± 2.555) 0.00 (± 0.241) 
Margins for error are calculated assuming a 95% confidence interval 
6.3.2 Pulsed Flows Optimisation Program 
A new optimisation program was written in order to include the changes that would be 
required for the pulsed flows. A flow chart summarising the key decisions made in the program is 
displayed in Figure 6.10. In summary, the program is identical to the original when creating the 
new conditions from the algorithm. Next the program enters the steady state timer, where it 
calculates the flow rate of the solvent pump and durations of the pulses 𝐴, 𝐵 and 𝑅. During the 
optimisations 𝑡𝑒𝑛𝑑 was calculated as the time from which the HPLC would be ready to sample 
(sum of the time of the previous sample and the method length). This time was calculated before 
the reactor reached the desired temperature and as a result the pulse 𝐴 could start after 𝑡𝑒𝑛𝑑 
resulting in a negative flow rate. For these reasons the minimum value of 𝐴 was set to zero (6.8). 
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Figure 6.10 Flow chart summary of the optimisation program, which includes the pulsed flows 
6.3.3 Space Time Yield Self-Optimisation 
The SNAr reaction (Scheme 6.3) was optimised for the space time yield (STY) of ortho 6.13 
using the pattern search algorithm. STY is a measure of reactor productivity and calculates the 
mass of product per unit time and volume 
 
𝑆𝑇𝑌 =
𝐶𝟔.𝟏𝟐𝑌𝑖(𝟔.𝟏𝟑)𝑀𝑊𝟔.𝟏𝟑
𝑡𝑅𝑒𝑠,𝑖
 
(6.10) 
 
where 𝐶𝟏𝟐 is the initial concentration of nitrobenzene 6.12 in the reactor, 𝑀𝑊𝟔.𝟏𝟑 is the molecular 
weight of ortho 6.13 and 𝑡𝑅𝑒𝑠,𝑖 is the residence time of experiment 𝑖. 
Table 6.3 – Optimisation limits for the STY optimisation of ortho 6.13 
Limit Residence time /  
min 
Morpholine /  
mol eq 
Concentration /  
mol L-1 
Temperature /  
°C 
Lower 1 1.0 0.200 60 
Upper 3 2.0 0.500 120 
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Figure 6.11 Summary of optimisation results. Each plot shows how an individual variables 
changes as the algorithm reaches the optimum. A – residence time, B – morpholine 
eq, C – concentration of 6.12, D – temperature. The colour of the point represents the 
target metric (STY). 
The reaction was optimised according to the limits in Table 6.3. The optimum conditions 
generated ortho 6.13 in an 82% yield with a STY of 5.27 kg L-1 h -1; a summary of results is shown 
in Figure 6.11. The optimum conditions were 1.05 min, 1.7 eq of morpholine, 0.50 mol L-1 and 
118.3 °C, which were at (or close to) the maximum limits for morpholine eq, concentration and 
temperature but minimum residence time. This was in order to maximise the yield of ortho 6.13 
whilst reducing the overall residence time to maximise the amount of material pumped per unit 
time. 
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Figure 6.12 Plot displaying the improved optimum with increasing experiment number 
Figure 6.12 shows how the optimum improved as the optimisation progressed. The algorithm 
did not have a built in stopping criterion and was stopped manually after 107 experiments. 
6.3.4 Material and Cost Savings 
The main objective of the pulsed flows approach was to save material during each 
experiment. Material savings were calculated based on three separate forms of operation: pulsed 
flow; step-flow, where the flow rate of all pumps was reduced whilst the reactor was reaching 
temperature; and full continuous flow operation. 
Further analysis of the reactor data showed that reactor pulses varied from 0.54 to 0.72 RV 
rather than the desired 0.50 RV. This is likely caused by the resolution of the program timers. 
Instead of calculating the time that the timer should run for then stopping, the timer would repeat 
its line of code at a fixed period then stop once it had carried out enough repetitions. This was to 
ensure that the program was constantly checking that all reactor components were at their desired 
values, ensuring that there were no sudden temperature spikes or pumps that had stopped because 
of a blockage. The period of each timer ranged from 15 to 20 s. It was important not to reduce this 
time period because the timer could try to restart whilst already running and cause the program to 
crash. In experiments with a residence time of 1 min, the time to pump the reaction pulse could 
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change by as much as a third. It is likely that this caused the deviation in reactor volume. For 
reactions that require a longer residence time, the error in timer period would be less significant. 
In previous step-flow optimisations, where steady state has been calculated, the program has 
waited for 1.5 RV. Because of the discrepancy with the pulse volume, the potential steady state 
reactor volumes for each experiment were calculated by adding 1 RV to the pulse volume. 
Therefore the step flow steady state volumes ranged from 1.54 to 1.72. For continuous flow 
operation, it was assumed that the pumps were continually pumping at the flow rates calculated by 
the algorithm during changes in reactor temperature, waiting for steady state and analysis and 
would only change when new conditions were calculated. 
Table 6.4 Comparison of material used during different optimisation approaches 
 Nitrobenzene 6.12 Morpholine 
Total / g Per experiment / mg Total / g Per experiment / mg 
Pulsed Flow 14.5 135 14.7 137 
Step Flow 37.1 347 37.7 352 
Continuous Flow 74.7 698 75.6 707 
 
The amount of material required for the different flow modes is shown in Table 6.4. The 
pulsed flows optimisation used a total of 14.5 g of nitrobenzene 6.12 and 14.7 g of morpholine, 
averaging 135 mg and 137 mg per experiment, respectively. This resulted in savings of 61% and 
81% compared to the step flow and continuous flow modes, respectively. 
6.4 Optimising For Multiple Targets 
STY is a useful metric to improve the productivity of a process but in this case has produced 
conditions that have not reached full conversion of nitrobenzene 6.12 and is therefore wasting 
material. According to the kinetic model of this reaction, a slight increase in the residence time is 
likely to result in a higher conversion and yield without overreacting to form di 6.15.60 However 
this would lower the reactor productivity. A more advantageous approach would be to optimise the 
reaction for more than one target function. Process mass intensity (PMI) measures the amount of 
waste in a synthetic step per mass unit of product 
 𝑃𝑀𝐼 =
𝑚𝑎𝑠𝑠𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡𝑠
𝑚𝑎𝑠𝑠𝑝𝑟𝑜𝑑𝑢𝑐𝑡
 (6.11) 
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and the American Chemistry Society Green Chemistry Institute Roundtable also selects it as the 
best metric for sustainable manufacture.182 Therefore it was decided to optimise the reaction for 
both STY and PMI in order to maximise productivity and minimise waste. 
6.4.1 Bayesian Approach to Multi-Objective Optimisations 
In order to optimise for more than one target, it is possible to create a single function that 
incorporates multiple targets,27 however a better strategy is to use a multi-objective optimising 
algorithm. In multi-objective optimisation, the main objectives are to form a Pareto front, a number 
of points that form a compromise between the different target functions; and to make this Pareto 
front as diverse as possible across experimental space.253 
The algorithm used was the Thompson sampling-evolutionary global optimisation 
algorithms (TS-EMO), developed at the University of Cambridge.254, 255 The algorithm uses 
Thompson sampling and Bayesian analysis to generate and validate surrogate models that satisfy 
the optimising function, in this case the SNAr reaction (Scheme 6.3). This algorithm is a second 
generation version of the multi-objective active learner (MOAL) algorithm,171 previously used for 
the multi-target optimisation of an emulsion polymerisation.26 
 
Figure 6.13 Bayesian analysis of surrogate models for a single factor variable, x, with response, 
f. The black dots signify existing experiments and responses, the coloured dashed 
lines signify surrogate models that fit the current experiments. The grey shading 
shows the uncertainty of the response of the unexplored experimental space. Note 
that the uncertainty is zero for the two experimental data points. 
The algorithm starts by generating an initial number of experiments using a latin hypercube 
generator.256 From this data, a number of surrogate models are created using Gaussian processes 
and the algorithm continually minimises the responses by using Thompson sampling, which is a 
f
x
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method of choosing the best potential surrogate model based on the expected maximum 
improvement over the existing responses.257 Thompson sampling is a form of Bayesian analysis, 
which choses new conditions based on the known response of existing experiments (Figure 6.13). 
6.4.2 Multi-Objective Self-Optimisation 
The SNAr reaction was optimised using the TS-EMO algorithm according to the limits 
displayed in Table 6.5. The limits were adjusted from the first optimisation based on the optimum 
STY and to better test the new algorithm. The residence time limits were reduced and morpholine 
limits increased with the aim to generate a large Pareto front of short residence times and high 
equivalents, leading to high STY; and longer residence times and low equivalents, leading to low 
PMI. The temperature was raised to increase yield in compensation for the shorter residence times. 
Table 6.5 Optimisation limits for the multi-objective optimisation of ortho 13 
Limit Residence time /  
min 
Morpholine /  
mol eq 
Concentration /  
mol L-1 
Temperature /  
°C 
Lower 0.5 1.0 0.100 60 
Upper 2 5.0 0.500 140 
 
The results of the optimisation are shown in Figure 6.14. It was necessary to transform the 
responses of both PMI and STY using natural logarithms so that the algorithm would be able to fit 
better models. The STY response was then converted to negative because the algorithm would 
minimise any response and STY needed to be maximised. 
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Figure 6.14 Results of the TS-EMO multi-objective optimisation. The x and y axes show the 
natural logarithm of PMI and the negative natural logarithm of STY, respectively. 
The blue data points show the initial latin hypercube data; black points show the 
experiments generated by the surrogate models of the algorithm; and red points show 
the experiments that converged to a pareto front. 
The initial latin hypercube generated 20 experiments with a general trend of low PMI but 
also low STY. The TS-EMO algorithm then generated a further 48 experiments, creating a dense 
Pareto front of 26 points. The conditions of the Pareto front are shown in Table 6.6 and all have 
consistently high temperature (140 ºC) and concentration (0.500 mol L-1). This can be explained by 
the very fast first step to form the desired ortho/para mono-substituted product, which donates more 
electron density to the aromatic ring thus making the compound less likely to undergo the second 
substitution to form the di. Therefore reactions could be carried out at the maximum temperature 
and morpholine eq without risk of overreaction to the di because of the short residence times. 
The compromise in the optimum conditions occurred between the residence time and 
morpholine eq. Conditions with a short residence time and high eq resulted in a maximum STY and 
high PMI (Table 6.6, entry 1, 0.50 min, 4.70 eq, 0.500 mol L-1, 140 ºC, STY = 218.62 kg L-1 h-1, 
PMI = 2.57). Conversely, a long residence time and low morpholine eq resulted in a low STY and 
minimum PMI (Table 6.6, entry 26, 1.62 min, 1.00 eq, 0.500 mol L-1, 140 ºC, STY = 60.76 kg L-1 
h-1, PMI = 1.24).  
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Table 6.6 Reaction conditions of Pareto points 
 Exp no tRes /  
min 
Morph eq Conc /  
mol L-1 
Temp /  
ºC 
STY /  
kg L-1 h-1 
PMI 
1 0.50 4.70 0.500 140.0 13.12 2.565 
2 0.50 4.51 0.500 140.0 13.08 2.498 
3 0.50 3.28 0.500 140.0 12.99 2.031 
4 0.50 3.19 0.500 140.0 12.91 2.005 
5 0.50 3.01 0.500 140.0 12.83 1.947 
6 0.50 2.89 0.500 140.0 12.76 1.908 
7 0.50 2.76 0.500 140.0 12.76 1.856 
8 0.50 2.58 0.500 140.0 12.65 1.801 
9 0.50 2.49 0.500 139.6 12.55 1.776 
10 0.50 2.29 0.500 137.8 12.40 1.717 
11 0.50 2.20 0.500 139.4 12.34 1.689 
12 0.50 2.00 0.500 140.0 12.10 1.635 
13 0.50 1.78 0.500 140.0 11.68 1.598 
14 0.50 1.60 0.500 140.0 11.39 1.558 
15 0.50 1.34 0.500 140.0 10.80 1.520 
16 0.53 1.23 0.500 140.0 10.01 1.486 
17 0.60 1.19 0.500 140.0 8.97 1.456 
18 0.70 1.37 0.500 140.0 8.30 1.419 
19 0.77 1.33 0.500 140.0 7.66 1.393 
20 0.81 1.07 0.500 140.0 6.85 1.359 
21 0.93 1.13 0.500 140.0 6.24 1.325 
22 1.05 1.00 0.500 140.0 5.34 1.306 
23 1.18 1.00 0.500 140.0 4.85 1.287 
24 1.32 1.00 0.500 140.0 4.37 1.269 
25 1.52 1.09 0.500 140.0 3.96 1.253 
26 1.62 1.00 0.500 140.0 3.65 1.239 
tRes – residence time, Morph – morpholine, Conc – concentration, Temp - temperature, STY – space time 
yield, PMI – process mass intensity. 
An advantage with using a dual-objective algorithm was that it provides a clear compromise 
between the two targets and allows the user to pick an optimum point based on the response of 
additional metrics such as cost, yield or selectivity (Figure 6.15). However the main advantage with 
using this algorithm is the amount of information the user obtains from the data compared to the 
number of experiments. The algorithm required a total of 68 experiments, which is within the same 
magnitude as has previously been carried out in other chapters for single objective optimisations. 
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Not only has the algorithm optimised for two targets but, in generating a Pareto front, has shown 
much more clearly how the conditions reach a compromise between different targets.  
 
Figure 6.15 Pareto front with optima for other targets highlighted. Blue - % yield (96.6%), red - 
% selectivity of para (96.7%), green – cost of raw materials £ kg-1 (£ 145.85 kg-1). 
6.5 Conclusions 
The desire to reduce the amount of material consumption in chemical development can 
clearly be explained by economic and environmental factors. Through automation of chemical 
reactors, numerous experiments can be carried out that screen multiple physical conditions and 
choices of substrates, reagents, solvents etc. therefore reducing the number of man-hours 
designated to performing tedious unskilled tasks. The successful automation of chemical discovery, 
220-223 synthesis, 96, 224-226 screening227-229 and optimisation14, 15, 20, 172, 215 has not only resulted in more 
efficient practical work but has also contributed to improving the quality of the desired output, be it 
physical product or numerical data. 
However there is still more that can be done. The self-optimisation of continuous flow 
reactors can generate a large amount of waste for numerous reasons. Firstly due to the nature of 
flow chemistry. Although there has been great success with the miniaturisation of flow reactors,35, 
45, 129, 258, 259 any flow reactor will typically use more material than a batch counterpart. The liquid 
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metering pumps need to be primed, which results in pumping material to waste (except some 
syringe pumps). When the experimental work is finished, any unused chemicals are disposed of 
either to prevent contamination or because they are mixed in a solution. In batch, the desired 
quantity of chemicals is transferred into the reactor with minimal excess waste. Secondly, for most 
applications only the data is required and the product stream is directly disposed of.22 Thirdly, more 
than one reactor volume needs to be pumped before steady state is reached, resulting in material 
wasted. Finally, a poor choice of algorithm is used, which either stops at a local optimum or does 
not provide enough information about the reaction system, requiring additional experimentation to 
take place. 
The first problem can be addressed by sensible planning and careful use of equipment to 
ensure that material is not unnecessarily wasted. The second is a general issue with experimenting 
for reaction development and optimisation because it is often not practical to keep the reaction 
contents. However, the best attempts can be made to reduce the amount of material that is used for 
each reaction, which addresses the third problem. The work in this chapter follows that of Reizman 
et al. to use compartmentalised flow that contains a reaction pulse smaller than the reactor volume. 
By using gas/liquid segmented flow, Reizman was able to introduce reactor pulses that would not 
suffer from dispersion and reduced the material required by 96%.9 However, the reactor setup used 
was complex and would potentially be intimidating to the novice user. The approach used in this 
chapter characterised the reactor RTD and showed that the error associated with dispersion from 
liquid/liquid pulsed flow was minimal and could provide material savings of 67%.9 Whilst the 
pulsed flows delivered less saving than the segmented flows, the approach in this chapter could be 
introduced into an existing automated continuous reactor, whereas a completely new reactor 
needed to be designed for Reizman’s approach. 
The next challenge is to further reduce the amount of material used in the pulsed flows. This 
can be achieved by either reducing the reactor or the pulse volume. Reducing the pulse size would 
result in too much dispersion to deliver accurate results, and it is highly likely that reducing the 
volume would lead to a loss of plug flow behaviour due to lower flow velocities to achieve the 
                                                 
9 Material savings are calculated based on 1.5 reactor volumes to reach steady state under continuous flow vs 
the volume of the pulse in the compartmentalised flow. 
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same residence time. However, it would be possible to use tubing with a narrower internal diameter 
in the reactor, which would provide the opportunity to use smaller pulse volumes and possibly even 
a smaller reactor size, depending on the RTD results of the new tubing. 
The final problem with self-optimisation is a poor choice of algorithm, which does not 
provide enough information about the system. The simplex algorithm,137 and its modifications,138, 
139, 149 is an effective algorithm for quickly finding the closest optimum from a starting point, 
however it can sometimes stop at a local, rather than a global, optimum. The use of global 
searching algorithms (e.g. SNOBFIT and genetic algorithm) can circumvent this problem by 
scanning all the experimental space, but can only optimise for one target at a time. The work in this 
chapter has shown how using a multi-objective algorithm can find a distribution of points that find 
a compromise between two different targets. With this set of points, optimum points for other 
targets can be found and optimum conditions for separate three target optimisations were found. 
Plus, the algorithm required a similar number of experiments (68) to single target global searching 
algorithms.  
In summary, two separate strategies were implemented to reduce material usage in self-
optimisation. First, pulsed flows were introduced, which resulted in a material saving of 81% vs 
continuous flow operation. Secondly, a multi-objective algorithm was used, which was able to find 
a set of compromising optimum conditions between STY and PMI and could be used to further 
create three-target optimum conditions. This was achieved using a similar number of experiments 
to single target optimisations and creates a theoretical three-fold material saving. 
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7. Conclusions 
The recurring theme of this thesis has been a reflective look at existing technologies 
associated with automated optimisation of flow reactors and how to improve them. In the first 
chapter, a list of disadvantages with existing self-optimisation technologies was identified that 
needed to be addressed before its widespread use in pharmaceutical process development. These 
were: 
 Applicability to complex pharmaceutical reaction steps 
 Integration with existing statistical design techniques 
 Combining self-optimisation with different types of online analytical equipment 
 Evaluating the correct target function and/or best algorithm 
 Minimising the amount of waste material 
This thesis has contributed to addressing all of these points in various different formats. In 
Chapter 3, the final bond-forming step in the synthesis of the API osimertinib (AZD9291) was self-
optimised in continuous flow. Osimertinib is an irreversible EGFR tyrosine kinase inhibitor for 
T790M mutations in non-small cell lung cancer, developed by AstraZeneca (AZ).160, 161, 168 Phase I 
clinical trials with osimertinib began in March 2015 and FDA approval was granted 2.5 years later 
in November 2015.260 In collaboration with AZ, self-optimisation studies started in early 2014 and 
it was hypothesised that the rapid technique could help AZ process development scientists, who 
were working on a much shorter timescale than for most pharmaceutical approval timescales.  
Initial optimisations were carried out on a model compound, which highlighted that the 
potential bottlenecks would be with generating flow conditions that could be pumped continuously 
without clogging. Once these conditions were discovered reaction screening was rapid and facile 
and two separate optimisations were carried out in order to maximise the yield of the desired model 
acrylamide 7 and a potential impurity. The coverage of experimental results across the process 
design space enabled by the SNOBFIT algorithm provided potential impurity routes, which could 
be verified using offline LC-MS. 
The initial experiments showed that the AZD9291 aniline had much lower reactivity than the 
model aniline and thus required much more forcing conditions. The AZD9291 optimisations also 
had a much more complex experimental space and as such had a smaller region of optimum values. 
This could be caused by more favourable impurity pathways caused by the more forcing conditions 
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but there was not the same success in mapping these impurity pathways than there was with the 
model compound. 
The biggest positive from the study was that self-optimisation could be used to optimise a 
pharmaceutical reaction step without consuming large amounts of starting material. The 
disadvantages was that the lack of restraint applied to the algorithm generated results with very 
high reagent stoichiometry and the results only focused on the reaction step and not any 
downstream processes. The first point could be addressed by improved algorithms or target 
functions, which unfortunately wasn’t possible within the scope of this study. The second point 
obviously requires integration of downstream processing equipment before online analysis. With 
techniques where an empirical model is obtained, it is possible to see the compromise between 
reagent stoichiometry, cost and yield. 
Chapter 4 addressed this point by using existing DoE fitting techniques and applying them to 
data obtained from a self-optimisation. It was necessary to change the boundary limits, and with it 
the experimental design space, in order to obtain models with a good fit and predictability. Once an 
empirical model was obtained, it was possible to find optimum conditions for different metrics as 
well as optima that compromised between these different target functions. 
A new form of analysis for automated flow reactor optimisation was introduced in Chapter 5 
– mass spectrometry (MS). The advantage with MS is that it has a very short acquisition time, will 
inherently separate compounds based on their molecular weight and can provide quantitative 
analysis. The disadvantage is that the MS signal can be difficult to calibrate because of a lack of 
linear response across the whole experimental area. In the chapter, the MS was calibrated to HPLC 
then used to optimise an amide bond formation using SNOBFIT algorithm and DoE. 
However, it has yet to be shown that MS can be used for quantitative analysis of 
pharmaceutically relevant reactions. All existing calibration techniques have calibrated all known 
compounds in the reactions including by-products and impurities. In pharmaceutical process 
development, it is not always possible to identify and isolate all impurities and therefore this 
technique cannot be used. A more advantageous technique could be to calibrate the desired 
compound relative to an internal standard, which is commonplace in chromatography and 
spectroscopy. However the signal of both the analyte and internal standard need to be linear across 
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the experimental space because an increase in calculated yield could be a result of internal standard 
suppression rather than actual reaction yield. Another technique could be to simply maximise the 
raw mass count of the product peak then quantify the optimum response by offline analysis of 
optimum conditions. However, this does not account for suppression of signal and would only 
provide information about the optimum and not any other experiments. In conclusion, MS is a very 
powerful technique but more work is required in its calibration. 
The final chapter addressed the need to reduce the amount of material wasted in automated 
optimisations. This was done in two parts: first, use of sub reactor volume pulses that are 
suspended between carried solvent; second, use of an algorithm that can optimise for more than one 
target function at a time. Initial reaction screening showed that 0.5 reactor pulse volume would 
provide the same results as waiting for 2 reactor volumes for steady state with minimal dispersion. 
A nucleophilic aromatic substitution was successfully optimised using this pulse volume. Next, a 
new evolutionary algorithm was used, which could generate a list of optimum values that 
compromised between maximum productivity and minimum waste. 
 It has already been proved that it is possible to reduce the pulse size volume by using gas as 
the carrier fluid in a dispersion-free system.20, 21, 185 However this reactor setup was incredibly 
complicated. In order to improve the liquid/liquid pulsed flow carrier system then the reactor 
volume can be decreased by using narrower tubing. Unfortunately this was out of the scope of this 
project but plans are already in place to continue the work in this direction. 
7.1 Future Work 
In the examples in this thesis, there was not strict control over the quenching of reactions and 
it was assumed that the small injection volume into the HPLC mobile phase would result in a low 
enough concentration to effectively stop the reaction before components were separated on the 
column. However the work-up and isolation of a product is incredibly important and can be an area 
where impurities are created, increased or purged. The ease at which multiple sets of reactors and 
downstream equipment can be combined in continuous reactors means that it should be easy to 
include work-up procedures as variables in an optimisation. For example, the flow rate of a quench 
pump can change the molar equivalents of quenching reagent and physical mixing of that quench, 
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which in turn can change the impurity profile of the product. In other processes it could be possible 
that a reaction is carried out in batch then purified using continuous distillation or purification and 
there doesn’t yet exist any automated optimisation of these processes. In summary, it would be 
highly advantageous to the pharmaceutical industry to see more example of self-optimised unit 
operations and not just reactions. 
Solubility is a problem that haunts many flow chemists and the requirement for homogeneity 
can drive researchers away from particular reactions or substrates.95 There have been reactors 
designed to incorporate solid formation and can result in niche reaction conditions, not achievable 
in batch.261 However for these reactors to be adopted in self-optimisation, there needs to be 
techniques to sample reaction slurries for online analysis. 
Another area of improvement is in the area of discrete variable optimisation. Continuous 
variables (e.g. concentration, time, temperature) are easy to optimise for by changing pump flow 
rates and reactor temperature. However it is difficult to screen which is the best catalyst, solvent, 
base or a combination of all using optimising algorithms because they need to correlate to a 
number. In work by Reizman and Jensen, multiple FEDs were carried out with each different 
discrete variable then steepest descent algorithm optimised the continuous variables.20, 21, 185 
However there was little intelligent initial screening of the discrete variables and it relied heavily 
on high throughput screening, where multiple reactions of different discrete variables are carried 
out then the results compared.227, 262 
Principal component analysis (PCA) is a technique that separates the properties of multiple 
discrete variables into two or three principal components.263 Murray et al. used PCA to transform 
two Pd sources, nine phosphine ligands, four bases and nine solvents into a three dimensional 
experimental space.264 With a 3-dimensional space, a series of DoE designs were used to hone in 
and then find the best combination of catalyst, base and solvent for a Buchwald-Hartwig 
sulfamidation, reducing the number of experiments from a possible 51 million to only 78. It is 
surely sensible to use an optimising algorithm to concurrently search the discrete variables and 
optimise the continuous variables with a tandem PCA-algorithm technique. 
The difficulty in screening multiple discrete variables is the reactor setup. If the reactor setup 
in this thesis was adopted, where each continuous variable is controlled by a piece of equipment, 
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then each solvent and reagent would need its own pump or a series of switching valves connected 
to a single pump, assuming everything is liquid. For solid reagents, all combinations of reagent in 
solvent would need to be prepared, requiring a very large number of pumps. E.g. four solid 
reagents in four different solvents would require 16 separate pumps. Assuming that there is the 
physical laboratory space to connect all this equipment, the costs associated would be very high, 
probably too high for an academic environment. 
Therefore the sensible approach would include robotics, with solid and liquid metering 
systems to prepare pump solutions of various compositions in order to test in the reactor. The 
disadvantage with this approach is the technological expertise required to operate robotics. The 
majority of researchers in self-optimisation are chemists/chemical engineers that have learnt to 
code laboratory equipment as part of their project requirements. Introducing robotics opens up a 
whole new field of electronic engineering which can be daunting to an adept coder, let alone a 
novice. 
This also fuels the final requirement – a commercially available self-optimisation platform. 
I.e. a software/hardware package that can be bought and used to integrate all sorts of pumps, 
reactors and analysis with intelligent program control and minimising algorithms. It has been 
mentioned a few times in this chapter how equipment is more readily integrated if it is 
commercially available and does not need specialist individual manufacture. This alone would 
contribute to the widespread use of automated flow reactors but would be very difficult to 
implement. There are several different companies that make analytical equipment, and they all use 
different software programs. This would require collaboration between companies in order to make 
it easy to integrate all their software together. Protection of intellectual property is paramount to a 
company’s success and integration of multiple forms of technology into one platform is not just a 
problem for chemical consumers. 
7.2 Summary and Outlook 
In summary, self-optimisation is a rapid form of finding optimum conditions and recent 
advances are making it a much more attractive form of technology for the pharmaceutical industry 
to adopt. The work in this thesis has looked at widespread approaches to improve self-
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optimisations by applying it to the synthesis of APIs, combining existing DoE techniques with 
newer self-optimisation algorithms, introducing new forms of online analysis, reducing the amount 
of material by carrying out reactions with pulsed flows and using more intelligent algorithms. 
However, like all forms of science, there is always scope for improvement. Self-optimising 
reactors will naturally advance with the progress of flow reactor technologies, but the reactor is just 
one part of the setup. Analytical methods that can provide quantitative data faster with higher 
resolution is necessary for self-optimisation advancement but the greatest progress can be made 
with the feedback loop. More rapid screening of discrete and continuous variables with intelligent 
algorithms enables faster process development and increases the likelihood of self-optimisation 
being adopted in the fine chemical industries 
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8. Experimental 
This chapter summarises the practical experimental information, procedures and raw data. 
Detailed descriptions about the automated flow reactor and general self-optimisation procedures 
can be found in Chapter 2. Any description of equipment in this chapter applies to offline analytical 
techniques. 
8.1 Analytical Equipment 
NMR analysis was carried out using a Bruker Advance 500 MHz or Bruker DPX 300MHz  
fourier transform machine. Chemical shifts are quoted as parts per million (ppm) with reference to 
an internal solvent peak of SiMe4. Peaks are quoted as s (singlet), br s (broad singlet), d (doublet), t 
(triplet), or multiplet (m). LC-MS analysis was collected using an Agilent 1290 UHPLC with 
Bruker HCT-Ultra detector. Accurate mass MS was carried out using a Bruker MaXis Impact. IR 
was collected using a Bruker Alpha FT-IR. 
8.2 Chapter 3 Procedures 
8.2.1 Chemicals 
All chemicals were commercially available and used without further purification, unless 
otherwise stated: 2,4-dimethoxyaniline (Maybridge, 97%), triethylamine (Acros 99%), 3- 
chloropropionyl chloride (Acros 98%), hydrochloric acid (Fisher, 37%) biphenyl (Aldrich, 99.5% 
GC), acetonitrile (VWR, 99.9%). Anhydrous acetonitrile was obtained from departmental solvent 
purification system with a water content of 2.6 ppm. AZD9291 aniline was supplied by 
AstraZeneca. 
8.2.2 Synthesis of N-(2,4-dimethoxyphenyl)prop-2-enamide standard, 3.13 
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2,4-Dimethoxy aniline (498 mg, 3.25 mmol) and triethylamine (1.15 mL, 8.26 mmol) were 
dissolved in acetonitrile. The black slurry was cooled to 0 °C (aq ice bath) and 3-chloropronionyl 
chloride (0.47 mL, 4.92 mmol) was added drop-wise with rigorous stirring. The reaction was 
stirred at 0 °C for 3 h and then quenched with HCl (2 M, 10 mL). Acetonitrile was removed under 
vacuum and the resultant residue was washed with dichloromethane (3 x 10 mL) The organic 
fractions were combined and washed with HCl (2 M, 3 x 10 mL) and then dried (Na2SO4) and 
concentrated under vacuum to leave the crude product as a black flaky solid. Crystalizing from 
EtOAc‒hexane gave the acrylamide 3.13 (512 mg, 2.47 mmol 76%) as dark brown plates, mp 119-
121 °C; H (500 MHz, CDCl3, SiMe4) 8.36 (1H, d, J 9.0, aryl 6-H), 7.68 (1H, br s, N-H), 6.48-6.50 
(2H, m, aryl 3-H and 5-H), 6.40 (1H, dd, J 17.0 and 1.0, vinyl 3-HA), 6.27 (1H, dd, J 16.5 and 10.0, 
vinyl 2-H) 5.72 (1H, dd, J 10.0 and 1.0, vinyl 3-HB), 3.87 (3H, s, methoxy 2-CH3), 3.80 (3H, s, 
methoxy 4-CH3); C (125 MHz, CDCl3, SiMe4) 163.0 (aryl 4-C), 156.5 (CO), 149.2 (aryl 2-C), 
133.0 (vinyl 2-C), 131.6 (vinyl 3-C), 121.2 (aryl 1-C), 120.8 (aryl 6-C), 103.8 (aryl 5-C), 98.6 (aryl 
3-C) 55.7 (methoxy 2-C), 55.5 (methoxy 4-C); νmax/cm-1 (solid); 1453, 1467, 1506, 1536, 1612, 
1652, 2942, 2973, 3010, 3233; m/z (ESI+) found [M+H]+ 208.0968, C11H14NO3 requires [M+H]+ 
208.0968. 
8.2.3 Temperature Profile 
Pump A reservoir solution: 2,4-dimethoxy aniline (7.70 g, 50.3 mmol) and biphenyl (135 
mg, 0.88 mmol) were dissolved in a acetonitrile (156 mL) and water (44 mL) under stirring at 
ambient temperature. Excess solid was filtered by gravity (0.252 mol L-1 aniline, 4.39 mmol L-1 
IS). Pump B: neat triethylamine (100 mL, 717 mmol, 7.17 mol L-1). Pump C: an oven dried quick 
fit flask was flushed with nitrogen. 3-chloropropionyl chloride (20 mL, 210 mmol) and anhydrous 
acetonitrile (75 mL) were added to the flask under nitrogen flow and stirring at ambient 
temperature (2.2 mol L-1). 
The pump flow rates were: A = 0.425 mL min-1, B = 0.078 mL min-1, C = 0.090 mL min-1. A 
BPR with a fixed pressure of 75 PSI (5 bar) was used and the reactor coil had a volume of 3 mL. A 
HPLC sample (See section 8.2.5 for method) was taken, 2 reactor volumes after the reactor had 
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reached the set conditions, at temperatures of 22, 26, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 
140 and 150 ºC. 
8.2.4 Preparation of Pump Reservoir Solutions for Self-Optimisations 
Pumps A and B: The desired reagents were dissolved in MeCN and H2O (7:2, v:v, 
MeCN:H2O) under stirring at ambient conditions. 2,4-Dimethoxyaniline solution was filtered 
before use. Pump C: 3-chloropropionyl chloride was added to a dry quick-fit conical flask, fitted 
with a septum and purged with nitrogen. Anhydrous acetonitrile was added under stirring and 
nitrogen flow. The solutions were prepared according to the concentrations in Table 8.1 
Table 8.1 Concentrations for Chapter 3 stock solutions 
 
Pump A Pump B Pump C 
Reagent 
Concentration 
/ mol L-1 
Reagent 
Concentration 
/ mol L-1 
Reagent 
Concentration 
/ mol L-1 
Model 
Aniline 
Biphenyl 
0.241 
0.0156 
NEt3 3.73 
3-chloropropionyl 
chloride 
1.00 
AZD9291 
Aniline 
Biphenyl 
0.241 
0.0156 
NEt3 3.73 
3-chloropropionyl 
chloride 
0.500 
 
8.2.5 Model Acrylamide Optimisation 
At-line HPLC analysis was carried out using an Agilent 1100 HPLC. Method: Sigma 
Ascentis Express C18 (50 x 6.6 mm, 2.7 μm) column; A 0.1 % (v:v) aqueous TFA, B 0.1 % (v:v) 
TFA in MeCN; 5% to 95% B over 8.5 min, to 5% B after 9.5 min, post time 30 s; 1.2 mL min-1 , 
254 nm, 20 °C. 
Table 8.2 Optimisation limits for the model compound optimisation 
Limits Pump A flow /  
mL min-1 
NEt3 mol eq Acid chloride mol 
eq 
Temperature /  
°C 
Lower 0.100 4.5 0.9 0 
Upper 0.400 20 2.1 130 
Table 8.3 List of conditions and yield of acrylamide for the model compound optimisation. 
Optimum conditions highlighted in bold. 
Entry A / mL min-1 C / eq B / eq Temperature / °C Ax/AIS Yield % 
1 0.495 1.0 7.1 0.1 1.86 26.2 
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Entry A / mL min-1 C / eq B / eq Temperature / °C Ax/AIS Yield % 
2 0.369 1.8 15.5 63.4 2.34 35.2 
3 0.333 1.9 8.0 96.7 2.43 38.8 
4 0.214 1.3 5.3 130.0 2.63 41.9 
5 0.480 1.9 13.2 16.0 2.34 35.7 
6 0.120 1.2 11.3 31.8 3.26 65.1 
7 0.340 1.2 11.3 80.9 2.65 45.3 
8 0.360 0.9 6.7 113.4 2.67 47.7 
9 0.180 1.5 7.8 47.7 2.94 49.6 
10 0.490 1.2 7.3 71.6 2.08 30.0 
11 0.490 1.6 12.6 105.4 2.53 39.9 
12 0.470 1.1 9.8 121.6 2.90 56.0 
13 0.500 0.9 8.6 13.1 1.94 30.4 
14 0.100 1.2 4.8 54.2 2.82 46.3 
15 0.220 1.7 9.2 64.2 2.93 49.2 
16 0.500 1.5 14.8 130.0 3.22 68.7 
17 0.100 1.5 15.2 23.4 3.58 77.3 
18 0.100 1.5 14.8 80.9 3.53 85.1 
19 0.200 1.7 13.9 80.9 3.48 67.9 
20 0.360 1.8 17.7 130.0 3.46 77.7 
21 0.340 1.5 14.8 130.0 3.55 80.2 
22 0.100 2.0 14.6 0.0 3.71 77.0 
23 0.100 1.9 18.5 7.5 3.69 79.1 
24 0.320 1.2 6.6 76.6 2.20 31.4 
25 0.100 2.0 18.0 84.4 3.61 71.3 
26 0.100 1.7 13.8 0.0 3.73 75.6 
27 0.100 1.9 15.3 76.3 3.79 77.5 
28 0.100 2.1 15.5 79.9 3.74 75.4 
29 0.150 1.2 9.8 105.5 3.44 64.8 
30 0.220 1.2 11.9 130.0 3.77 91.1 
31 0.200 1.0 8.7 15.9 3.00 51.5 
32 0.100 2.1 19.5 74.8 3.53 81.1 
33 0.100 1.4 9.9 82.7 3.56 69.1 
34 0.100 1.8 12.9 89.2 3.64 71.7 
35 0.100 1.7 16.3 117.8 3.82 91.9 
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Table 8.4 Composition of impurities from the list of experiments in Table 8.3. 
Entry 
Conditions Yield % 
A / mL 
min-1 
C / eq B / eq 
Temperature 
/ °C 
Aniline Chloroamide Enolate Dimer 
1 0.495 1.0 7.1 0.1 0.0 68.4 4.4 0.5 
2 0.369 1.8 15.5 63.4 0.0 58.2 5.5 0.4 
3 0.333 1.9 8.0 96.7 0.3 54 5.7 0.4 
4 0.214 1.3 5.3 130.0 0.0 51 6.3 0.6 
5 0.480 1.9 13.2 16.0 0.0 57.6 5.5 0.6 
6 0.120 1.2 11.3 31.8 0.5 21.1 12.6 0.8 
7 0.340 1.2 11.3 80.9 0.3 47.6 6.1 0.5 
8 0.360 0.9 6.7 113.4 0.5 47.1 3.8 0.6 
9 0.180 1.5 7.8 47.7 0.0 39.3 9.3 0.6 
10 0.490 1.2 7.3 71.6 0.0 63.7 5 0.3 
11 0.490 1.6 12.6 105.4 0.0 54.4 4.7 0.4 
12 0.470 1.1 9.8 121.6 0.7 40.4 1.6 0.5 
13 0.500 0.9 8.6 13.1 0.5 63 5.3 0.4 
14 0.100 1.2 4.8 54.2 0.0 42.7 9.6 0.5 
15 0.220 1.7 9.2 64.2 0.0 40.8 8.7 0.5 
16 0.500 1.5 14.8 130.0 0.4 28.2 1.4 0.7 
17 0.100 1.5 15.2 23.4 0.5 6.4 15 0.9 
18 0.100 1.5 14.8 80.9 0.5 3.5 9.9 0.9 
19 0.200 1.7 13.9 80.9 0.0 21.4 10 0.7 
20 0.360 1.8 17.7 130.0 0.3 19.1 1.5 0.8 
21 0.340 1.5 14.8 130.0 0.5 17.1 0.9 0.8 
22 0.100 2.0 14.6 0.0 0.0 7.8 13.9 0.6 
23 0.100 1.9 18.5 7.5 0.0 5.7 14.4 0.8 
24 0.320 1.2 6.6 76.6 0.0 62 5.5 0.3 
25 0.100 2.0 18.0 84.4 0.0 15.8 12.2 0.7 
26 0.100 1.7 13.8 0.0 0.0 8.6 14.6 0.9 
27 0.100 1.9 15.3 76.3 0.0 7.1 14.1 0.8 
28 0.100 2.1 15.5 79.9 0.0 10.2 13.1 0.8 
29 0.150 1.2 9.8 105.5 0.0 23.5 10.3 0.7 
30 0.220 1.2 11.9 130.0 1.0 5.4 0.8 1 
31 0.200 1.0 8.7 15.9 0.0 36.9 9.9 0.6 
32 0.100 2.1 19.5 74.8 0.0 4.9 12.6 0.8 
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Entry 
Conditions Yield % 
A / mL 
min-1 
C / eq B / eq 
Temperature 
/ °C 
Aniline Chloroamide Enolate Dimer 
33 0.100 1.4 9.9 82.7 0.0 16.7 13 0.7 
34 0.100 1.8 12.9 89.2 0.0 13.9 13.2 0.7 
35 0.100 1.7 16.3 117.8 0.0 2.7 3.9 0.9 
8.2.6 Model Enolate Optimisation 
At-line HPLC analysis was carried out according to the equipment and methods described 
for the model acrylamide optimisation (8.2.5) 
Table 8.5 List of conditions and yield of enolate for the model enolate optimisation. 
Experiments from the previous acrylamide optimisation are highlighted with grey 
fill. Optimum conditions highlighted in bold. 
Entry A / mL min-1 C / eq B / eq Temperature / °C Ax/AIS Yield % 
1 0.495 1.0 7.1 0.1 0.31 4.4 
2 0.214 1.3 5.3 130.0 0.4 6.2 
3 0.369 1.8 15.5 63.4 0.37 5.5 
4 0.333 1.9 8.0 96.7 0.36 5.7 
5 0.480 1.9 13.2 16.0 0.36 5.4 
6 0.120 1.2 11.3 31.8 0.63 12.5 
7 0.340 1.2 11.3 80.9 0.36 6 
8 0.360 0.9 6.7 113.4 0.21 3.7 
9 0.180 1.5 7.8 47.7 0.55 9.3 
10 0.490 1.2 7.3 71.6 0.35 5 
11 0.490 1.6 12.6 105.4 0.3 4.7 
12 0.470 1.1 9.8 121.6 0.09 1.6 
13 0.500 0.9 8.6 13.1 0.34 5.3 
14 0.100 1.2 4.8 54.2 0.58 9.5 
15 0.220 1.7 9.2 64.2 0.52 8.6 
16 0.500 1.5 14.8 130.0 0.07 1.4 
17 0.100 1.5 15.2 23.4 0.69 14.7 
18 0.100 1.5 14.8 80.9 0.41 9.7 
19 0.200 1.7 13.9 80.9 0.52 9.8 
20 0.360 1.8 17.7 130.0 0.06 1.4 
21 0.340 1.5 14.8 130.0 0.04 0.9 
22 0.100 2.0 14.6 0.0 0.67 13.7 
23 0.100 1.9 18.5 7.5 0.67 14.1 
24 0.320 1.2 6.6 76.6 0.38 5.4 
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Entry A / mL min-1 C / eq B / eq Temperature / °C Ax/AIS Yield % 
25 0.100 2.0 18.0 84.4 0.62 11.9 
26 0.100 1.7 13.8 0.0 0.72 14.4 
27 0.100 1.9 15.3 76.3 0.69 13.7 
28 0.100 2.1 15.5 79.9 0.65 12.8 
29 0.150 1.2 9.8 105.5 0.54 10.1 
30 0.220 1.2 11.9 130.0 0.03 0.7 
31 0.200 1.0 8.7 15.9 0.58 9.9 
32 0.100 2.1 19.5 74.8 0.55 12.2 
33 0.100 1.4 9.9 82.7 0.67 12.8 
34 0.100 1.8 12.9 89.2 0.67 12.9 
35 0.100 1.7 16.3 117.8 0.16 3.8 
36 0.100 1.3 12.4 0.0 0.26 8.1 
37 0.260 1.5 11.1 23.8 0.5 7.7 
38 0.100 1.7 12.8 38.4 0.73 14.1 
39 0.100 1.5 10.5 74.7 0.73 14.1 
40 0.100 0.9 8.6 93.3 0.12 3.4 
41 0.100 1.5 8.6 2.5 0.62 11.4 
42 0.100 1.3 9.6 5.1 0.56 10.2 
43 0.160 1.9 8.9 32.1 0.57 10.7 
44 0.100 1.9 10.4 66.7 0.68 13.5 
45 0.370 1.4 6.6 38.3 0.37 5.3 
46 0.100 2.0 18.9 44.3 0.64 12.3 
47 0.100 1.7 11.7 66.7 0.68 13.7 
48 0.100 2.1 11.9 85.9 0.65 13 
49 0.100 2.1 18.2 11.8 0.67 13.6 
50 0.100 1.5 8.7 37.3 0.72 14.1 
51 0.380 1.7 9.2 48.3 0.29 4.3 
52 0.100 1.3 8.3 71.5 0 0 
53 0.100 1.6 6.3 82.7 0.49 8.1 
54 0.310 1.2 8.9 31.8 0.53 8.9 
55 0.490 1.3 5.2 68.5 0.33 4.6 
56 0.300 1.7 9.5 74.5 0.44 7.2 
57 0.500 1.6 8.1 75.2 0.38 5.5 
58 0.100 1.8 11.2 76.5 0.68 12.7 
59 0.220 1.7 9.6 16.1 0.48 7.8 
60 0.270 2.1 12.9 67.7 0.39 6.4 
61 0.500 1.3 5.6 69.5 0.3 4.2 
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8.2.7 Impurity Identification with Offline LC-MS 
 
Figure 8.1 Structures and molecular weights of enolate (left) and dimer (right) impurities 
 
Figure 8.2 LC-MS chromatogram (above) and MS-MS spectra of compound tR 1.22 min 
(below), identified as model enolate. 
 
Figure 8.3 LC-MS chromatogram (above) and MS spectrum (below) of compound tR 1.80 min, 
identified as model dimer. 
 169 
8.2.8 AZD9291 Acrylamide Optimisation 
At-line HPLC was carried out using an Agilent 1100 HPLC. Method: Waters X-Bridge C18 
(150 x 30 mm, 3.5 µm) column; A H2O, B MeCN, C 10% (v:v) aqueous TFA; 5% to 38% B over 
10 min, to 95% B after 15 min to 5% B after 15.1 min, 3% C hold over 15.1 min, post time 3 min 
(5% B, 3% C); 1.0 mL min-1, 210 nm, 40 °C. 
Table 8.6 Optimisation limits for the AZD9291 compound optimisation 
Limits Pump A flow /  
mL min-1 
NEt3 mol eq Acid chloride mol 
eq 
Temperature /  
°C 
Lower 0.080 2.2 0.75 80 
Upper 0.150 15 3.0 150 
Table 8.7 List of conditions and acrylamide yield for the AZD9291 optimisation. Optimum 
conditions are highlighted in bold. 
Entry A / mL min-1 C / eq B / eq Temperature / °C Ax/AIS Yield % 
1 0.100 1.3 5.0 80.1 1.80 37.1 
2 0.118 2.4 9.4 149.8 2.87 68.0 
3 0.130 0.9 3.7 141.1 2.97 53.7 
4 0.100 1.9 5.0 105.4 3.52 72.3 
5 0.120 1.0 3.3 106.3 2.37 47.3 
6 0.080 0.8 2.2 150.0 1.99 55.8 
7 0.150 1.9 8.6 150.0 2.93 67.8 
8 0.080 0.8 2.6 93.6 1.80 41.1 
9 0.080 2.8 7.6 99.6 3.82 79.4 
10 0.080 2.4 6.3 107.1 2.69 57.1 
11 0.100 1.4 5.4 119.4 1.98 51.1 
12 0.150 0.8 2.6 147.6 2.21 51.3 
13 0.090 3.0 9.5 88.2 2.70 71.2 
14 0.120 2.4 6.5 104.4 3.23 77.1 
15 0.110 3.0 8.0 106.1 3.59 82.3 
16 0.110 2.7 10.5 123.9 4.49 88.9 
17 0.120 1.0 3.3 86.6 2.15 48.8 
18 0.100 0.9 2.5 106.3 2.41 56.7 
19 0.110 1.8 4.8 124.0 3.18 83.2 
20 0.090 3.0 9.9 124.2 3.86 85.6 
21 0.080 1.8 4.7 103.0 3.34 75.1 
22 0.100 1.4 6.7 110.9 2.81 69.3 
23 0.130 3.0 13.8 123.3 4.29 83.2 
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Entry A / mL min-1 C / eq B / eq Temperature / °C Ax/AIS Yield % 
24 0.090 2.4 6.4 123.3 3.47 81.6 
25 0.120 3.0 14.9 141.1 3.77 75.7 
26 0.100 3.0 10.6 111.0 3.14 74.0 
27 0.090 3.0 13.6 124.1 3.35 74.7 
28 0.140 3.0 11.4 138.3 3.77 81.0 
29 0.110 1.3 4.3 145.6 3.36 72.0 
30 0.120 1.1 5.3 121.7 2.49 61.6 
31 0.150 3.0 10.9 123.4 3.69 80.7 
32 0.130 3.0 11.1 124.1 3.84 86.5 
33 0.130 3.0 14.9 132.6 3.39 86.1 
34 0.080 3.0 9.5 103.0 3.93 80.1 
35 0.150 3.0 13.1 122.5 3.34 68.5 
36 0.090 1.0 2.6 124.9 2.82 62.8 
37 0.090 2.4 6.4 125.2 3.37 79.9 
38 0.110 2.1 6.7 141.2 3.25 81.3 
39 0.130 1.4 5.4 119.4 2.58 65.7 
40 0.110 3.0 12.4 122.4 3.56 71.5 
41 0.150 2.2 11.0 123.3 2.83 67.3 
42 0.150 2.7 13.4 123.8 2.47 68.0 
Table 8.8 Composition of impurities from the list of experiments in Table 8.7. 
Entry 
Conditions Yield / % 
A / mL 
min-1 
C / eq B / eq 
Temp / 
°C 
Imp 1 Aniline Dimer 
Chloro-
amide 
Imp 2 Imp 3 
1 0.100 1.3 5.0 80.1 0.3 57.3 1.6 1.2 0.0 0.4 
2 0.118 2.4 9.4 149.8 0.3 21.4 4.7 3.1 0.0 0.4 
3 0.130 0.9 3.7 141.1 1.9 39.9 0.3 0.0 0.0 0.6 
4 0.100 1.9 5.0 105.4 0.3 14.1 4.2 1.8 0.0 0.8 
5 0.120 1.0 3.3 106.3 0.6 44.6 2.1 0.6 0.3 0.6 
6 0.080 0.8 2.2 150.0 3.0 34.3 0.9 0.0 0.0 0.8 
7 0.150 1.9 8.6 150.0 0.7 25.9 0.4 0.0 0.3 0.6 
8 0.080 0.8 2.6 93.6 0.7 48.5 2.3 0.6 0.3 0.8 
9 0.080 2.8 7.6 99.6 0.0 5.1 6.7 4.0 0.6 0.7 
10 0.080 2.4 6.3 107.1 0.4 29.8 2.1 2.1 1.3 0.6 
11 0.100 1.4 5.4 119.4 0.8 41.4 0.7 0.4 0.6 1.3 
12 0.150 0.8 2.6 147.6 1.4 40.8 0.4 0.4 0.2 0.8 
13 0.090 3.0 9.5 88.2 0.3 12.3 4.2 4.5 0.7 0.7 
14 0.120 2.4 6.5 104.4 0.4 5.7 4.4 3.6 0.6 0.6 
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Entry 
Conditions Yield / % 
A / mL 
min-1 
C / eq B / eq 
Temp / 
°C 
Imp 1 Aniline Dimer 
Chloro-
amide 
Imp 2 Imp 3 
15 0.110 3.0 8.0 106.1 0.3 1.3 4.6 4.6 0.5 0.7 
16 0.110 2.7 10.5 123.9 0.0 2.6 1.8 1.1 1.2 0.8 
17 0.120 1.0 3.3 86.6 0.2 39.2 2.4 1.4 0.6 0.8 
18 0.100 0.9 2.5 106.3 0.8 33.3 2.5 0.7 0.3 1.0 
19 0.110 1.8 4.8 124.0 0.4 7.8 1.1 0.7 0.4 0.7 
20 0.090 3.0 9.9 124.2 0.5 4.6 0.9 1.3 0.7 0.8 
21 0.080 1.8 4.7 103.0 0.3 9.3 4.7 2.0 0.8 0.8 
22 0.100 1.4 6.7 110.9 0.4 18.3 2.7 1.4 0.7 0.9 
23 0.130 3.0 13.8 123.3 0.0 6.9 2.2 1.7 1.1 0.9 
24 0.090 2.4 6.4 123.3 0.4 8.9 0.9 0.8 0.6 0.8 
25 0.120 3.0 14.9 141.1 0.0 15.4 1.0 0.8 0.8 0.8 
26 0.100 3.0 10.6 111.0 0.0 11.2 3.0 3.1 1.0 0.7 
27 0.090 3.0 13.6 124.1 0.0 14.9 0.7 2.1 1.1 0.8 
28 0.140 3.0 11.4 138.3 0.0 10.4 0.5 1.0 0.8 1.2 
29 0.110 1.3 4.3 145.6 1.2 19.3 0.4 0.3 0.0 1.0 
30 0.120 1.1 5.3 121.7 0.7 29.5 0.7 0.5 0.6 1.0 
31 0.150 3.0 10.9 123.4 0.0 7.2 1.7 2.3 1.3 0.8 
32 0.130 3.0 11.1 124.1 0.0 3.5 1.5 1.8 1.0 0.9 
33 0.130 3.0 14.9 132.6 0.0 4.1 0.7 1.4 1.2 0.7 
34 0.080 3.0 9.5 103.0 0.0 3.9 4.8 3.3 0.8 1.1 
35 0.150 3.0 13.1 122.5 0.0 18.6 1.5 2.1 1.0 0.9 
36 0.090 1.0 2.6 124.9 1.4 27.0 0.6 0.2 0.8 1.1 
37 0.090 2.4 6.4 125.2 0.5 9.4 0.8 0.8 0.9 0.9 
38 0.110 2.1 6.7 141.2 0.5 10.7 0.7 0.0 0.4 1.4 
39 0.130 1.4 5.4 119.4 0.4 22.9 1.1 1.0 0.7 0.9 
40 0.110 3.0 12.4 122.4 0.0 16.2 1.0 1.5 1.1 1.4 
41 0.150 2.2 11.0 123.3 0.0 21.3 1.1 1.6 1.0 1.0 
42 0.150 2.7 13.4 123.8 0.0 20.2 1.0 1.2 0.9 1.0 
 
8.3 Chapter 4 Procedures 
8.3.1 Chemicals and Procedures 
All practical experimental work was carried out by the Bourne group MChem student 
Mohammed Jeraal. Please see his report for all practical experimental details.265 
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8.3.2 Empirical Model Fitting 
All models were fitted using MODDE Pro version 11 (MKS Umetrics) software using 
multiple linear regressions. Anomalous experiments were measured according to their deleted 
studentised residuals and removed from models. Model coefficients were removed if their 𝑝-value 
was greater than 0.05. Some model responses were transformed according to their 𝐿𝑚𝑎𝑥(𝜆) values. 
Please see chapter 4 for detailed explanations of model fitting procedures. 
8.3.3 First Model Data 
Table 8.9 List of experiments included in the first set of models. Greyed out cells were 
removed as anomalies. 
Entry 
P1 /  
mmol min-1 
Acetone 
eq 
NaOH / 
mmol min-1 
Temp / °C PhCHO / % BA / % DBA / % 
1 0.736 6.747 0.0421 10.1 95.55 2.69 0 
2 1.202 5.579 0.0373 79.9 101.95 2.71 0 
3 0.413 4.154 0.0575 55.8 98.04 0 0 
4 1.355 4.96 0.0249 33 101.81 2.36 0 
5 0.977 1.812 0.0713 21.9 37.43 4.04 0.7 
6 1.739 5.435 0.0158 44.5 99.01 0 0 
7 0.958 3.205 0.0713 61.9 98.97 0.81 0 
8 1.016 2.3 0.099 68 7.97 31.78 4.59 
9 1.564 1.533 0.0614 15.9 92.84 1.06 0 
10 1.466 2.578 0.0891 38.8 9.89 34.11 8.37 
11 0.84 5.923 0.0911 50.3 2.63 52.28 4.72 
12 1.349 4.599 0.0218 73.9 4.51 52.01 8.7 
13 1.29 6.968 0.099 49.1 3.39 59.67 6.04 
14 1.114 2.996 0.0356 50.4 3.38 42.19 10.46 
15 1.739 1.812 0.0158 51.8 93.09 0.16 0 
16 1.818 3.205 0.0079 72.1 97.83 3.42 0 
17 1.603 3.693 0.0079 75.6 94.46 3.41 0 
18 0.645 2.578 0.0337 38.7 4.19 36.24 11.11 
19 0.45 6.968 0.0158 65.6 4.1 39.58 0.94 
20 1.016 4.808 0.0079 66 100.07 2.34 0 
21 0.879 5.993 0.0079 66.6 91.89 0 0 
22 0.41 6.968 0.0594 33 4.91 61.4 6.19 
23 1.329 2.021 0.0218 36 42.18 4.48 0.61 
24 1.954 5.087 0.0535 72.2 2.73 49.61 5.3 
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Entry 
P1 /  
mmol min-1 
Acetone 
eq 
NaOH / 
mmol min-1 
Temp / °C PhCHO / % BA / % DBA / % 
25 1.818 5.784 0.0614 72.7 2.87 47.19 3.11 
26 0.41 4.111 0.0079 73.3 4.62 47.53 9.73 
27 1.739 6.968 0.099 33.2 13.06 25.97 1.27 
28 0.528 1.812 0.0535 53.3 5.42 29.53 5.88 
29 0.391 6.968 0.0574 69.8 5.28 32.11 0.46 
30 0.879 5.784 0.0297 72.8 5.38 42.01 1.48 
31 1.349 5.435 0.0713 15.8 14.97 5.99 0.29 
32 0.391 6.968 0.0812 41.5 4.16 57.97 3.97 
33 0.762 4.181 0.0079 46.6 99.29 0 0 
34 1.231 3.833 0.099 46.8 4.51 49.11 8.28 
35 1.407 6.968 0.0772 50.1 5.02 59.25 6.07 
36 0.391 6.968 0.0851 32.5 7.37 65.57 5.81 
37 1.114 5.993 0.0356 41.3 11.13 42.26 3.78 
38 0.997 6.968 0.0713 46.6 4.56 59.37 5.58 
39 1.72 6.968 0.099 52.5 5.63 59.37 6.12 
40 1.896 6.968 0.099 53 5.43 60.82 6.23 
41 0.977 2.857 0.0356 12.9 29.34 3.57 0.24 
42 0.391 6.968 0.0832 28.3 7.18 58.12 5.03 
43 0.391 6.968 0.099 35.8 6.76 66 5.87 
44 0.625 6.968 0.099 46.2 4.45 58.35 4.12 
45 0.391 6.968 0.099 33.6 6.83 59.1 6.21 
46 0.919 6.481 0.095 38.1 8.94 53.98 5.8 
47 0.645 6.968 0.099 39.2 6.39 60.45 5.88 
48 1.954 6.968 0.099 49.9 9.79 55.62 5.6 
49 1.466 2.16 0.0594 51.9 8.7 34.44 12.35 
50 0.391 6.968 0.0614 37.5 7.48 59.69 5.34 
51 0.391 2.021 0.0851 39.1 5.99 32.12 11.85 
52 0.704 2.369 0.0673 49 7.08 33.94 8.23 
53 1.72 3.624 0.0733 59.9 5.96 45.18 8.83 
54 0.391 4.739 0.0752 37.2 6.48 52.1 6.96 
55 1.466 4.39 0.0614 50.9 7.88 48.64 8.32 
56 0.704 5.017 0.0079 51.7 101.53 2.99 0 
57 0.391 6.968 0.0574 62.1 7.05 35.5 0.45 
58 0.391 6.968 0.0851 30.6 8.08 58.7 5.82 
59 1.739 3.972 0.0416 38.7 30.57 6.87 0.4 
60 1.954 6.968 0.099 51.3 8.73 56.29 6.14 
61 1.954 5.296 0.0416 56.2 26.25 30.23 2.25 
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Entry 
P1 /  
mmol min-1 
Acetone 
eq 
NaOH / 
mmol min-1 
Temp / °C PhCHO / % BA / % DBA / % 
62 1.681 6.062 0.0634 59 7.27 55.24 6.88 
63 1.739 6.968 0.0574 38.7 17.48 20.61 0.96 
64 1.544 5.017 0.0079 49.7 98.17 0 0 
65 1.349 3.624 0.0733 59.4 6.2 43.65 6.6 
66 1.954 6.968 0.0871 62.3 7.19 59.24 5.95 
67 0.391 6.968 0.0594 32.9 7.95 57.98 5.95 
68 1.309 3.415 0.0891 50.3 6.34 45.2 8.87 
69 1.837 4.39 0.0614 50.9 13.92 44.85 6.5 
70 1.681 5.296 0.099 56.3 6.21 52.66 6.53 
P1 = pump 1 benzaldehyde, PHCHO = benzaldehyde yield, BA = benzylideneacetone yield, DBA = 
dibenzylideneacetone yield 
Table 8.10 Model coefficients and 𝒑-values 
Coefficeint 
PHCHO BA DBA 
Value p-value Value p-value Value p-value 
Constant 0.98 1.1E-26 37.17 7.3E-28 7.43 5.9E-22 
P1 0.30 4.0E-07 -5.62 7.5E-03 -2.07 3.2E-07 
Acetone 0.02 6.9E-01 7.16 1.6E-04 -2.38 2.2E-08 
NaOH -0.49 1.3E-11 21.98 1.3E-19 3.63 1.8E-14 
Temperature -0.63 1.1E-10 16.38 2.8E-09 2.13 3.3E-05 
P1*P1 
 
   
-1.78 6.6E-03 
Ace*Ace 
  
 
 
 
 NaOH*NaOH 0.54 1.1E-07 -12.73 3.0E-06 -3.04 5.6E-07 
Temp*Temp 
 
 
-33.16 9.1E-12 -6.87 8.3E-12 
P1*Ace 
  
-8.91 2.2E-03 
  P1*NaOH -0.19 1.2E-02 9.67 8.4E-04 2.54 8.8E-06 
P1*Temp 
 
 
29.17 7.1E-10 6.39 2.6E-10 
Ace*NaOH -0.23 2.6E-02 
    Ace*Temp 
  
    NaOH*Temp 
    
-2.68 5.2E-03 
P1 = pump 1 benzaldehyde, Ace = Acetone eq, Temp = Temperature, PHCHO = benzaldehyde yield, BA = 
benzylideneacetone yield, DBA = dibenzylideneacetone yield. 
8.3.4 Second Model Data 
Table 8.11 List of experiments included in the second set of models. Greyed out cells were 
removed as anomalies.  
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Entry 
P1 / 
mmol 
min-1 
Acetone 
eq 
NaOH 
/ mmol 
min-1 
Temp / 
°C 
PhCHO 
/ % 
BA / 
% 
DBA 
/ % 
PMI 
STY /  
g L-1 h-1 
Cost /  
£ kg-1 
1 0.736 6.747 0.042 10.1 95.55 2.69 0 266.24 26.7 524.53 
2 0.413 4.154 0.057 55.8 98.04 0 0 34551.6 0.1 71245.6 
3 0.977 1.812 0.071 21.9 37.43 4.04 0.7 138.59 53.6 310.04 
4 0.84 5.923 0.091 50.3 2.63 52.28 4.72 15.66 596.2 31.3 
5 0.645 2.578 0.034 38.7 4.19 36.24 11.11 14.74 317.2 32.54 
6 0.41 6.968 0.059 33 4.91 61.4 6.19 15.61 341.9 30.61 
7 0.528 1.812 0.053 53.3 5.42 29.53 5.88 21.58 211.4 47.54 
8 0.391 6.968 0.081 41.5 4.16 57.97 3.97 19.48 307.5 38.18 
9 0.762 4.181 0.008 46.6 99.29 0 0 37111.4 0.1 79194.4 
10 0.391 6.968 0.085 32.5 7.37 65.57 5.81 17.64 347.8 34.58 
11 0.997 6.968 0.071 46.6 4.56 59.37 5.58 12.8 802.9 25.1 
12 0.977 2.857 0.036 12.9 29.34 3.57 0.24 140.84 47.3 310.76 
13 0.391 6.968 0.083 28.3 7.18 58.12 5.03 19.66 308.3 38.55 
14 0.391 6.968 0.099 35.8 6.76 66 5.87 18.98 350.1 37.21 
15 0.625 6.968 0.099 46.2 4.45 58.35 4.12 17.06 495.2 33.44 
16 0.391 6.968 0.099 33.6 6.83 59.1 6.21 21.2 313.5 41.55 
17 0.919 6.481 0.095 38.1 8.94 53.98 5.8 15.33 672.8 30.32 
18 0.645 6.968 0.099 39.2 6.39 60.45 5.88 16.25 529.0 31.86 
19 0.391 6.968 0.061 37.5 7.48 59.69 5.34 16.62 316.6 32.58 
20 0.391 2.021 0.085 39.1 5.99 32.12 11.85 29.92 170.4 63.27 
21 0.704 2.369 0.067 49 7.08 33.94 8.23 18.97 324.0 41.26 
22 0.391 4.739 0.075 37.2 6.48 52.1 6.96 19.19 276.3 38.91 
23 0.704 5.017 0.008 51.7 101.53 2.99 0 173.79 28.5 360.42 
24 0.391 6.968 0.085 30.6 8.08 58.7 5.82 19.7 311.3 38.63 
25 0.391 6.968 0.059 32.9 7.95 57.98 5.95 16.87 307.5 33.07 
26 0.907 5.943 0.014 47.1 5.77 37.85 4.69 14.96 465.5 30.16 
27 0.743 6.829 0.107 27.2 2.38 50.95 1.08 18.67 513.2 36.69 
28 0.444 11.647 0.142 59.9 15.26 55.64 5.33 29.05 334.8 54.42 
29 0.787 9.889 0.042 34.2 6.06 43.8 2.21 18.88 467.8 35.02 
30 0.879 8.223 0.127 40.5 3.66 59.45 6.08 16.94 709.1 32.57 
31 0.704 13.24 0.147 50.1 6.98 57.22 1.91 24.1 546.1 43.95 
32 0.86 13.867 0.018 56.6 6.37 43.33 6.83 20.66 505.4 35.73 
33 0.762 13.519 0.059 30.8 6.59 63.48 4.32 16.33 656.3 28.92 
34 0.958 12.404 0.149 38.9 4.66 59.59 3.97 20.17 774.0 36.8 
35 0.977 11.08 0.149 40.9 4.17 63.5 4.83 17.97 841.7 33.28 
36 0.625 10.871 0.048 51 2.68 53.46 2.17 17.34 453.5 31.8 
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Entry 
P1 / 
mmol 
min-1 
Acetone 
eq 
NaOH 
/ mmol 
min-1 
Temp / 
°C 
PhCHO 
/ % 
BA / 
% 
DBA 
/ % 
PMI 
STY /  
g L-1 h-1 
Cost /  
£ kg-1 
37 0.84 13.937 0.149 56.6 3.54 56.73 1.76 23.29 646.7 41.96 
38 0.977 13.937 0.083 60 2.81 53.06 1.35 20.21 703.3 35.69 
39 0.586 8.92 0.061 27.1 6.03 45.84 3.42 20.23 364.5 38.39 
40 0.547 6.481 0.149 41.4 3.4 55.52 6.47 23.11 412.1 45.56 
41 0.84 13.937 0.109 45.2 3.56 65.37 3.73 18.25 745.1 32.59 
42 0.977 8.501 0.149 45.6 2.7 58.4 5.36 17.79 774.1 34.1 
43 0.645 13.937 0.01 49.9 12.37 30.17 1.03 29.28 263.9 50.49 
44 0.645 6.899 0.046 33.6 4.09 49.71 5.52 15.19 434.9 29.83 
45 0.977 7.386 0.149 36.6 4.97 53.18 5.66 18.71 704.9 36.45 
46 0.821 11.219 0.107 45.3 3.51 62.01 4.13 17.54 690.4 32.33 
47 0.977 13.937 0.149 45.6 4.11 66.05 4.02 18.99 875.4 34.05 
48 0.743 9.268 0.113 42 3.59 58.75 5.14 18.2 591.8 34.51 
49 0.704 13.937 0.149 42.8 1.68 66.08 3.97 21.4 630.6 38.79 
50 0.762 13.937 0.149 43 1.78 66.61 3.97 20.57 688.7 37.18 
51 0.547 13.937 0.109 45.5 3.97 62.89 2.83 21.97 466.8 39.74 
52 0.801 8.432 0.099 53.8 2.59 50.87 2.41 18.86 552.9 36.11 
53 0.977 13.867 0.095 41.6 2.13 63.61 4.13 17.34 843.2 30.73 
54 0.977 5.923 0.139 42.9 2.94 54.01 6.82 16.84 715.9 33.6 
55 0.977 10.522 0.149 43.1 3.42 62.34 5.03 17.95 826.3 33.48 
56 0.821 13.937 0.149 45.3 4.52 65.82 3.71 20.24 732.8 36.51 
57 0.919 10.871 0.048 51 3.38 59.42 4.08 14.49 740.4 26.44 
58 0.84 13.937 0.149 44 1.72 65.4 3.93 20.2 745.5 36.4 
59 0.684 13.937 0.149 45.4 3.73 64.72 3.4 22.11 600.5 40.1 
60 0.977 13.937 0.113 47.5 1.75 63.91 3.67 18.07 847.1 32.16 
61 0.84 9.407 0.028 55.5 3.03 57.37 4.13 13.11 653.9 24.44 
P1 = pump 1 benzaldehyde, PHCHO = benzaldehyde yield, BA = benzylideneacetone yield, DBA = 
dibenzylideneacetone yield, PMI = process mass intensity, STY = space time yield.
  
 
Table 8.12 Model coefficients and 𝒑-values 
Coefficeint 
PHCHO BA DBA PMI STY Cost 
Value 𝑝-value Value 𝑝-value Value 𝑝-value Value 𝑝-value Value 𝑝-value Value 𝑝-value 
Constant 5.49 2.5E-15 57.86 0.0E+00 5.56 7.2E-30 16.27 3.5E-35 470.17 0 31.62 3.3E-35 
P1 0.41 5.4E-01 -7.56 1.8E-06 0.00 9.9E-01 -2.31 2.6E-05 251.49 3.8E-27 -4.53 2.2E-05 
Acetone -1.69 2.9E-02 17.19 4.6E-16 -4.33 3.6E-20 1.71 1.7E-02 113.59 5.3E-13 -0.53 7.0E-01 
NaOH 0.49 4.9E-01 6.61 9.0E-06 0.58 7.8E-03 2.72 1.5E-05 86.78 2.2E-06 5.42 1.0E-05 
Temperature -6.06 1.8E-05 13.26 2.1E-07 -1.35 1.1E-03 -4.69 1.2E-05 90.48 2.8E-05 -8.93 1.7E-05 
P1*P1 2.70 2.8E-02 
  
-1.05 3.0E-02 2.59 8.5E-03 
  
5.00 8.8E-03 
Ace*Ace 
  
-11.54 3.3E-08 2.99 3.2E-11 3.34 2.1E-05 -115.30 2.4E-08 7.47 2.0E-06 
NaOH*NaOH 
  
-5.68 5.3E-03 
  
2.73 3.5E-06 -74.08 1.1E-05 5.07 7.0E-06 
Temp*Temp 7.64 6.4E-05 -26.98 2.5E-14 -6.06 2.0E-17 12.95 1.1E-09 -240.85 2.1E-13 25.40 8.2E-10 
P1*Ace 
            P1*NaOH -1.99 6.4E-02 
    
-3.05 3.1E-04 
  
-5.76 4.2E-04 
P1*Temp -6.94 6.1E-05 12.30 1.1E-03 5.64 1.9E-11 -6.53 8.2E-04 187.70 8.7E-08 -12.73 7.7E-04 
Ace*NaOH 
      
-2.53 1.6E-03 120.16 7.2E-08 -4.31 4.9E-03 
Ace*Temp 2.61 9.7E-02 
    
-3.80 6.8E-03 
  
-8.53 2.0E-03 
NaOH*Temp 
      
3.46 8.6E-03 -139.29 6.0E-05 6.34 1.3E-02 
P1 = pump 1 benzaldehyde, Ace = Acetone eq, Temp = Temperature, PHCHO = benzaldehyde yield, BA = benzylideneacetone yield, DBA = dibenzylideneacetone yield, 
PMI = process mass intensity, STY = space time yield. 
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8.4 Chapter 5 Procedures 
8.4.1 Chemicals 
Methyl nicotinate (99%, Alfa Aesar), methylamine (40% wt in water, Merck; 2 M in 
methanol, Alfa Aesar), methanol (HPLC grade, Sigma-Aldrich), niacin (99.5%, Acros) were used 
as starting materials and/or analytical standards. N’-methyl nicotinamide standard was synthesized 
and was determined as >99% by 1H NMR. All commercial chemicals were used without further 
purification. 
8.4.2 Online Analysis Methods 
An Advion Expression CMS operating in positive APCI mode was used for collecting online 
and offline MS spectra. A mobile phase of 1:1 (v:v) H2O:MeCN was used with 0.1% (v:v) formic 
acid buffer and flow rate 0.3 mL min-1. An Agilent G1311A quaternary pump was used to pump 
the mobile phase with separate feeds of H2O, MeCN and formic acid (10%, v:v). Agilent capillary 
tubing (0.17 mm ID) delivered mobile phase from the pump to the sample loop, peek tubing (red, 
1/16” OD, 0.005” ID) from the sample loop to the MS. 
A 5:2 flow splitter was created by attaching 6.5 cm and 16.5 cm peek tubing (red) to a 
microvolume tee-piece, where the input was mobile phase from the sample loop. The shorter tubing 
was a waste outlet, and the longer tube was the MS input. The change in back pressure between the 
different tube lengths was used to control the flow splitter. The mobile phase flow rate into the MS 
was calculated to be 0.12 mL min-1 (calculated based on the approximate pressure drop across the 2 
tee-piece outlets). 
At-line HPLC analysis was carried out using an Agilent 1100 HPLC. Method: Sigma 
Ascentis Express C18 (50 x 6.6 mm, 2.7 μm) column; A H2O, B MeCN, C 10% aqueous formic 
acid (v:v); 5% to 50% B over 5 min, to 5% B after 5.5 min, 3% hold C over 5.5 min, flow rate 1.2 
mL min-1, 254 nm, 20 °C. 
8.4.3 Synthesis of N’-methyl nicotinamide 
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Methyl nicotinate (10.03 g, 73.2 mmol) was added in portions to a cooled solution (0 °C, ice 
bath) of methylamine in methanol (145 mL, 2 M, 292 mmol). The reaction was allowed to warm to 
room temperature and stirred for 24 h. The solvent was removed under vacuum to leave the amide 
as a white solid (9.23 g, 67.8 mmol, 99%) which was used without any further purification, mp 
102-104 °C; δH: (300 MHz, CDCl3, TMS) 8.96 (1H, dd, J 2.4 and 0.9, Ar 2-H), 8.71 (1H, dd, J 4.8 
and 1.5, Ar 6-H), 8.12 (1H, dt, J 2.0 and 7.8, Ar 5-H), 7.38 (1H, ddd, J 7.8, 4.8 and 0.9, Ar 4-H), 
6.36 (1H, br s, N-H), 3.04 (3H, d, J 4.8, NCH3); MS (APCI+) 137 [M+H]+, 178 [M+MeCN+H]+. 
Analysis matches existing literature266 
8.4.4 Pump Reservoir Solutions 
Solution reservoirs for the pumps were prepared by dissolving methyl nicotinate (50 g, 36.5 
mmol) in methanol (200 mL); and methylamine solution (40% wt aq, 200 mL, 5.15 mol) in 
distilled water (200 mL). Ester solution concentration = 1.46 mol L-1, methylamine solution = 5.77 
mol L-1. 
8.4.5 Steady State Determination 
Online MS was tested for its ability to be used as real-time analysis to check for steady state 
in the reactor. The reagent pumps were primed, and then 1 was pumped at 0.2 mL min-1 and 
MeNH2 was pumped at 0.023 mL min-1 (2 mol eq) for a period of 30 min, during which a MS 
sample was taken at 60 s intervals. After the 30 min reagent pulse, methanol was pumped at 1 mL 
min-1 for 10 min. This was to clean the reactor and prevent accumulation in the MS. The process 
was repeated using 3 and 4 mol eq of MeNH2 carrying out the three flow experiments sequentially. 
The results were analyzed by internal normalization and linearity was observed when the standard 
deviation of the previous three points was less than or equal to 1.5%. 
8.4.6 Isotope Calculations 
There is an overlap in the peaks between 1 and 2 due to the [M+H]+ adduct of 1 masking the 
[M+H+1]+ isotope adduct of 2. To correct this, the isotope abundance for each compound was 
predicted using ChemDraw (ver 13.0.0.3015) and verified experimentally. 
The following calculations were used when calculating the MS response: 
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𝐸𝑠𝑡𝑒𝑟 = (𝑃137 − (𝑃138 × 0.077)) × 1.077 
𝐴𝑚𝑖𝑑𝑒 = 𝑃138 × 1.077 
𝐴𝑐𝑖𝑑 = 𝑃124 × 1.066 
 
 
Figure 8.4 Isotope adundances for compounds 5.12 to 5.14 
8.4.7 MS Calibration 
8.4.7.1 HPLC 
The HPLC response was calibrated by preparing a single solution containing compounds 
5.12-5.14 at 0.35 mol L-1 in DMSO. HPLC samples were taken at dilution factors of 1, 2, 4 and 8 
(corresponding to concentrations of 0.35, 0.175, 0.0875, 0.0438 M) and the relative response 
factors were calculated by internal normalization. Existing calibration curves showed a linear 
response up to 1.4 M for 5.12 and 5.13 and 0.5 mol L-1 for 5.14, which is in the same concentration 
range in which optimizations were carried out. 
8.4.7.2 MS 
A central composite faced (CCF) Design of Experiment (DoE) was constructed and ran 
using both HPLC and MS as analysis. 
Table 8.13 Summary of experiments in the CCF DoE 
Experiment 5.12 / mL min-1 MeNH2 / mol eq Temperature / °C 
1 0.1 1 0 
2 0.1 10 0 
3 0.25 5.5 0 
4 0.4 1 0 
5 0.4 10 0 
6 0.1 5.5 65 
7 0.25 1 65 
8 0.25 5.5 65 
9 0.25 5.5 65 
10 0.25 5.5 65 
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11 0.25 5.5 65 
12 0.25 10 65 
13 0.4 5.5 65 
14 0.1 10 130 
15 0.25 5.5 130 
16 0.4 1 130 
17 0.4 10 130 
18 0.1 1 130 
Table 8.14 Results from HPLC CCF, showing absolute peak area and calibrated internally 
normalised percentage yield 
Experiment HPLC Area Percentage Yield / % 
5.14 5.13 5.12 5.14 5.13 5.12 
1 9.5 126.9 1480.8 0.5 5.7 93.8 
2 18.8 548.4 0.0 4.0 96.0 0.0 
3 24.5 525.1 247.3 3.3 58.1 38.6 
4 5.5 67.9 1469.0 0.3 3.2 96.5 
5 15.7 364.8 160.3 3.1 59.8 37.1 
6 161.4 761.6 0.0 20.5 79.5 0.0 
7 71.6 255.9 1220.4 4.2 12.4 83.4 
8 148.2 694.5 12.7 20.2 77.8 2.0 
9 151.3 701.4 13.2 20.4 77.5 2.1 
10 136.8 659.2 5.1 20.0 79.1 0.9 
11 157.5 722.8 28.0 20.1 75.7 4.1 
12 94.5 459.1 0.0 20.1 79.9 0.0 
13 136.7 652.7 54.1 18.6 72.9 8.5 
14 199.6 346.7 0.0 41.3 58.7 0.0 
15 361.6 524.2 0.0 45.7 54.3 0.0 
16 235.2 245.7 1118.2 13.6 11.6 74.8 
17 195.2 313.5 0.0 43.2 56.8 0.0 
18 499.4 448.8 782.5 28.2 20.7 51.1 
Table 8.15 Results from the MS CCF showing uncalibrated internally normalised percentage 
yield with isotope correction calculations. 
Experiment 5.14 / % 5.13 / % 5.12 / % 
1 1.2 3.7 95.5 
2 1.1 95.9 2.8 
3 1.5 70.6 27.8 
4 1.2 6.8 92.5 
5 1.5 67.7 30.8 
6 4.8 93.4 1.5 
7 2.0 16.1 82.3 
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8 5.3 90.2 4.3 
9 5.6 90.2 4.0 
10 5.6 90.2 4.0 
11 6.0 89.6 4.1 
12 5.3 92.7 1.8 
13 5.1 85.6 9.1 
14 13.2 84.2 2.4 
15 14.6 83.7 1.3 
16 4.8 17.0 78.5 
17 13.9 83.4 2.5 
18 1.2 2.0 97.3 
 
The error in the measurement was calculated by using sum of squares, where Ri is the 
response of compound i: 
𝐸𝑟𝑟𝑜𝑟 =∑(𝑅𝑖,𝐻𝑃𝐿𝐶 − 𝑅𝑖,𝑀𝑆)
2
3
𝑖=1
 
 
A ‘new’ yield was calculated by multiplying the existing response by a response factor 
(initially set to 1). The error in the measurement between the ‘new’ MS yield and existing HPLC 
yield was minimized by changing the values of the 3 response factors. Optimum minimized values 
were calculated using the MS Excel solver add-in (GRG Non-Linear algorithm). A comparison 
between the calibrated LC and MS responses are shown in Table S4 and 
Table 8.16 Comparison between calibrated MS and LC responces 
Experiment Percentage Yield (HPLC)/ % Calibrated MS response / % 
5.14 5.13 5.12 5.14 5.13 5.12 
1 0.5 5.7 93.8 3.7 2.5 93.8 
2 4.0 96.0 0.0 4.5 91.8 3.8 
3 3.3 58.1 38.6 5.6 60.4 34.0 
4 0.3 3.2 96.5 3.7 4.7 91.7 
5 3.1 59.8 37.1 5.3 57.4 37.3 
6 20.5 79.5 0.0 17.8 80.4 1.9 
7 4.2 12.4 83.4 6.1 11.3 82.6 
8 20.2 77.8 2.0 19.2 75.7 5.1 
9 20.4 77.5 2.1 20.1 75.2 4.7 
10 20.0 79.1 0.9 20.1 75.2 4.7 
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11 20.1 75.7 4.1 21.3 73.9 4.8 
12 20.1 79.9 0.0 19.3 78.6 2.1 
13 18.6 72.9 8.5 18.3 71.0 10.8 
14 41.3 58.7 0.0 39.4 58.3 2.3 
15 45.7 54.3 0.0 42.5 56.2 1.3 
16 13.6 11.6 74.8 13.9 11.3 74.8 
17 43.2 56.8 0.0 40.8 56.8 2.4 
18 28.2 20.7 51.1 3.7 2.5 93.8 
 
 
Figure 8.5 Comparison between the calibrated responses by MS and HPLC for each individual 
compound. 
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Figure 8.6 Comparison between the calibrated responses by MS and HPLC for all combined 
compounds. 
8.4.8 N’-Methyl Nicotinamide Optimisation 
Table 8.17 Optimisation limits used in the self-optimisation and design of experiment 
Limits Ester flow /  
mL min-1 
MeNH2 eq Temperature /  
°C 
Upper 0.100 1 0 
Lower 0.400 10 130 
Table 8.18 Conditions and responses from the self-optimisation, Optimum conditions are 
highlighted in bold. 
Entry 
Ester flow / 
mL min-1 
MeNH2 
mol eq 
Temperature / 
°C 
Yield % 
1 0.187 6.0 0.2 70.8 
2 0.264 5.6 129.6 71.8 
3 0.256 1.5 33.4 12.8 
4 0.344 4.8 65.5 74.7 
5 0.343 1.8 16.6 12.6 
6 0.341 9.7 49.4 88.9 
7 0.392 3.8 81.5 62.2 
8 0.100 9.1 97.6 86.3 
9 0.209 2.2 8.1 30.7 
10 0.123 2.6 25.0 35.9 
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11 0.298 6.1 113.4 70.7 
12 0.367 1.9 121.3 30.6 
13 0.400 8.8 0.0 68.4 
14 0.222 7.4 32.7 87.0 
15 0.400 7.3 36.8 83.5 
16 0.246 9.9 130.0 74.9 
17 0.100 9.9 10.6 93.4 
18 0.100 8.2 32.8 92.3 
19 0.133 8.7 49.1 88.0 
20 0.262 8.7 55.2 87.1 
21 0.161 5.2 65.1 78.4 
Table 8.19 List of experiments and responses for all compounds in the CCF DoE 
Experiment Ester flow / 
mL min-1 
MeNH2 
 mol eq 
Temperature /  
°C 
Acid /  
% 
Amide /  
% 
Ester /  
% 
1 0.1 1 0 3.7 2.5 93.8 
2 0.1 10 0 4.5 91.8 3.8 
3 0.25 5.5 0 5.6 60.4 34.0 
4 0.4 1 0 3.7 4.7 91.7 
5 0.4 10 0 5.3 57.4 37.3 
6 0.1 5.5 65 17.8 80.4 1.9 
7 0.25 1 65 6.1 11.3 82.6 
8 0.25 5.5 65 19.2 75.7 5.1 
9 0.25 5.5 65 20.1 75.2 4.7 
10 0.25 5.5 65 20.1 75.2 4.7 
11 0.25 5.5 65 21.3 73.9 4.8 
12 0.25 10 65 19.3 78.6 2.1 
13 0.4 5.5 65 18.3 71.0 10.8 
14 0.1 10 130 39.4 58.3 2.3 
15 0.25 5.5 130 42.5 56.2 1.3 
16 0.4 1 130 13.9 11.3 74.8 
17 0.4 10 130 40.8 56.8 2.4 
18 0.1 1 130 3.7 2.5 93.8 
 
8.4.9 DoE Model Analysis 
The CCF design was analyzed and response surface models were fitted using Umetrics 
Modde (ver 10.1) by including all square and interactions then removing terms with a 𝑝-value less 
than 0.05. The model for 3 (acid) was transformed logarithmically (𝑦 = log 𝑥) to improve the 
normality of its distribution. The following figures show a summary of the model displaying Figure 
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8.7 a) replicates plot, b) summary of fit, c) coefficients and d) residual normality plot for the model 
of amide 5.13; Figure 8.8, summary of the fit; Figure 8.9, model coefficients; Figure 8.10, observed 
vs predicted plots for each compound model; and Figure 8.11, contour plot, using the predictor 
function of the model for amide 5.13. 
 
Figure 8.7 Model summary for the model of 2: a) Replicates, shown in blue, highlight the 
reproducibility of the model; b) summary of fit, displaying 𝑹𝟐, which shows the 
accuracy of the fit, 𝑸𝟐, which shows how accurately the model can predict, vailidity, 
which is low due to the high reproducibility (i.e. the model does not believe it is 
valid due to such high reproducibility); c) model coefficients and their weighting; d) 
normal probability plot, which a good model will fit a straight line with all points 
within the 4 SD (4 standard deviations) markers. 
( (
((
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Figure 8.8 Summary of fit for the models of 5.12 (ester), 5.13 (amide) and 5.14 (acid). 
 
Figure 8.9 Coefficients of each model for compounds 5.12 (ester), 5.13 (amide) and 5.14 (acid). 
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Figure 8.10 Plot of observed vs predicted of each model from the compounds 
 
Figure 8.11 Contour plot at showing the effect of ester flow rate (mL/min) and MeNH2 eq on the 
yield of amide at fixed temperature (0 °C). 
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8.5 Chapter 6 Procedures 
8.5.1 Chemicals 
2,4-Difluoronitrobenzene (99%, Aldrich), morpholine (≥99.0%, Merck), triethylamine (99%, 
Acros), ethanol (99.8%, VWR) and biphenyl (99.5% GC, Aldrich) were all used without further 
purification. Standards of 4-(5-fluoro-2-nitrophenyl)morpholine, N-(3-fluoro-4-nitrophenyl) 
morpholine and 4,4'-(4-nitro-1,3-phenylene)dimorpholine were synthesised by C. A. Hone.267 
8.5.2 Measuring Dispersion 
Dispersion was measured at residence times (tRes) of 1 and 3 min. A 3 mL tubular reactor 
internal dimension 1/32” (0.79 mm) and external dimensions 1/16” (1.59 mm) and length of 6.25 m 
was fitted to 2 separate pumps. The pumps contained reservoir solutions of A: biphenyl in ethanol 
(0.050 mol L-1) and B: neat ethanol. For 1 min tRes, the solvent (ethanol) pump was set to 3 mL min-
1 for 1 min then stopped and the biphenyl pump was set to 3 mL min-1 for 1 min and this sequence 
was repeated for 50 min. During this time, the sample loop was set to acquire a HPLC sample at a 
125 s intervals. This resulted in 25 chromatograms displaying the composition of biphenyl at 5 s 
intervals across the 1 min repeated pulse.60 For 3 min tres, the solvent pulse was set to 1 mL min-1 
for 3 min, then the biphenyl pump set to 1 mL min-1 for 3 min. This was repeated for a duration of 
216 min with HPLC sampling frequency of 370 s. The data for these two sets of dispersion 
experiments are shown in Table 8.20 and Table 8.21. 
Table 8.20 List of experiments for the dispersion experiments with 1 min tRes 
Entry Time point /  
s 
HPLC 
area 
1 5 107.64 
2 10 55.12 
3 15 37.69 
4 20 32.66 
5 25 106.37 
6 30 367.94 
7 35 1019.68 
8 40 1696.92 
9 45 2708.71 
10 50 3342.98 
11 55 3545.33 
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12 60 3829.05 
13 65 3882.24 
14 70 3892.96 
15 75 3911.81 
16 80 3910.99 
17 85 3801.22 
18 90 3543.15 
19 95 3172.44 
20 100 2283.46 
21 105 1500.20 
22 110 750.75 
23 115 462.75 
24 120 245.54 
25 125 92.61 
Table 8.21 List of experiments for the dispersion experiments with 3 min tRes 
Entry Time point / 
s 
HPLC 
area 
1 10 79.74 
2 20 49.90 
3 30 22.60 
4 40 16.53 
5 50 14.37 
6 60 12.12 
7 70 16.82 
8 80 31.49 
9 90 411.93 
10 100 825.72 
11 110 1334.26 
12 120 2087.43 
13 130 2578.46 
14 140 3013.16 
15 150 3622.97 
16 160 3738.19 
17 170 3858.24 
18 180 3883.66 
19 190 3908.44 
20 200 3940.44 
21 210 3917.88 
22 220 3925.23 
23 230 3928.72 
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Entry Time point / 
s 
HPLC 
area 
24 240 3917.58 
25 250 3906.46 
26 260 3838.19 
27 270 3652.44 
28 280 3361.13 
29 290 2786.56 
30 300 2328.88 
31 310 1471.10 
32 320 955.52 
33 330 592.77 
34 350 320.39 
35 360 185.50 
 
8.5.3 Preparation of Pump Reservoir Solutions 
Reservoir solutions were prepared by dissolving the desired reagents in solvent under stirring 
at ambient conditions. Pump A: 2,4-difluoronitrobenzene (50 mL, 0.46 mol, 2.03 mol L-1) and 
biphenyl (3.51 g, 22.7 mmol, 0.101 mol L-1) in ethanol (175 mL); Pump B: morpholine (70 mL, 
0.81 mol, 4.17 mol L-1) in triethylamine (124 mL, 0.89 mol, 4.59 mol L-1); Pump C: ethanol. 
8.5.4 Determining Pulse Volume 
The pump reservoirs were prepared according to the instructions above. The following list of 
experiments were carried out in sequence and repeated 4 times with HPLC samples acquired at 6 
min intervals. The reactor was 1 mL and maintained at constant a temperature of 90 °C. The 
reaction conditions are 2.75 min residence time (165 s), 1.5 eq of morpholine and a nitrobenzene 
concentration of 0.30 mol L-1, corresponding to the centre-point of the optimisation limits. 
 
Table 8.22 List of experiments used to determined the minimum possible reactor pulse size 
Steady State 
Volume 
Pulse type 
Duration / 
s 
Pump A / 
mL min-1 
Pump B / 
mL min-1 
Pump C / 
mL min-1 
2 
A 30 0 0 0.364 
R 330 0.054 0.039 0.271 
B 0 N/A N/A N/A 
1.5 A 71 0 0 0.364 
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R 247 0.054 0.039 0.271 
B 41 0 0 0.364 
1.0 
A 113 0 0 0.364 
R 165 0.054 0.039 0.271 
B 82 0 0 0.364 
0.5 
A 154 0 0 0.364 
R 82 0.054 0.039 0.271 
B 124 0 0 0.364 
0.2 
A 179 0 0 0.364 
R 33 0.054 0.039 0.271 
B 148 0 0 0.364 
0.1 
A 187 0 0 0.364 
R 16 0.054 0.039 0.271 
B 157 0 0 0.364 
0.05 
A 191 0 0 0.364 
R 8 0.054 0.039 0.271 
B 161 0 0 0.364 
 
 Next the accuracy of each experiment was measured using a confidence interval of 95% 
after removal of anomalous results. Table 8.23 shows the % yield of ortho product for each 
experiment.  
Table 8.23 List of % yield of desired ortho product after removal of anomalous experiments 
Steady State 
Volume ortho % 
2 61.69 
2 63.05 
2 62.07 
1.5 63.14 
1.5 61.93 
1.5 62.46 
1.5 62.52 
1 63.14 
1 61.98 
1 63.01 
1 62.04 
0.5 61.12 
0.5 61.22 
0.5 61.25 
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0.2 45.95 
0.2 48.73 
0.2 45.39 
0.1 22.95 
0.1 23.03 
0.1 20.26 
0.05 5.37 
0.05 5.97 
0.05 7.14 
0.05 5.11 
 
The mean of each steady state pulse volume was calculated by simply dividing the sum of 
yields by the population number (𝑛). Next the “real” mean was calculated by calculating the mean 
from the volumes 1-2 as it was determined these values were at true steady state and did not suffer 
from dispersion. The residual error (𝑆𝑆𝐸) was calculated by squaring the difference between each 
yield value and the “real” mean value 
𝑆𝑆𝐸 =∑(𝑌𝑖 − ?̅?)
2 
where 𝑌𝑖 is the yield of a particular experiment and ?̅? is the “real” mean value. The standard 
deviation (𝜎) for each steady state volume was calculated 
𝜎 = √
𝑆𝑆𝐸
𝑛
 
Next, the 𝑍-value for a confidence interval of 95% was calculated, where 𝛼 = 0.05. This is 
carried out by finding the value for 0.475 ((1−𝛼)/2) in cumulative distribution table of a standard 
normal distribution (Z-table). For 0.475 the 𝑍-value is 1.96. Therefore the error can be calculated 
𝑒𝑟𝑟𝑜𝑟 = 𝑍1−𝛼
2
(
𝜎
√𝑛
) 
Table 8.24 shows a summary of calculations for ortho product. 
Table 8.24 Statistical analysis of the results from Table 8.23. 
Steady State 
volume Mean SSE Std Conf Error 
2 62.27 1.074659 0.518329 0.95 0.508 
1.5 62.51 0.753329 0.433973 0.95 0.425 
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1 62.54 1.185654 0.544439 0.95 0.534 
0.5 61.20 4.673808 1.248173 0.95 1.412 
0.2 46.69 750.7423 15.81921 0.95 17.901 
0.1 22.08 4892.09 40.38189 0.95 45.696 
0.05 5.90 12792.22 65.29986 0.95 63.994 
 
8.5.5 Pattern Search STY Optimisation 
The optimisation target function was space time yield (STY, units: kg L-1 h-1) 
𝑆𝑇𝑌 =
𝐶(𝑆𝑀)𝑌𝑖(𝑜𝑟𝑡ℎ𝑜)𝑀𝑊(𝑜𝑟𝑡ℎ𝑜)
𝑡𝑅𝑒𝑠,𝑖
 
where 𝐶(SM) is the concentration of 2,4-dilfuoronitrobenzene, 𝑌𝑖,(𝑜𝑟𝑡ℎ𝑜) is the yield of ortho for 
experiment 𝑖, 𝑀𝑊(𝑜𝑟𝑡ℎ𝑜) is the molecular weight of ortho and 𝑡𝑅𝑒𝑠,𝑖 is the residence time.  
 
Table 8.25 Limits for the STY optimisation using pattern search algorithm 
Limit tRes /  
min 
Morpholine /  
mol eq 
Concentration /  
mol L-1 
Temperature /  
°C 
Lower 1 1.0 0.200 60 
Upper 3 2.0 0.500 120 
Table 8.26 List of results from the STY pattern search optimisation. Optimum conditions 
highlighted in bold 
Entry 
tRes /  
min 
Morpholine 
eq 
Concentration /  
mol L-1 
Temperature /  
°C 
STY /  
kg L-1 h-1 
1 3.000 1.000 0.200 60.0 0.10 
2 1.268 1.000 0.200 60.0 0.19 
3 3.000 1.000 0.200 60.0 0.06 
4 1.268 1.000 0.200 60.0 0.37 
5 3.000 1.707 0.200 60.0 0.07 
6 1.268 1.707 0.200 60.0 0.50 
7 3.000 1.707 0.200 60.0 0.12 
8 2.134 1.707 0.200 60.0 0.33 
9 1.268 1.707 0.358 60.0 0.71 
10 3.000 1.707 0.358 60.0 0.36 
11 2.134 1.707 0.358 60.0 0.95 
12 1.268 1.707 0.358 102.4 1.21 
13 3.000 1.707 0.358 102.4 0.88 
14 2.134 1.707 0.358 102.4 1.67 
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Entry 
tRes /  
min 
Morpholine 
eq 
Concentration /  
mol L-1 
Temperature /  
°C 
STY /  
kg L-1 h-1 
15 1.268 1.707 0.358 60.0 2.72 
16 1.701 1.707 0.358 102.4 0.67 
17 1.268 1.707 0.437 102.4 3.00 
18 2.134 1.707 0.437 102.4 1.78 
19 1.268 1.707 0.279 102.4 2.15 
20 1.268 1.707 0.437 60.0 2.53 
21 1.701 1.707 0.437 102.4 0.98 
22 1.268 1.354 0.437 102.4 3.15 
23 1.268 1.707 0.358 102.4 2.14 
24 1.268 1.707 0.437 81.2 2.76 
25 1.484 1.707 0.437 102.4 1.94 
26 1.268 1.884 0.437 102.4 3.06 
27 1.701 1.884 0.437 102.4 2.37 
28 1.268 1.530 0.437 102.4 3.44 
29 1.268 1.884 0.358 102.4 2.39 
30 1.268 1.884 0.437 81.2 3.04 
31 1.484 1.884 0.437 102.4 2.10 
32 1.268 1.884 0.477 102.4 3.54 
33 1.701 1.884 0.477 102.4 2.67 
34 1.268 1.530 0.477 102.4 3.86 
35 1.268 1.884 0.398 102.4 2.78 
36 1.268 1.884 0.477 81.2 3.46 
37 1.484 1.884 0.477 102.4 2.47 
38 1.268 1.884 0.477 113.0 3.68 
39 1.701 1.884 0.477 113.0 2.87 
40 1.268 1.530 0.477 113.0 4.06 
41 1.268 1.884 0.398 113.0 3.01 
42 1.268 1.884 0.477 91.8 3.80 
43 1.484 1.884 0.477 113.0 2.88 
44 1.051 1.884 0.477 113.0 4.94 
45 1.484 1.884 0.477 113.0 3.22 
46 1.051 1.530 0.477 113.0 4.83 
47 1.051 1.884 0.398 113.0 3.48 
48 1.051 1.884 0.477 91.8 4.37 
49 1.268 1.884 0.477 113.0 3.18 
50 1.051 1.707 0.477 113.0 4.72 
51 1.051 1.884 0.437 113.0 4.03 
52 1.051 1.884 0.477 102.4 4.50 
53 1.160 1.884 0.477 113.0 3.84 
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Entry 
tRes /  
min 
Morpholine 
eq 
Concentration /  
mol L-1 
Temperature /  
°C 
STY /  
kg L-1 h-1 
54 1.051 1.972 0.477 113.0 4.59 
55 1.268 1.972 0.477 113.0 3.86 
56 1.051 1.795 0.477 113.0 4.82 
57 1.051 1.972 0.437 113.0 4.13 
58 1.051 1.972 0.477 102.4 4.62 
59 1.160 1.972 0.477 113.0 4.00 
60 1.051 1.972 0.496 113.0 4.90 
61 1.268 1.972 0.496 113.0 4.06 
62 1.051 1.795 0.496 113.0 5.17 
63 1.051 1.972 0.457 113.0 4.33 
64 1.051 1.972 0.496 102.4 4.87 
65 1.160 1.972 0.496 113.0 4.17 
66 1.051 1.972 0.496 118.3 4.99 
67 1.051 1.884 0.496 113.0 4.94 
68 1.051 1.972 0.477 113.0 4.67 
69 1.051 1.972 0.496 107.7 4.92 
70 1.106 1.972 0.496 113.0 4.59 
71 1.051 1.972 0.496 115.7 4.97 
72 1.051 1.928 0.496 113.0 4.98 
73 1.051 1.972 0.487 113.0 4.85 
74 1.051 1.972 0.496 110.4 4.93 
75 1.079 1.972 0.496 113.0 4.81 
76 1.051 1.994 0.496 113.0 4.94 
77 1.106 1.994 0.496 113.0 4.74 
78 1.051 1.994 0.496 115.7 5.02 
79 1.160 1.994 0.496 115.7 4.57 
80 1.051 1.906 0.496 115.7 5.14 
81 1.051 1.994 0.477 115.7 4.82 
82 1.051 1.994 0.496 110.4 5.05 
83 1.106 1.994 0.496 115.7 4.68 
84 1.051 1.994 0.496 118.3 5.10 
85 1.160 1.994 0.496 118.3 4.59 
86 1.051 1.906 0.496 118.3 5.24 
87 1.268 1.906 0.496 118.3 4.26 
88 1.051 1.729 0.496 118.3 5.27 
89 1.051 1.906 0.457 118.3 4.51 
90 1.051 1.906 0.496 107.7 4.99 
91 1.160 1.906 0.496 118.3 4.38 
92 1.051 1.994 0.496 118.3 4.98 
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Entry 
tRes /  
min 
Morpholine 
eq 
Concentration /  
mol L-1 
Temperature /  
°C 
STY /  
kg L-1 h-1 
93 1.051 1.818 0.496 118.3 5.04 
94 1.051 1.906 0.477 118.3 4.70 
95 1.051 1.906 0.496 113.0 5.03 
96 1.106 1.906 0.496 118.3 4.72 
97 1.051 1.950 0.496 118.3 5.11 
98 1.051 1.862 0.496 118.3 5.11 
99 1.051 1.906 0.487 118.3 4.90 
100 1.051 1.906 0.496 115.7 5.02 
101 1.079 1.906 0.496 118.3 4.88 
102 1.051 1.928 0.496 118.3 5.09 
103 1.051 1.906 0.496 119.7 5.10 
104 1.024 1.906 0.496 118.3 5.22 
105 1.079 1.906 0.496 118.3 4.95 
106 1.024 1.950 0.496 118.3 5.20 
107 1.133 1.950 0.496 118.3 4.68 
 
8.5.6 Multi-Objective Optimisation 
The target functions were STY and process mass intensity (PMI) 
𝑃𝑀𝐼 =
𝑚𝑎𝑠𝑠𝑟𝑒𝑎𝑐𝑡𝑎𝑛𝑡𝑠
𝑚𝑎𝑠𝑠𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑠
 
Table 8.27 Limits for the multi-objective optimisation using TS-EMO algorithm. 
Limit tRes /  
min 
Morpholine /  
mol eq 
Concentration /  
mol L-1 
Temperature /  
°C 
Lower 0.5 1.0 0.100 60 
Upper 2 5.0 0.500 140 
Table 8.28 List of experiments from the multi-objective TS-EMO optimisation. Optimum 
conditions highlighted in bold. 
Entry 
tRes /  
min 
Morpholine 
eq 
Concentration / 
mol L-1 
Temperature / 
°C 
PMI 
STY /  
kg L-1 h-1 
1 1.45 2.04 0.165 60.5 6.15 0.37 
2 1.24 2.43 0.361 64.8 3.06 2.08 
3 0.81 4.59 0.484 71.6 2.94 6.69 
4 0.69 1.97 0.141 74.7 8.07 0.50 
5 1.49 3.31 0.194 79.4 3.03 1.14 
6 1.04 1.27 0.334 80.7 2.89 1.79 
7 1.96 3.19 0.229 84.2 2.37 1.28 
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Entry 
tRes /  
min 
Morpholine 
eq 
Concentration / 
mol L-1 
Temperature / 
°C 
PMI 
STY /  
kg L-1 h-1 
8 0.98 4.05 0.456 88.8 2.44 5.78 
9 1.66 4.75 0.214 92.2 2.76 1.58 
10 1.74 3.43 0.425 97.1 2.08 3.19 
11 1.27 1.73 0.111 103.9 2.98 0.54 
12 1.58 1.44 0.264 105.1 1.75 1.62 
13 0.59 3.70 0.388 111.6 2.35 7.91 
14 1.17 3.84 0.400 115.2 2.23 4.50 
15 0.74 4.37 0.248 116.3 2.61 4.10 
16 1.82 2.73 0.134 122.6 2.00 0.87 
17 1.92 4.96 0.313 124.8 2.68 2.13 
18 0.88 1.12 0.295 132.0 1.63 3.13 
19 1.35 2.91 0.357 134.5 1.86 3.48 
20 0.53 2.28 0.465 139.4 1.72 10.78 
21 0.50 4.09 0.500 111.0 2.48 12.28 
22 0.97 1.00 0.500 140.0 1.33 5.71 
23 0.50 1.34 0.500 140.0 1.52 10.80 
24 0.64 1.00 0.500 140.0 1.44 8.01 
25 2.00 1.00 0.500 129.1 1.25 2.94 
26 0.50 2.29 0.500 137.8 1.72 12.40 
27 0.81 1.07 0.500 140.0 1.36 6.85 
28 1.18 1.00 0.500 140.0 1.29 4.85 
29 0.50 2.89 0.500 140.0 1.91 12.76 
30 0.50 1.78 0.500 140.0 1.60 11.68 
31 0.60 1.19 0.500 140.0 1.46 8.97 
32 0.69 1.00 0.500 140.0 1.42 7.51 
33 1.27 1.00 0.500 121.5 1.42 4.09 
34 1.02 1.19 0.499 126.7 1.40 5.42 
35 0.75 1.43 0.500 129.7 1.47 7.63 
36 0.61 1.43 0.500 130.6 1.55 8.89 
37 1.80 1.10 0.500 140.0 1.27 3.34 
38 0.77 1.33 0.500 140.0 1.39 7.66 
39 1.52 1.09 0.500 140.0 1.25 3.96 
40 0.50 2.00 0.500 140.0 1.63 12.10 
41 0.92 1.22 0.500 139.9 1.36 6.36 
42 0.50 4.51 0.500 140.0 2.50 13.08 
43 0.61 1.56 0.500 140.0 1.50 9.55 
44 1.08 1.14 0.500 140.0 1.33 5.37 
45 0.50 3.19 0.500 140.0 2.01 12.91 
46 0.50 2.58 0.500 140.0 1.80 12.65 
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Entry 
tRes /  
min 
Morpholine 
eq 
Concentration / 
mol L-1 
Temperature / 
°C 
PMI 
STY /  
kg L-1 h-1 
47 1.05 1.00 0.500 140.0 1.31 5.34 
48 1.32 1.00 0.500 140.0 1.27 4.37 
49 1.88 1.00 0.425 134.5 1.30 2.54 
50 1.73 1.00 0.460 137.9 1.26 3.10 
51 1.60 1.00 0.490 139.8 1.26 3.58 
52 0.53 1.23 0.500 140.0 1.49 10.01 
53 0.50 4.70 0.500 140.0 2.57 13.12 
54 0.50 1.60 0.500 140.0 1.56 11.39 
55 0.62 1.00 0.499 140.0 1.46 8.01 
56 0.92 1.00 0.500 140.0 1.34 5.95 
57 1.79 1.00 0.500 140.0 1.25 3.29 
58 0.70 1.37 0.500 140.0 1.42 8.30 
59 1.62 1.00 0.500 140.0 1.24 3.65 
60 0.93 1.13 0.500 140.0 1.32 6.24 
61 1.26 1.00 0.500 134.1 1.32 4.42 
62 1.41 1.00 0.500 134.2 1.29 4.03 
63 0.50 2.20 0.500 139.4 1.69 12.34 
64 0.50 2.49 0.500 139.6 1.78 12.55 
65 0.50 3.01 0.500 140.0 1.95 12.83 
66 0.50 2.76 0.500 140.0 1.86 12.76 
67 0.50 3.28 0.500 140.0 2.03 12.99 
68 1.12 1.00 0.500 140.0 1.30 5.03 
Table 8.29 List of experiments in Pareto front in order from optimum STY to optimum PMI 
Entrya 
tRes / 
min 
Morpholine 
eq 
Concentration / 
mol L-1 
Temperature / 
°C 
PMI 
STY / 
kg L-1 h-1 
53 0.50 4.70 0.500 140.0 2.57 13.12 
42 0.50 4.51 0.500 140.0 2.50 13.08 
67 0.50 3.28 0.500 140.0 2.03 12.99 
45 0.50 3.19 0.500 140.0 2.01 12.91 
65 0.50 3.01 0.500 140.0 1.95 12.83 
29 0.50 2.89 0.500 140.0 1.91 12.76 
66 0.50 2.76 0.500 140.0 1.86 12.76 
46 0.50 2.58 0.500 140.0 1.80 12.65 
64 0.50 2.49 0.500 139.6 1.78 12.55 
26 0.50 2.29 0.500 137.8 1.72 12.40 
63 0.50 2.20 0.500 139.4 1.69 12.34 
40 0.50 2.00 0.500 140.0 1.63 12.10 
30 0.50 1.78 0.500 140.0 1.60 11.68 
 200 
 
54 0.50 1.60 0.500 140.0 1.56 11.39 
23 0.50 1.34 0.500 140.0 1.52 10.80 
52 0.53 1.23 0.500 140.0 1.49 10.01 
31 0.60 1.19 0.500 140.0 1.46 8.97 
58 0.70 1.37 0.500 140.0 1.42 8.30 
38 0.77 1.33 0.500 140.0 1.39 7.66 
27 0.81 1.07 0.500 140.0 1.36 6.85 
60 0.93 1.13 0.500 140.0 1.32 6.24 
47 1.05 1.00 0.500 140.0 1.31 5.34 
28 1.18 1.00 0.500 140.0 1.29 4.85 
48 1.32 1.00 0.500 140.0 1.27 4.37 
39 1.52 1.09 0.500 140.0 1.25 3.96 
59 1.62 1.00 0.500 140.0 1.24 3.65 
a – relates to the entry in Table 8.28 
Table 8.30 List of experiments from Paerto front displaying different target functions 
Entry 
PMI 
STY / 
kg L-1 h-1 Ortho % Selectivity % 
Cost / 
£ kg-1 
53 2.565 13.1172 96.6 93.9 155.2238 
42 2.498 13.0801 96.4 93.6 154.4462 
67 2.031 12.9896 95.7 94.8 148.405 
45 2.005 12.9096 95.1 94.9 148.8133 
65 1.947 12.8272 94.5 95.1 148.6954 
29 1.908 12.7624 94.0 95.1 148.774 
66 1.856 12.7559 94.1 95.3 147.8451 
46 1.801 12.6535 93.2 95.4 148.1953 
64 1.776 12.5549 92.5 95.5 148.7739 
26 1.717 12.399 91.4 95.7 149.3435 
63 1.689 12.3368 90.9 95.9 149.6126 
40 1.635 12.0956 89.1 96.0 151.3827 
30 1.598 11.6764 86.0 96.2 155.4122 
54 1.558 11.3868 83.9 96.4 158.1052 
23 1.520 10.7985 79.6 96.5 164.8236 
52 1.486 10.0054 78.5 96.7 166.3514 
31 1.456 8.9676 79.2 96.6 164.5994 
58 1.419 8.29794 86.0 96.2 152.7523 
38 1.393 7.65563 86.7 96.2 151.2616 
27 1.359 6.85096 81.3 96.4 159.5242 
60 1.325 6.24299 85.2 96.3 152.615 
47 1.306 5.34426 82.7 96.5 156.3514 
28 1.287 4.84947 84.0 96.3 153.9317 
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48 1.269 4.37047 85.2 96.3 151.7636 
39 1.253 3.96485 89.0 96.0 145.8481 
59 1.239 3.64542 87.2 96.2 148.2828 
 
 
 
  
 202 
 
References 
1. H.-J. Federsel, Drug Discov. Today, 2006, 11, 966-974. 
2. S. A. Weissman and N. G. Anderson, Org. Process Res. Dev., 2015, 19, 1605-1633. 
3. M. R. Owen, C. Luscombe, Lai, S. Godbert, D. L. Crookes and D. Emiabata-Smith, Org. 
Process Res. Dev., 2001, 5, 308-323. 
4. P. Poechlauer, J. Colberg, E. Fisher, M. Jansen, M. D. Johnson, S. G. Koenig, M. Lawler, 
T. Laporte, J. Manley, B. Martin and A. O’Kearney-McMullan, Org. Process Res. Dev., 
2013, 17, 1472-1478. 
5. P. Poechlauer, J. Manley, R. Broxterman, B. Gregertsen and M. Ridemark, Org. Process 
Res. Dev., 2012, 16, 1586-1590. 
6. I. R. Baxendale, R. D. Braatz, B. K. Hodnett, K. F. Jensen, M. D. Johnson, P. Sharratt, J.-P. 
Sherlock and A. J. Florence, J. Pharmaceut. Sci., 2014, 104, 781-791. 
7. M. Baumann and I. R. Baxendale, Beilstein J. Org. Chem., 2015, 11, 1194-1219. 
8. M. Rasheed and T. Wirth, Angew. Chem., Int. Ed., 2011, 50, 357-358. 
9. D. C. Fabry, E. Sugiono and M. Rueping, React. Chem. Eng., 2016, 1, 126-133. 
10. V. Sans and L. Cronin, Chem. Soc. Rev., 2016, 45, 2032-2043. 
11. S. Krishnadasan, R. J. C. Brown, A. J. de Mello and J. C. de Mello, Lab Chip, 2007, 7, 
1434-1441. 
12. J. P. McMullen and K. F. Jensen, Org. Process Res. Dev., 2010, 14, 1169-1176. 
13. J. P. McMullen and K. F. Jensen, Org. Process Res. Dev., 2011, 15, 398-407. 
14. J. P. McMullen, M. T. Stone, S. L. Buchwald and K. F. Jensen, Angew. Chem., Int. Ed., 
2010, 49, 7076-7080. 
15. A. J. Parrott, R. A. Bourne, G. R. Akien, D. J. Irvine and M. Poliakoff, Angew. Chem., Int. 
Ed., 2011, 50, 3788-3792. 
16. R. A. Bourne, R. A. Skilton, A. J. Parrott, D. J. Irvine and M. Poliakoff, Org. Process Res. 
Dev., 2011, 15, 932-938. 
17. D. N. Jumbam, R. A. Skilton, A. J. Parrott, R. A. Bourne and M. Poliakoff, J. Flow Chem., 
2012, 2, 24-27. 
18. R. A. Skilton, A. J. Parrott, M. W. George, M. Poliakoff and R. A. Bourne, Appl. 
Spectrosc., 2013, 67, 1127-1131. 
19. B. J. Reizman and K. F. Jensen, Org. Process Res. Dev., 2012, 16, 1770-1782. 
20. B. J. Reizman and K. F. Jensen, Chem. Commun., 2015, 51, 13290-13293. 
21. B. J. Reizman, Y.-M. Wang, S. L. Buchwald and K. F. Jensen, React. Chem. Eng., 2016, 1, 
658-666. 
22. R. A. Skilton, R. A. Bourne, Z. Amara, R. Horvath, J. Jin, M. J. Scully, E. Streng, S. L. Y. 
Tang, P. A. Summers, J. Wang, E. Perez, N. Asfaw, G. L. P. Aydos, J. Dupont, G. Comak, 
M. W. George and M. Poliakoff, Nat. Chem., 2015, 7, 1-5. 
23. Z. Amara, E. S. Streng, R. A. Skilton, J. Jin, M. W. George and M. Poliakoff, Eur. J. Org. 
Chem., 2015, 2015, 6141-6145. 
24. V. Sans, S. Glatzel, F. J. Douglas, D. A. Maclaren, A. Lapkin and L. Cronin, Chem. Sci., 
2014, 5, 1153-1157. 
25. V. Sans, L. Porwol, V. Dragone and L. Cronin, Chem. Sci., 2015, 6, 1258-1264. 
26. C. Houben, N. Peremezhney, A. Zubov, J. Kosek and A. A. Lapkin, Org. Process Res. 
Dev., 2015, 19, 1049-1053. 
27. D. E. Fitzpatrick, C. Battilocchio and S. V. Ley, Org. Process Res. Dev., 2015, 20, 386–
394. 
28. D. Cortés-Borda, K. V. Kutonova, C. Jamet, M. E. Trusova, F. Zammattio, C. Truchet, M. 
Rodriguez-Zubiri and F.-X. Felpin, Org. Process Res. Dev., 2016, 20, 1979-1987. 
29. V. Hessel, Chem. Eng. Technol., 2009, 32, 1655-1681. 
30. V. Hessel, B. Cortese and M. H. J. M. de Croon, Chem. Eng. Sci., 2011, 66, 1426-1448. 
31. V. Hessel, D. Kralisch, N. Kockmann, T. Noël and Q. Wang, ChemSusChem, 2013, 6, 746-
789. 
32. D. L. Browne, M. Baumann, B. H. Harji, I. R. Baxendale and S. V. Ley, Org. Lett., 2011, 
13, 3312-3315. 
33. D. L. Browne, B. H. Harji and S. V. Ley, Chem. Eng. Technol., 2013, 36, 959-967. 
 203 
 
34. J. A. Newby, D. W. Blaylock, P. M. Witt, R. M. Turner, P. L. Heider, B. H. Harji, D. L. 
Browne and S. V. Ley, Org. Process Res. Dev., 2014, 18, 1221-1228. 
35. J.-i. Yoshida, A. Nagaki and T. Yamada, Chem. - Eur. J., 2008, 14, 7450-7459. 
36. J.-i. Yoshida, Y. Takahashi and A. Nagaki, Chem. Commun., 2013, 49, 9896-9904. 
37. Y. Su, N. J. W. Straathof, V. Hessel and T. Noël, Chem. - Eur. J., 2014, 20, 10562-10589. 
38. D. M. Roberge, N. Bieler, M. Mathier, M. Eyholzer, B. Zimmermann, P. Barthe, C. 
Guermeur, O. Lobet, M. Moreno and P. Woehl, Chem. Eng. Technol., 2008, 31, 1155-
1161. 
39. C. B. McPake and G. Sandford, Org. Process Res. Dev., 2012, 16, 844-851. 
40. B. J. Deadman, R. M. O'Mahony, D. Lynch, D. C. Crowley, S. G. Collins and A. R. 
Maguire, Org. Biomol. Chem., 2016, 14, 3423-3431. 
41. C. J. Mallia and I. R. Baxendale, Org. Process Res. Dev., 2016, 20, 327-360. 
42. B. J. Deadman, S. G. Collins and A. R. Maguire, Chem. - Eur. J., 2015, 21, 2298-2308. 
43. S. G. Newman, L. Gu, C. Lesniak, G. Victor, F. Meschke, L. Abahmane and K. F. Jensen, 
Green Chem., 2014, 16, 176-180. 
44. B. Gutmann, J.-P. Roduit, D. Roberge and C. O. Kappe, Angew. Chem. Int. Ed., 2010, 49, 
7101-7105. 
45. R. L. Hartman, J. P. McMullen and K. F. Jensen, Angew. Chem., Int. Ed., 2011, 50, 7502-
7519. 
46. D. M. Roberge, B. Zimmermann, F. Rainone, M. Gottsponer, M. Eyholzer and N. 
Kockmann, Org. Process Res. Dev., 2008, 12, 905-910. 
47. D. T. McQuade and P. H. Seeberger, J. Org. Chem., 2013, 78, 6384-6389. 
48. P. Watts and S. J. Haswell, Chem. Soc. Rev., 2005, 34, 235-246. 
49. B. Gutmann, D. Cantillo and C. O. Kappe, Angew. Chem., Int. Ed., 2015, 54, 6688-6728. 
50. T. Razzaq and C. O. Kappe, Chem. - Asian J., 2010, 5, 1274-1289. 
51. D. Webb and T. F. Jamison, Chem. Sci., 2010, 1, 675-680. 
52. B. P. Mason, K. E. Price, J. L. Steinbacher, A. R. Bogdan and D. T. McQuade, Chemical 
Reviews, 2007, 107, 2300-2318. 
53. S. V. Ley, D. E. Fitzpatrick, R. J. Ingham and R. M. Myers, Angew. Chem. Int. Ed., 2015, 
54, 3449-3464. 
54. S. V. Ley, D. E. Fitzpatrick, R. M. Myers, C. Battilocchio and R. J. Ingham, Angew. 
Chem., Int. Ed., 2015, 54, 10122-10136. 
55. K. F. Jensen, AIChE Journal, 2017, 63, 858-869. 
56. S. Borukhova, T. Noel, B. Metten, E. de Vos and V. Hessel, Green Chem., 2016, 18, 4947-
4953 
57. S. Borukhova, T. Noël and V. Hessel, Org. Process Res. Dev., 2016, 20, 568-573. 
58. S. Borukhova, T. Noel, B. Metten, E. de Vos and V. Hessel, ChemSusChem, 2013, 6, 
2220-2225. 
59. D. R. Snead and T. F. Jamison, Chem. Sci., 2013, 4, 2822-2827. 
60. C. A. Hone, N. Holmes, G. R. Akien, R. A. Bourne and F. L. Muller, React. Chem. Eng., 
2017,2, 103-108. 
61. B. Gutmann, P. Elsner, A. O'Kearney-McMullan, W. Goundry, D. M. Roberge and C. O. 
Kappe, Org. Process Res. Dev., 2015, 19, 1062-1067. 
62. H. Kim, K.-I. Min, K. Inoue, D. J. Im, D.-P. Kim and J.-i. Yoshida, Science, 2016, 352, 
691-694. 
63. T. Kawaguchi, H. Miyata, K. Ataka, K. Mae and J.-I. Yoshida, Angew. Chem., Int. Ed., 
2005, 44, 2413-2416. 
64. Z. Amara, J. Bellamy, F. B., R. Horvath, S. J. Miller, A. Beeby, A. Burgard, K. Rossen, M. 
Poliakoff and M. W. George, Nat. Chem., 2015, 7, 489-495. 
65. K. Gilmore, D. Kopetzki, J. W. Lee, Z. Horvath, D. T. McQuade, A. Seidel-Morgenstern 
and P. H. Seeberger, Chem. Commun., 2014, 50, 12652-12655. 
66. D. Kopetzki, F. Lévesque and P. H. Seeberger, Chem. - Eur. J., 2013, 19, 5450-5456. 
67. F. Lévesque and P. H. Seeberger, Angew. Chem. Int. Ed., 2012, 51, 1706-1709. 
68. K. Watts, A. Baker and T. Wirth, J. Flow Chem., 2014, 4, 2-11. 
69. J.-i. Yoshida, Chem. Commun., 2005, 4509-4516. 
70. I. R. Baxendale and M. R. Pitts, Chim. Oggi Chem. Today, 2006, 24, 41. 
71. T. N. Glasnov and C. O. Kappe, Macromol. Rapid Commun., 2007, 28, 395-410. 
 204 
 
72. S. Ceylan, C. Friese, C. Lammel, K. Mazac and A. Kirschning, Angew. Chem. Int. Ed., 
2008, 47, 8950-8953. 
73. A. Kirschning, L. Kupracz and J. Hartwig, Chem. Lett., 2012, 41, 562-570. 
74. R. L. Hartman, J. R. Naber, N. Zaborenko, S. L. Buchwald and K. F. Jensen, Org. Process 
Res. Dev., 2010, 14, 1347-1357. 
75. S. Kuhn, T. Noel, L. Gu, P. L. Heider and K. F. Jensen, Lab Chip, 2011, 11, 2488-2492. 
76. N. P. Tu, J. E. Hochlowski and S. W. Djuric, Molec. Divers., 2012, 16, 53-58. 
77. R. D. Chambers, D. Holling, R. C. H. Spink and G. Sandford, Lab Chip, 2001, 1, 132-137. 
78. R. D. Chambers, M. A. Fox, D. Holling, T. Nakano, T. Okazoe and G. Sandford, Lab Chip, 
2005, 5, 191-198. 
79. J. R. Breen, G. Sandford, D. S. Yufit, J. A. K. Howard, J. Fray and B. Patel, Beilstein 
Journal of Organic Chemistry, 2011, 7, 1048-1054. 
80. P. Poechlauer, S. Braune, B. Dielemans, B. Kaptein, R. Obermueller and M. Thathagar, 
Chim. Oggi Chem. Today, 2012, 30, 4. 
81. M. O'Brien, P. Koos, D. L. Browne and S. V. Ley, Org. Biomol. Chem., 2012, 10, 7031-
7036. 
82. A. Adamo, P. L. Heider, N. Weeranoppanant and K. F. Jensen, Ind. Eng. Chem. Res., 2013, 
52, 10802-10808. 
83. J. J. John, S. Kuhn, L. Braeken and T. Van Gerven, Chem. Eng. Process., 2017, 113, 35-
41. 
84. B. J. Deadman, C. Battilocchio, E. Sliwinski and S. V. Ley, Green Chem., 2013, 15, 2050-
2055. 
85. R. L. Hartman, J. R. Naber, S. L. Buchwald and K. F. Jensen, Angew. Chem. Int. Ed., 2010, 
49, 899-903. 
86. B. Z. Cvetkovic, O. Lade, L. Marra, V. Arima, R. Rinaldi and P. S. Dittrich, RSC Adv., 
2012, 2, 11117-11122. 
87. S. V. Ley, I. R. Baxendale, R. N. Bream, P. S. Jackson, A. G. Leach, D. A. Longbottom, 
M. Nesi, J. S. Scott, R. I. Storer and S. J. Taylor, J. Chem. Soc., Perkin Trans. 1, 2000, 0, 
3815-4195. 
88. B. J. Deadman, D. L. Browne, I. R. Baxendale and S. V. Ley, Chem. Eng. Technol., 2015, 
38, 259-264. 
89. D. Rossi, R. Jamshidi, N. Saffari, S. Kuhn, A. Gavriilidis and L. Mazzei, Cryst. Growth 
Des., 2015, 15, 5519-5529. 
90. H. Zhang, R. Lakerveld, P. L. Heider, M. Tao, M. Su, C. J. Testa, A. N. D’Antonio, P. I. 
Barton, R. D. Braatz, B. L. Trout, A. S. Myerson, K. F. Jensen and J. M. B. Evans, Cryst. 
Growth Des., 2014, 14, 2148-2157. 
91. S. Mascia, P. L. Heider, H. Zhang, R. Lakerveld, B. Benyahia, P. I. Barton, R. D. Braatz, 
C. L. Cooney, J. M. B. Evans, T. F. Jamison, K. F. Jensen, A. S. Myerson and B. L. Trout, 
Angew. Chem. Int. Ed., 2013, 52, 12359-12363. 
92. I. R. Baxendale, C. M. Griffiths-Jones, S. V. Ley and G. K. Tranmer, Synlett, 2006, 2006, 
0427-0430. 
93. A. R. Bogdan, S. L. Poe, D. C. Kubis, S. J. Broadwater and D. T. McQuade, Angew. Chem. 
Int. Ed., 2009, 48, 8547-8550. 
94. D. R. Snead and T. F. Jamison, Angew. Chem., Int. Ed., 2015, 54, 983-987. 
95. R. L. Hartman, Org. Process Res. Dev., 2012, 16, 870-887. 
96. A. Adamo, R. L. Beingessner, M. Behnam, J. Chen, T. F. Jamison, K. F. Jensen, J.-C. M. 
Monbaliu, A. S. Myerson, E. M. Revalor, D. R. Snead, T. Stelzer, N. Weeranoppanant, S. 
Y. Wong and P. Zhang, Science, 2016, 352, 61-67. 
97. J. S. Moore and K. F. Jensen, Org. Process Res. Dev., 2012, 16, 1409-1415. 
98. W. Ferstl, S. Loebbecke, J. Antes, H. Krause, M. Haeberl, D. Schmalz, H. Muntermann, 
M. Grund, A. Steckenborn, A. Lohf, J. Hassel, T. Bayer, M. Kinzl and I. Leipprand, Chem. 
Eng. J. (Amsterdam, Neth.), 2004, 101, 431-438. 
99. W. Ferstl, T. Klahn, W. Schweikert, G. Billeb, M. Schwarzer and S. Loebbecke, Chem. 
Eng. Technol., 2007, 30, 370-378. 
100. R. Herzig-Marx, K. T. Queeney, R. J. Jackman, M. A. Schmidt and K. F. Jensen, Anal. 
Chem., 2004, 76, 6476-6483. 
 205 
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